activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	1476108	CHEMBL830593	Percent inhibition against AMPK at 10 uM using 100 uM ATP	B	CCn1c(-c2nonc2N)nc2cnccc21		CHEMBL189657	=	Inhibition	%	59.0	CHEMBL4045	Homo sapiens	Inhibition	%	59.0
	1476108	CHEMBL830593	Percent inhibition against AMPK at 10 uM using 100 uM ATP	B	CCn1c(-c2nonc2N)nc2cnccc21		CHEMBL189657	=	Inhibition	%	59.0	CHEMBL4045	Homo sapiens	Inhibition	%	59.0
Not Active	1650189	CHEMBL860896	Average Binding Constant for PRKAA1; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL4045	Homo sapiens	Kd		
Not Active	1650190	CHEMBL860896	Average Binding Constant for PRKAA1; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707		Kd			CHEMBL4045	Homo sapiens	Kd		
Not Active	1650191	CHEMBL860896	Average Binding Constant for PRKAA1; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL4045	Homo sapiens	Kd		
	1650192	CHEMBL860896	Average Binding Constant for PRKAA1; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	52.0	CHEMBL4045	Homo sapiens	Kd	uM	0.052
Not Active	1650193	CHEMBL860896	Average Binding Constant for PRKAA1; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL4045	Homo sapiens	Kd		
Not Active	1650194	CHEMBL860896	Average Binding Constant for PRKAA1; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829		Kd			CHEMBL4045	Homo sapiens	Kd		
Not Active	1650195	CHEMBL860896	Average Binding Constant for PRKAA1; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		Kd			CHEMBL4045	Homo sapiens	Kd		
Not Active	1650196	CHEMBL860896	Average Binding Constant for PRKAA1; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL4045	Homo sapiens	Kd		
	1650197	CHEMBL860896	Average Binding Constant for PRKAA1; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	6600.0	CHEMBL4045	Homo sapiens	Kd	uM	6.6
	1651533	CHEMBL860896	Average Binding Constant for PRKAA1; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	9.0	CHEMBL4045	Homo sapiens	Kd	uM	0.009
Not Active	1651534	CHEMBL860896	Average Binding Constant for PRKAA1; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL4045	Homo sapiens	Kd		
Not Active	1651535	CHEMBL860896	Average Binding Constant for PRKAA1; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL4045	Homo sapiens	Kd		
Not Active	1651536	CHEMBL860896	Average Binding Constant for PRKAA1; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Kd			CHEMBL4045	Homo sapiens	Kd		
Not Active	1651537	CHEMBL860896	Average Binding Constant for PRKAA1; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667		Kd			CHEMBL4045	Homo sapiens	Kd		
Not Active	1651538	CHEMBL860896	Average Binding Constant for PRKAA1; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279		Kd			CHEMBL4045	Homo sapiens	Kd		
Not Active	1651539	CHEMBL860896	Average Binding Constant for PRKAA1; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL4045	Homo sapiens	Kd		
Not Active	1651540	CHEMBL860896	Average Binding Constant for PRKAA1; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL4045	Homo sapiens	Kd		
Not Active	1651541	CHEMBL860896	Average Binding Constant for PRKAA1; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL4045	Homo sapiens	Kd		
	1651542	CHEMBL860896	Average Binding Constant for PRKAA1; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	uM	10.0
Not Active	1651543	CHEMBL860896	Average Binding Constant for PRKAA1; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965		Kd			CHEMBL4045	Homo sapiens	Kd		
Not Evaluated	2149613	CHEMBL931310	Inhibition of human AMPKalpha1	B	NC(=O)c1c(NC(=O)C2CC2)sc2c1CCCC2		CHEMBL379367		Activity			CHEMBL4045	Homo sapiens	Activity		
	2206861	CHEMBL990536	Inhibition of PRKAA1	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	52.0	CHEMBL4045	Homo sapiens	Kd	nM	52.0
	2251029	CHEMBL1011053	Inhibition of AMPKalpha1 at 100 nM relative to control	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL525385	=	Inhibition	%	51.0	CHEMBL4045	Homo sapiens	INH	%	51.0
	2396061	CHEMBL1006300	Inhibition of AMPK alpha-1/beta-1/gamma-1 at 1 uM relative to control	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)Nc2cccc(NC(C)=O)c2)cc1		CHEMBL515560	=	Inhibition	%	31.0	CHEMBL4045	Homo sapiens	INH	%	31.0
	2470107	CHEMBL1032250	Inhibition of AMPKalpha1 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL4045	Homo sapiens	INH	%	10.0
Not Evaluated	2476721	CHEMBL982749	Binding affinity to human AMPKA1 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL4045	Homo sapiens	Activity		
	2477875	CHEMBL988908	Binding affinity to human AMPKA1	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Kd	nM	19.0	CHEMBL4045	Homo sapiens	Kd	nM	19.0
Not Evaluated	2478560	CHEMBL982749	Binding affinity to human AMPKA1 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL4045	Homo sapiens	Activity		
	2478763	CHEMBL982749	Binding affinity to human AMPKA1 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755	=	Activity	%	24.0	CHEMBL4045	Homo sapiens	Activity	%	24.0
Not Evaluated	2479618	CHEMBL982749	Binding affinity to human AMPKA1 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL4045	Homo sapiens	Activity		
	2479821	CHEMBL982749	Binding affinity to human AMPKA1 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	27.8	CHEMBL4045	Homo sapiens	Activity	%	27.8
Active	2480618	CHEMBL982749	Binding affinity to human AMPKA1 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL4045	Homo sapiens	Activity		
	2480820	CHEMBL982749	Binding affinity to human AMPKA1 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	16.0	CHEMBL4045	Homo sapiens	Activity	%	16.0
	2512033	CHEMBL970562	Inhibition of AMPK A1/B1/G1 at 1 uM	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	=	Inhibition	%	20.0	CHEMBL4045	Homo sapiens	INH	%	20.0
Not Evaluated	2577239	CHEMBL982749	Binding affinity to human AMPKA1 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL4045	Homo sapiens	Activity		
	2577442	CHEMBL982749	Binding affinity to human AMPKA1 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337	=	Activity	%	33.3	CHEMBL4045	Homo sapiens	Activity	%	33.3
Not Evaluated	2593647	CHEMBL982749	Binding affinity to human AMPKA1 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL4045	Homo sapiens	Activity		
	2593913	CHEMBL982749	Binding affinity to human AMPKA1 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519	=	Activity	%	25.6	CHEMBL4045	Homo sapiens	Activity	%	25.6
Not Evaluated	2594116	CHEMBL982749	Binding affinity to human AMPKA1 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL4045	Homo sapiens	Activity		
Not Evaluated	2594856	CHEMBL982749	Binding affinity to human AMPKA1 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL4045	Homo sapiens	Activity		
Not Evaluated	2595059	CHEMBL982749	Binding affinity to human AMPKA1 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL4045	Homo sapiens	Activity		
Not Evaluated	2596256	CHEMBL982749	Binding affinity to human AMPKA1 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL4045	Homo sapiens	Activity		
Not Evaluated	2596459	CHEMBL982749	Binding affinity to human AMPKA1 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL4045	Homo sapiens	Activity		
Not Evaluated	2597728	CHEMBL982749	Binding affinity to human AMPKA1 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL4045	Homo sapiens	Activity		
	2626897	CHEMBL999781	Binding affinity to human AMPKalpha1 at 5 uM	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Nc3ncnc4ccc(N)cc34)cc2)c1		CHEMBL497033	=	Activity	%	100.0	CHEMBL4045	Homo sapiens	Activity	%	100.0
	2626924	CHEMBL999781	Binding affinity to human AMPKalpha1 at 5 uM	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Nc3ncnc4ccc(N)cc34)c2)c1		CHEMBL497615	=	Activity	%	75.0	CHEMBL4045	Homo sapiens	Activity	%	75.0
	2897424	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	uM	10.0
	2897425	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	uM	10.0
	2897426	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	1400.0	CHEMBL4045	Homo sapiens	Kd	nM	1400.0
	2897427	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	uM	10.0
	2897428	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	uM	10.0
	2897429	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	uM	10.0
	2897430	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	520.0	CHEMBL4045	Homo sapiens	Kd	nM	520.0
	2897431	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	4500.0	CHEMBL4045	Homo sapiens	Kd	nM	4500.0
	2897432	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	uM	10.0
	2897433	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	uM	10.0
	2897434	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	uM	10.0
	2897435	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	uM	10.0
	2897436	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	uM	10.0
	2897437	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	uM	10.0
	2897438	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	uM	10.0
	2897439	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	uM	10.0
	2897440	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	uM	10.0
	2897441	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	uM	10.0
	2897442	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	uM	10.0
	2897443	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	1700.0	CHEMBL4045	Homo sapiens	Kd	nM	1700.0
	2897444	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	uM	10.0
	2897445	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	uM	10.0
	2897446	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	uM	10.0
	2897447	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	uM	10.0
	2897448	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	uM	10.0
	2897449	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	180.0	CHEMBL4045	Homo sapiens	Kd	nM	180.0
	2897450	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	uM	10.0
	2897451	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	uM	10.0
	2897452	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	uM	10.0
	2897453	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	uM	10.0
	2897454	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	uM	10.0
	2897455	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	uM	10.0
	2897456	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	3.7	CHEMBL4045	Homo sapiens	Kd	nM	3.7
	2897457	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	100.0	CHEMBL4045	Homo sapiens	Kd	nM	100.0
	2897458	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	19.0	CHEMBL4045	Homo sapiens	Kd	nM	19.0
	2897459	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	1100.0	CHEMBL4045	Homo sapiens	Kd	nM	1100.0
	2897460	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	uM	10.0
	2897461	CHEMBL1060175	Binding constant for AMPK-alpha1 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	uM	10.0
	2921440	CHEMBL1057571	Inhibition of AMPKalpha1 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	89.0	CHEMBL4045	Homo sapiens	Activity	%	89.0
	2992246	CHEMBL1047122	Inhibition of human AMPK subunitA1 at 20 uM by FRET assay	B	C#Cn1c(C#CCCO)nc(-c2ccc(F)cc2)c1-c1ccncc1	Outside typical range	CHEMBL576620	=	Inhibition	%	-11.0	CHEMBL4045	Homo sapiens	INH	%	-11.0
	3052527	CHEMBL1047778	Residual activity of AMPK-alpha1 fl at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	77.0	CHEMBL4045	Homo sapiens	Residual activity	%	77.0
	3052779	CHEMBL1046512	Residual activity of AMPK-alpha1 fl at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	57.0	CHEMBL4045	Homo sapiens	Residual activity	%	57.0
	3054088	CHEMBL1066606	Residual activity of AMPK-alpha1 fl at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	94.0	CHEMBL4045	Homo sapiens	Residual activity	%	94.0
	3055375	CHEMBL1047778	Residual activity of AMPK-alpha1 fl at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	76.0	CHEMBL4045	Homo sapiens	Residual activity	%	76.0
	3055627	CHEMBL1046512	Residual activity of AMPK-alpha1 fl at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	61.0	CHEMBL4045	Homo sapiens	Residual activity	%	61.0
	3056932	CHEMBL1066606	Residual activity of AMPK-alpha1 fl at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	101.0	CHEMBL4045	Homo sapiens	Residual activity	%	101.0
	3058252	CHEMBL1047778	Residual activity of AMPK-alpha1 fl at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	91.0	CHEMBL4045	Homo sapiens	Residual activity	%	91.0
	3058504	CHEMBL1046512	Residual activity of AMPK-alpha1 fl at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	73.0	CHEMBL4045	Homo sapiens	Residual activity	%	73.0
	3072850	CHEMBL1066606	Residual activity of AMPK-alpha1 fl at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	86.0	CHEMBL4045	Homo sapiens	Residual activity	%	86.0
	3331826	CHEMBL1168785	Inhibition of AMPK-alpha1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL4045	Homo sapiens	INH	%	50.0
	3333241	CHEMBL1168785	Inhibition of AMPK-alpha1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL4045	Homo sapiens	INH	%	50.0
	3334646	CHEMBL1168785	Inhibition of AMPK-alpha1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL4045	Homo sapiens	INH	%	50.0
	3336066	CHEMBL1168785	Inhibition of AMPK-alpha1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL4045	Homo sapiens	INH	%	50.0
	3337452	CHEMBL1168785	Inhibition of AMPK-alpha1 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL4045	Homo sapiens	INH	%	50.0
	3337700	CHEMBL1168785	Inhibition of AMPK-alpha1 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL4045	Homo sapiens	INH	%	50.0
	3339031	CHEMBL1168785	Inhibition of AMPK-alpha1 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL4045	Homo sapiens	INH	%	50.0
	3339287	CHEMBL1168785	Inhibition of AMPK-alpha1 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL4045	Homo sapiens	INH	%	50.0
	3340594	CHEMBL1168785	Inhibition of AMPK-alpha1 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	=	Inhibition	%	66.0	CHEMBL4045	Homo sapiens	INH	%	66.0
	3342010	CHEMBL1168785	Inhibition of AMPK-alpha1 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL4045	Homo sapiens	INH	%	50.0
	3358453	CHEMBL1174067	Inhibition of AMPK-alpha1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	1.2	CHEMBL4045	Homo sapiens	INH	%	1.2
	3358895	CHEMBL1174067	Inhibition of AMPK-alpha1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.8	CHEMBL4045	Homo sapiens	INH	%	0.8
	3445027	CHEMBL1244723	Binding affinity to AMPK-alpha1	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	25.0	CHEMBL4045	Homo sapiens	Kd	nM	25.0
	3446212	CHEMBL1244352	Inhibition of PRKAA1 at 10	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Inhibition	%	60.0	CHEMBL4045	Homo sapiens	INH	%	60.0
	3448879	CHEMBL1244723	Binding affinity to AMPK-alpha1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	180.0	CHEMBL4045	Homo sapiens	Kd	nM	180.0
	3449099	CHEMBL1244723	Binding affinity to AMPK-alpha1	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	19.0	CHEMBL4045	Homo sapiens	Kd	nM	19.0
	3449559	CHEMBL1244723	Binding affinity to AMPK-alpha1	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	uM	10.0
	3449984	CHEMBL1244723	Binding affinity to AMPK-alpha1	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	uM	10.0
	3450913	CHEMBL1244723	Binding affinity to AMPK-alpha1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	uM	10.0
	3451203	CHEMBL1244723	Binding affinity to AMPK-alpha1	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	uM	10.0
Not Active	3499115	CHEMBL1259859	Inhibition of AMPKA1 at 10 uM relative to control	B	CCNC(=O)NCc1ccccc1-c1cc(-c2cnc(NC(C)C)s2)nc(NCCN(C)C)n1		CHEMBL1230171		Inhibition	%		CHEMBL4045	Homo sapiens	INH		
	5123785	CHEMBL1649025	Inhibition of AMPK-alpha1 at 1 uM	B	CCN1C(=O)CCC(C)(C)c2ccc(Nc3ncc(Cl)c(Nc4c(F)cccc4C(=O)NC)n3)cc21		CHEMBL1644812	=	Inhibition	%	96.0	CHEMBL4045	Homo sapiens	INH	%	96.0
	6173412	CHEMBL1768216	Inhibition of AMPK A1 at 25 uM by TR-FRET assay	B	NC(=O)c1ccsc1NC(=O)Cc1csc2ccccc12		CHEMBL1767254	=	Inhibition	%	0.0	CHEMBL4045	Homo sapiens	INH	%	0.0
	6341018	CHEMBL1827643	Activity of AMPK-alpha1 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL4045	Homo sapiens	Activity	%	100.0
	7567167	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7567626	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7568097	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7568565	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	310.0	CHEMBL4045	Homo sapiens	Kd	nM	310.0
	7568997	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	19.0	CHEMBL4045	Homo sapiens	Kd	nM	19.0
	7569140	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7569600	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	2400.0	CHEMBL4045	Homo sapiens	Kd	nM	2400.0
	7570072	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7571116	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7571573	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7572049	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	200.0	CHEMBL4045	Homo sapiens	Kd	nM	200.0
	7572070	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7572486	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	27.0	CHEMBL4045	Homo sapiens	Kd	nM	27.0
	7573097	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	87.0	CHEMBL4045	Homo sapiens	Kd	nM	87.0
	7573554	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7574057	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	180.0	CHEMBL4045	Homo sapiens	Kd	nM	180.0
	7574465	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7575075	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7575565	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7576030	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7576438	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	2400.0	CHEMBL4045	Homo sapiens	Kd	nM	2400.0
	7577049	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7577066	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	730.0	CHEMBL4045	Homo sapiens	Kd	nM	730.0
	7577544	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	430.0	CHEMBL4045	Homo sapiens	Kd	nM	430.0
	7578014	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7578419	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	3000.0	CHEMBL4045	Homo sapiens	Kd	nM	3000.0
	7578615	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7579439	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7579913	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7580382	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7580785	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	1100.0	CHEMBL4045	Homo sapiens	Kd	nM	1100.0
	7580973	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7581358	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7581803	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7582274	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7582738	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	300.0	CHEMBL4045	Homo sapiens	Kd	nM	300.0
	7583138	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7583319	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7583716	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	8200.0	CHEMBL4045	Homo sapiens	Kd	nM	8200.0
	7584161	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7584632	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7585094	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7585649	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7586057	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7586503	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7586974	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7587610	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7588029	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	25.0	CHEMBL4045	Homo sapiens	Kd	nM	25.0
	7588482	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7588962	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7589575	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7589999	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	520.0	CHEMBL4045	Homo sapiens	Kd	nM	520.0
	7590466	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7590498	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7590949	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7591548	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	1400.0	CHEMBL4045	Homo sapiens	Kd	nM	1400.0
	7591970	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	4500.0	CHEMBL4045	Homo sapiens	Kd	nM	4500.0
	7592473	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7592926	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	3900.0	CHEMBL4045	Homo sapiens	Kd	nM	3900.0
	7593515	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7593980	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7594453	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7594905	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7595485	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7595959	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7596430	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7596877	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	3.7	CHEMBL4045	Homo sapiens	Kd	nM	3.7
	7597013	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7597466	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7597939	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7598409	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL4045	Homo sapiens	Kd	nM	10000.0
	7598851	CHEMBL1908470	Binding constant for AMPK-alpha1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	100.0	CHEMBL4045	Homo sapiens	Kd	nM	100.0
	7996673	CHEMBL1944004	Inhibition of AMPK-alpha1 at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939491	=	Inhibition	%	97.0	CHEMBL4045	Homo sapiens	INH	%	97.0
Active	8012299	CHEMBL1941712	Inhibition of AMPKalpha1 at 10 uM by colorimetric analysis	B	Clc1ccc(-n2cc(-c3ccncc3)nn2)cc1		CHEMBL1938953		Inhibition	%		CHEMBL4045	Homo sapiens	INH		
Active	8012300	CHEMBL1941712	Inhibition of AMPKalpha1 at 10 uM by colorimetric analysis	B	Clc1cccc(-n2cc(-c3ccncc3)nn2)c1		CHEMBL1938954		Inhibition	%		CHEMBL4045	Homo sapiens	INH		
Active	8012301	CHEMBL1941712	Inhibition of AMPKalpha1 at 10 uM by colorimetric analysis	B	Clc1ccc(-n2nncc2-c2ccncc2)cc1		CHEMBL62965		Inhibition	%		CHEMBL4045	Homo sapiens	INH		
Active	8012302	CHEMBL1941712	Inhibition of AMPKalpha1 at 10 uM by colorimetric analysis	B	Clc1cccc(-n2nncc2-c2ccncc2)c1		CHEMBL303351		Inhibition	%		CHEMBL4045	Homo sapiens	INH		
	8047077	CHEMBL1958812	Inhibition of AMPK-alpha1 at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL4045	Homo sapiens	INH	%	50.0
	8061252	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	0.17	CHEMBL4045	Homo sapiens	Inhibition	%	0.17
	8061429	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-0.19	CHEMBL4045	Homo sapiens	Inhibition	%	-0.19
	8061760	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	3.64	CHEMBL4045	Homo sapiens	Inhibition	%	3.64
	8061951	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	5.84	CHEMBL4045	Homo sapiens	Inhibition	%	5.84
	8062175	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	14.81	CHEMBL4045	Homo sapiens	Inhibition	%	14.81
	8062291	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	3.36	CHEMBL4045	Homo sapiens	Inhibition	%	3.36
	8062677	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	5.93	CHEMBL4045	Homo sapiens	Inhibition	%	5.93
	8062775	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.79	CHEMBL4045	Homo sapiens	Inhibition	%	0.79
	8062999	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.21	CHEMBL4045	Homo sapiens	Inhibition	%	1.21
	8063131	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	-1.38	CHEMBL4045	Homo sapiens	Inhibition	%	-1.38
	8063298	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	2.31	CHEMBL4045	Homo sapiens	Inhibition	%	2.31
	8063522	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	2.56	CHEMBL4045	Homo sapiens	Inhibition	%	2.56
	8063630	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	2.69	CHEMBL4045	Homo sapiens	Inhibition	%	2.69
	8064036	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	1.41	CHEMBL4045	Homo sapiens	Inhibition	%	1.41
	8064151	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	3.2	CHEMBL4045	Homo sapiens	Inhibition	%	3.2
	8064375	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	1.59	CHEMBL4045	Homo sapiens	Inhibition	%	1.59
	8064585	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-0.92	CHEMBL4045	Homo sapiens	Inhibition	%	-0.92
	8064723	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	0.83	CHEMBL4045	Homo sapiens	Inhibition	%	0.83
	8065113	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.15	CHEMBL4045	Homo sapiens	Inhibition	%	1.15
	8065229	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	2.55	CHEMBL4045	Homo sapiens	Inhibition	%	2.55
	8065453	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	2.86	CHEMBL4045	Homo sapiens	Inhibition	%	2.86
	8065628	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	0.35	CHEMBL4045	Homo sapiens	Inhibition	%	0.35
	8065967	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	2.17	CHEMBL4045	Homo sapiens	Inhibition	%	2.17
	8066177	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	1.0	CHEMBL4045	Homo sapiens	Inhibition	%	1.0
	8066313	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	5.29	CHEMBL4045	Homo sapiens	Inhibition	%	5.29
	8066537	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	3.39	CHEMBL4045	Homo sapiens	Inhibition	%	3.39
	8066703	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	2.02	CHEMBL4045	Homo sapiens	Inhibition	%	2.02
	8067051	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	2.58	CHEMBL4045	Homo sapiens	Inhibition	%	2.58
	8067226	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	1.79	CHEMBL4045	Homo sapiens	Inhibition	%	1.79
	8067571	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.13	CHEMBL4045	Homo sapiens	Inhibition	%	1.13
	8067781	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-1.23	CHEMBL4045	Homo sapiens	Inhibition	%	-1.23
	8068140	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	16.72	CHEMBL4045	Homo sapiens	Inhibition	%	16.72
	8068304	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	1.1	CHEMBL4045	Homo sapiens	Inhibition	%	1.1
	8068653	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.88	CHEMBL4045	Homo sapiens	Inhibition	%	1.88
	8068827	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	1.58	CHEMBL4045	Homo sapiens	Inhibition	%	1.58
	8069051	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	3.11	CHEMBL4045	Homo sapiens	Inhibition	%	3.11
	8069176	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	-0.08	CHEMBL4045	Homo sapiens	Inhibition	%	-0.08
	8069471	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	5.26	CHEMBL4045	Homo sapiens	Inhibition	%	5.26
	8069632	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	1.53	CHEMBL4045	Homo sapiens	Inhibition	%	1.53
	8069856	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.67	CHEMBL4045	Homo sapiens	Inhibition	%	1.67
	8069982	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.54	CHEMBL4045	Homo sapiens	Inhibition	%	1.54
	8070378	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	1.29	CHEMBL4045	Homo sapiens	Inhibition	%	1.29
	8070503	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-0.34	CHEMBL4045	Homo sapiens	Inhibition	%	-0.34
	8070801	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	26.86	CHEMBL4045	Homo sapiens	Inhibition	%	26.86
	8071182	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	4.05	CHEMBL4045	Homo sapiens	Inhibition	%	4.05
	8071308	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	1.82	CHEMBL4045	Homo sapiens	Inhibition	%	1.82
	8071532	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.12	CHEMBL4045	Homo sapiens	Inhibition	%	0.12
	8071705	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	3.65	CHEMBL4045	Homo sapiens	Inhibition	%	3.65
	8071830	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-1.2	CHEMBL4045	Homo sapiens	Inhibition	%	-1.2
	8072054	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-0.71	CHEMBL4045	Homo sapiens	Inhibition	%	-0.71
	8072144	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	1.64	CHEMBL4045	Homo sapiens	Inhibition	%	1.64
	8072368	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.51	CHEMBL4045	Homo sapiens	Inhibition	%	0.51
	8072525	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	2.62	CHEMBL4045	Homo sapiens	Inhibition	%	2.62
	8072874	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-0.68	CHEMBL4045	Homo sapiens	Inhibition	%	-0.68
	8073041	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	3.4	CHEMBL4045	Homo sapiens	Inhibition	%	3.4
	8073390	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	0.03	CHEMBL4045	Homo sapiens	Inhibition	%	0.03
	8073509	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	1.77	CHEMBL4045	Homo sapiens	Inhibition	%	1.77
	8073733	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	6.53	CHEMBL4045	Homo sapiens	Inhibition	%	6.53
	8073966	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	2.98	CHEMBL4045	Homo sapiens	Inhibition	%	2.98
	8074118	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	2.79	CHEMBL4045	Homo sapiens	Inhibition	%	2.79
	8074472	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-0.02	CHEMBL4045	Homo sapiens	Inhibition	%	-0.02
	8074629	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	2.61	CHEMBL4045	Homo sapiens	Inhibition	%	2.61
	8074853	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	1.44	CHEMBL4045	Homo sapiens	Inhibition	%	1.44
	8074980	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.27	CHEMBL4045	Homo sapiens	Inhibition	%	0.27
	8075315	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.37	CHEMBL4045	Homo sapiens	Inhibition	%	0.37
	8075552	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	3.34	CHEMBL4045	Homo sapiens	Inhibition	%	3.34
	8075693	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	3.69	CHEMBL4045	Homo sapiens	Inhibition	%	3.69
	8075917	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	3.89	CHEMBL4045	Homo sapiens	Inhibition	%	3.89
	8076059	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.57	CHEMBL4045	Homo sapiens	Inhibition	%	-0.57
	8076431	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	2.79	CHEMBL4045	Homo sapiens	Inhibition	%	2.79
	8076565	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.86	CHEMBL4045	Homo sapiens	Inhibition	%	0.86
	8076891	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-1.12	CHEMBL4045	Homo sapiens	Inhibition	%	-1.12
	8077138	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	79.25	CHEMBL4045	Homo sapiens	Inhibition	%	79.25
	8077490	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	2.8	CHEMBL4045	Homo sapiens	Inhibition	%	2.8
	8077641	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	3.14	CHEMBL4045	Homo sapiens	Inhibition	%	3.14
	8078008	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	4.42	CHEMBL4045	Homo sapiens	Inhibition	%	4.42
	8078147	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	0.53	CHEMBL4045	Homo sapiens	Inhibition	%	0.53
	8078371	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	15.18	CHEMBL4045	Homo sapiens	Inhibition	%	15.18
	8078473	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-0.26	CHEMBL4045	Homo sapiens	Inhibition	%	-0.26
	8078723	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	88.09	CHEMBL4045	Homo sapiens	Inhibition	%	88.09
	8079063	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	2.03	CHEMBL4045	Homo sapiens	Inhibition	%	2.03
	8079221	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	0.18	CHEMBL4045	Homo sapiens	Inhibition	%	0.18
	8079445	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	5.73	CHEMBL4045	Homo sapiens	Inhibition	%	5.73
	8079587	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.77	CHEMBL4045	Homo sapiens	Inhibition	%	0.77
	8079950	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	5.5	CHEMBL4045	Homo sapiens	Inhibition	%	5.5
	8080055	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-1.59	CHEMBL4045	Homo sapiens	Inhibition	%	-1.59
	8080307	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	23.4	CHEMBL4045	Homo sapiens	Inhibition	%	23.4
	8080531	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	72.26	CHEMBL4045	Homo sapiens	Inhibition	%	72.26
	8080646	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	2.15	CHEMBL4045	Homo sapiens	Inhibition	%	2.15
	8081034	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-1.82	CHEMBL4045	Homo sapiens	Inhibition	%	-1.82
	8081169	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	-0.08	CHEMBL4045	Homo sapiens	Inhibition	%	-0.08
	8081537	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	26.87	CHEMBL4045	Homo sapiens	Inhibition	%	26.87
	8081640	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.08	CHEMBL4045	Homo sapiens	Inhibition	%	1.08
	8081864	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	8.5	CHEMBL4045	Homo sapiens	Inhibition	%	8.5
	8082116	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	0.66	CHEMBL4045	Homo sapiens	Inhibition	%	0.66
	8082229	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.44	CHEMBL4045	Homo sapiens	Inhibition	%	1.44
	8082453	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	2.2	CHEMBL4045	Homo sapiens	Inhibition	%	2.2
	8082626	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.26	CHEMBL4045	Homo sapiens	Inhibition	%	0.26
	8082749	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.41	CHEMBL4045	Homo sapiens	Inhibition	%	1.41
	8082973	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.46	CHEMBL4045	Homo sapiens	Inhibition	%	1.46
	8083129	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	18.01	CHEMBL4045	Homo sapiens	Inhibition	%	18.01
	8083452	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.97	CHEMBL4045	Homo sapiens	Inhibition	%	1.97
	8083706	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	5.36	CHEMBL4045	Homo sapiens	Inhibition	%	5.36
	8084040	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	7.91	CHEMBL4045	Homo sapiens	Inhibition	%	7.91
	8084225	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	54.75	CHEMBL4045	Homo sapiens	Inhibition	%	54.75
	8084567	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.65	CHEMBL4045	Homo sapiens	Inhibition	%	2.65
	8084728	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	64.4	CHEMBL4045	Homo sapiens	Inhibition	%	64.4
	8085050	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.56	CHEMBL4045	Homo sapiens	Inhibition	%	1.56
	8085306	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-1.23	CHEMBL4045	Homo sapiens	Inhibition	%	-1.23
	8085638	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	2.05	CHEMBL4045	Homo sapiens	Inhibition	%	2.05
	8085827	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	82.68	CHEMBL4045	Homo sapiens	Inhibition	%	82.68
	8086166	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	3.27	CHEMBL4045	Homo sapiens	Inhibition	%	3.27
	8086328	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	5.11	CHEMBL4045	Homo sapiens	Inhibition	%	5.11
	8086552	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	18.7	CHEMBL4045	Homo sapiens	Inhibition	%	18.7
	8086651	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	2.35	CHEMBL4045	Homo sapiens	Inhibition	%	2.35
	8086862	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	2.85	CHEMBL4045	Homo sapiens	Inhibition	%	2.85
	8087086	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	3.59	CHEMBL4045	Homo sapiens	Inhibition	%	3.59
	8087244	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	1.31	CHEMBL4045	Homo sapiens	Inhibition	%	1.31
	8087582	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	1.74	CHEMBL4045	Homo sapiens	Inhibition	%	1.74
	8087720	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.0	CHEMBL4045	Homo sapiens	Inhibition	%	3.0
	8087944	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	2.1	CHEMBL4045	Homo sapiens	Inhibition	%	2.1
	8088086	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	4.88	CHEMBL4045	Homo sapiens	Inhibition	%	4.88
	8088234	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.7	CHEMBL4045	Homo sapiens	Inhibition	%	0.7
	8088458	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.42	CHEMBL4045	Homo sapiens	Inhibition	%	1.42
	8088586	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	3.57	CHEMBL4045	Homo sapiens	Inhibition	%	3.57
	8088903	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	1.63	CHEMBL4045	Homo sapiens	Inhibition	%	1.63
	8089255	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	8.12	CHEMBL4045	Homo sapiens	Inhibition	%	8.12
	8089403	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	13.91	CHEMBL4045	Homo sapiens	Inhibition	%	13.91
	8089747	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.54	CHEMBL4045	Homo sapiens	Inhibition	%	1.54
	8089927	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.36	CHEMBL4045	Homo sapiens	Inhibition	%	-0.36
	8090316	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	3.93	CHEMBL4045	Homo sapiens	Inhibition	%	3.93
	8090483	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.89	CHEMBL4045	Homo sapiens	Inhibition	%	2.89
	8090846	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	0.3	CHEMBL4045	Homo sapiens	Inhibition	%	0.3
	8091051	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.94	CHEMBL4045	Homo sapiens	Inhibition	%	2.94
	8091412	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	4.78	CHEMBL4045	Homo sapiens	Inhibition	%	4.78
	8091567	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	2.54	CHEMBL4045	Homo sapiens	Inhibition	%	2.54
	8091907	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	3.31	CHEMBL4045	Homo sapiens	Inhibition	%	3.31
	8092268	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	0.47	CHEMBL4045	Homo sapiens	Inhibition	%	0.47
	8092419	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	2.39	CHEMBL4045	Homo sapiens	Inhibition	%	2.39
	8092791	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	0.51	CHEMBL4045	Homo sapiens	Inhibition	%	0.51
	8092920	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	10.62	CHEMBL4045	Homo sapiens	Inhibition	%	10.62
	8093144	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	2.16	CHEMBL4045	Homo sapiens	Inhibition	%	2.16
	8093232	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	2.58	CHEMBL4045	Homo sapiens	Inhibition	%	2.58
	8093596	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	26.62	CHEMBL4045	Homo sapiens	Inhibition	%	26.62
	8093735	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	56.57	CHEMBL4045	Homo sapiens	Inhibition	%	56.57
	8093959	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	1.04	CHEMBL4045	Homo sapiens	Inhibition	%	1.04
	8094079	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	0.82	CHEMBL4045	Homo sapiens	Inhibition	%	0.82
	8094259	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.43	CHEMBL4045	Homo sapiens	Inhibition	%	0.43
	8094483	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.33	CHEMBL4045	Homo sapiens	Inhibition	%	1.33
	8094658	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	6.33	CHEMBL4045	Homo sapiens	Inhibition	%	6.33
	8094814	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	6.04	CHEMBL4045	Homo sapiens	Inhibition	%	6.04
	8095038	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	2.75	CHEMBL4045	Homo sapiens	Inhibition	%	2.75
	8095178	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	1.3	CHEMBL4045	Homo sapiens	Inhibition	%	1.3
	8095381	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	3.44	CHEMBL4045	Homo sapiens	Inhibition	%	3.44
	8095605	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.78	CHEMBL4045	Homo sapiens	Inhibition	%	0.78
	8095746	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	29.49	CHEMBL4045	Homo sapiens	Inhibition	%	29.49
	8095894	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	1.38	CHEMBL4045	Homo sapiens	Inhibition	%	1.38
	8096118	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	3.13	CHEMBL4045	Homo sapiens	Inhibition	%	3.13
	8096235	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	3.44	CHEMBL4045	Homo sapiens	Inhibition	%	3.44
	8096598	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.09	CHEMBL4045	Homo sapiens	Inhibition	%	0.09
	8096754	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	3.88	CHEMBL4045	Homo sapiens	Inhibition	%	3.88
	8096978	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	2.82	CHEMBL4045	Homo sapiens	Inhibition	%	2.82
	8097125	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	0.48	CHEMBL4045	Homo sapiens	Inhibition	%	0.48
	8097432	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	1.3	CHEMBL4045	Homo sapiens	Inhibition	%	1.3
	8097656	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	1.39	CHEMBL4045	Homo sapiens	Inhibition	%	1.39
	8097806	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	66.88	CHEMBL4045	Homo sapiens	Inhibition	%	66.88
	8098163	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	4.37	CHEMBL4045	Homo sapiens	Inhibition	%	4.37
	8098283	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.92	CHEMBL4045	Homo sapiens	Inhibition	%	0.92
	8098687	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.67	CHEMBL4045	Homo sapiens	Inhibition	%	0.67
	8098872	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	33.53	CHEMBL4045	Homo sapiens	Inhibition	%	33.53
	8099240	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	2.96	CHEMBL4045	Homo sapiens	Inhibition	%	2.96
	8099382	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	1.8	CHEMBL4045	Homo sapiens	Inhibition	%	1.8
	8099800	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.77	CHEMBL4045	Homo sapiens	Inhibition	%	0.77
	8099947	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	1.9	CHEMBL4045	Homo sapiens	Inhibition	%	1.9
	8100317	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	3.38	CHEMBL4045	Homo sapiens	Inhibition	%	3.38
	8100433	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	4.51	CHEMBL4045	Homo sapiens	Inhibition	%	4.51
	8100657	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	2.27	CHEMBL4045	Homo sapiens	Inhibition	%	2.27
	8100797	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.19	CHEMBL4045	Homo sapiens	Inhibition	%	1.19
	8101181	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	5.78	CHEMBL4045	Homo sapiens	Inhibition	%	5.78
	8101323	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	0.26	CHEMBL4045	Homo sapiens	Inhibition	%	0.26
	8101732	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	2.45	CHEMBL4045	Homo sapiens	Inhibition	%	2.45
	8101985	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	6.84	CHEMBL4045	Homo sapiens	Inhibition	%	6.84
	8102140	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	3.35	CHEMBL4045	Homo sapiens	Inhibition	%	3.35
	8102495	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	1.56	CHEMBL4045	Homo sapiens	Inhibition	%	1.56
	8102615	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	2.35	CHEMBL4045	Homo sapiens	Inhibition	%	2.35
	8102839	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.13	CHEMBL4045	Homo sapiens	Inhibition	%	1.13
	8103017	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	2.29	CHEMBL4045	Homo sapiens	Inhibition	%	2.29
	8103213	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	17.7	CHEMBL4045	Homo sapiens	Inhibition	%	17.7
	8103575	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	-0.48	CHEMBL4045	Homo sapiens	Inhibition	%	-0.48
	8103725	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	2.83	CHEMBL4045	Homo sapiens	Inhibition	%	2.83
	8103949	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	3.22	CHEMBL4045	Homo sapiens	Inhibition	%	3.22
	8104134	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.94	CHEMBL4045	Homo sapiens	Inhibition	%	0.94
	8104282	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	6.98	CHEMBL4045	Homo sapiens	Inhibition	%	6.98
	8104506	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	6.05	CHEMBL4045	Homo sapiens	Inhibition	%	6.05
	8104652	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	15.86	CHEMBL4045	Homo sapiens	Inhibition	%	15.86
	8104990	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	3.89	CHEMBL4045	Homo sapiens	Inhibition	%	3.89
	8105130	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	10.03	CHEMBL4045	Homo sapiens	Inhibition	%	10.03
	8105520	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	5.35	CHEMBL4045	Homo sapiens	Inhibition	%	5.35
	8105658	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	9.16	CHEMBL4045	Homo sapiens	Inhibition	%	9.16
	8105882	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	2.43	CHEMBL4045	Homo sapiens	Inhibition	%	2.43
	8105938	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.72	CHEMBL4045	Homo sapiens	Inhibition	%	1.72
	8106162	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	-0.52	CHEMBL4045	Homo sapiens	Inhibition	%	-0.52
	8106327	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	1.32	CHEMBL4045	Homo sapiens	Inhibition	%	1.32
	8106483	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	18.46	CHEMBL4045	Homo sapiens	Inhibition	%	18.46
	8106707	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	0.48	CHEMBL4045	Homo sapiens	Inhibition	%	0.48
	8106836	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	3.48	CHEMBL4045	Homo sapiens	Inhibition	%	3.48
	8107181	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.82	CHEMBL4045	Homo sapiens	Inhibition	%	1.82
	8107353	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.29	CHEMBL4045	Homo sapiens	Inhibition	%	2.29
	8107554	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	65.67	CHEMBL4045	Homo sapiens	Inhibition	%	65.67
	8107778	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	3.82	CHEMBL4045	Homo sapiens	Inhibition	%	3.82
	8107913	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	3.96	CHEMBL4045	Homo sapiens	Inhibition	%	3.96
	8108295	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	4.14	CHEMBL4045	Homo sapiens	Inhibition	%	4.14
	8108470	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.58	CHEMBL4045	Homo sapiens	Inhibition	%	0.58
	8108841	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	24.49	CHEMBL4045	Homo sapiens	Inhibition	%	24.49
	8108983	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	-0.69	CHEMBL4045	Homo sapiens	Inhibition	%	-0.69
	8109321	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	3.33	CHEMBL4045	Homo sapiens	Inhibition	%	3.33
	8109451	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-0.04	CHEMBL4045	Homo sapiens	Inhibition	%	-0.04
	8109675	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	0.72	CHEMBL4045	Homo sapiens	Inhibition	%	0.72
	8109846	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	21.59	CHEMBL4045	Homo sapiens	Inhibition	%	21.59
	8110202	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	5.67	CHEMBL4045	Homo sapiens	Inhibition	%	5.67
	8110481	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	2.86	CHEMBL4045	Homo sapiens	Inhibition	%	2.86
	8110647	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	1.37	CHEMBL4045	Homo sapiens	Inhibition	%	1.37
	8111029	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	4.78	CHEMBL4045	Homo sapiens	Inhibition	%	4.78
	8111152	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	1.46	CHEMBL4045	Homo sapiens	Inhibition	%	1.46
	8111503	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	6.0	CHEMBL4045	Homo sapiens	Inhibition	%	6.0
	8111669	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.17	CHEMBL4045	Homo sapiens	Inhibition	%	2.17
	8111893	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	26.01	CHEMBL4045	Homo sapiens	Inhibition	%	26.01
	8112098	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	4.04	CHEMBL4045	Homo sapiens	Inhibition	%	4.04
	8112235	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-0.66	CHEMBL4045	Homo sapiens	Inhibition	%	-0.66
	8112459	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.55	CHEMBL4045	Homo sapiens	Inhibition	%	0.55
	8112627	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	3.66	CHEMBL4045	Homo sapiens	Inhibition	%	3.66
	8112799	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-0.71	CHEMBL4045	Homo sapiens	Inhibition	%	-0.71
	8113175	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	2.74	CHEMBL4045	Homo sapiens	Inhibition	%	2.74
	8113311	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	1.2	CHEMBL4045	Homo sapiens	Inhibition	%	1.2
	8113535	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-1.82	CHEMBL4045	Homo sapiens	Inhibition	%	-1.82
	8113659	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	4.68	CHEMBL4045	Homo sapiens	Inhibition	%	4.68
	8113999	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.27	CHEMBL4045	Homo sapiens	Inhibition	%	-0.27
	8114175	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	1.06	CHEMBL4045	Homo sapiens	Inhibition	%	1.06
	8114531	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	2.46	CHEMBL4045	Homo sapiens	Inhibition	%	2.46
	8114807	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	0.6	CHEMBL4045	Homo sapiens	Inhibition	%	0.6
	8114973	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	2.02	CHEMBL4045	Homo sapiens	Inhibition	%	2.02
	8115197	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	1.94	CHEMBL4045	Homo sapiens	Inhibition	%	1.94
	8115362	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-0.86	CHEMBL4045	Homo sapiens	Inhibition	%	-0.86
	8115482	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	0.41	CHEMBL4045	Homo sapiens	Inhibition	%	0.41
	8115706	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	2.39	CHEMBL4045	Homo sapiens	Inhibition	%	2.39
	8115839	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	39.34	CHEMBL4045	Homo sapiens	Inhibition	%	39.34
	8116222	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	72.32	CHEMBL4045	Homo sapiens	Inhibition	%	72.32
	8116425	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	40.52	CHEMBL4045	Homo sapiens	Inhibition	%	40.52
	8116783	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-0.83	CHEMBL4045	Homo sapiens	Inhibition	%	-0.83
	8116955	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	4.69	CHEMBL4045	Homo sapiens	Inhibition	%	4.69
	8117126	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-0.55	CHEMBL4045	Homo sapiens	Inhibition	%	-0.55
	8117350	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	4.83	CHEMBL4045	Homo sapiens	Inhibition	%	4.83
	8117508	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	8.37	CHEMBL4045	Homo sapiens	Inhibition	%	8.37
	8117862	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-0.45	CHEMBL4045	Homo sapiens	Inhibition	%	-0.45
	8118000	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	4.6	CHEMBL4045	Homo sapiens	Inhibition	%	4.6
	8118340	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	1.83	CHEMBL4045	Homo sapiens	Inhibition	%	1.83
	8118512	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	5.76	CHEMBL4045	Homo sapiens	Inhibition	%	5.76
	8118736	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	1.39	CHEMBL4045	Homo sapiens	Inhibition	%	1.39
	8118872	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	4.38	CHEMBL4045	Homo sapiens	Inhibition	%	4.38
	8119143	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	1.03	CHEMBL4045	Homo sapiens	Inhibition	%	1.03
	8119526	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	2.74	CHEMBL4045	Homo sapiens	Inhibition	%	2.74
	8119693	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	3.32	CHEMBL4045	Homo sapiens	Inhibition	%	3.32
	8120036	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.3	CHEMBL4045	Homo sapiens	Inhibition	%	1.3
	8120175	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.51	CHEMBL4045	Homo sapiens	Inhibition	%	0.51
	8120399	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	3.23	CHEMBL4045	Homo sapiens	Inhibition	%	3.23
	8120559	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	1.24	CHEMBL4045	Homo sapiens	Inhibition	%	1.24
	8120760	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	82.6	CHEMBL4045	Homo sapiens	Inhibition	%	82.6
	8121112	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.29	CHEMBL4045	Homo sapiens	Inhibition	%	0.29
	8121284	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	2.64	CHEMBL4045	Homo sapiens	Inhibition	%	2.64
	8121675	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	8.26	CHEMBL4045	Homo sapiens	Inhibition	%	8.26
	8121838	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	2.42	CHEMBL4045	Homo sapiens	Inhibition	%	2.42
	8122183	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-1.41	CHEMBL4045	Homo sapiens	Inhibition	%	-1.41
	8122321	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	5.31	CHEMBL4045	Homo sapiens	Inhibition	%	5.31
	8122545	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	21.12	CHEMBL4045	Homo sapiens	Inhibition	%	21.12
	8122665	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	4.47	CHEMBL4045	Homo sapiens	Inhibition	%	4.47
	8123056	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	3.97	CHEMBL4045	Homo sapiens	Inhibition	%	3.97
	8123198	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	5.52	CHEMBL4045	Homo sapiens	Inhibition	%	5.52
	8123476	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	0.78	CHEMBL4045	Homo sapiens	Inhibition	%	0.78
	8123850	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	4.76	CHEMBL4045	Homo sapiens	Inhibition	%	4.76
	8124017	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	1.05	CHEMBL4045	Homo sapiens	Inhibition	%	1.05
	8124360	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	2.19	CHEMBL4045	Homo sapiens	Inhibition	%	2.19
	8124723	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	2.33	CHEMBL4045	Homo sapiens	Inhibition	%	2.33
	8124888	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	3.86	CHEMBL4045	Homo sapiens	Inhibition	%	3.86
	8125089	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	5.5	CHEMBL4045	Homo sapiens	Inhibition	%	5.5
	8125313	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	8.69	CHEMBL4045	Homo sapiens	Inhibition	%	8.69
	8125443	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.35	CHEMBL4045	Homo sapiens	Inhibition	%	-0.35
	8125611	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.94	CHEMBL4045	Homo sapiens	Inhibition	%	1.94
	8125835	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	1.91	CHEMBL4045	Homo sapiens	Inhibition	%	1.91
	8125999	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.5	CHEMBL4045	Homo sapiens	Inhibition	%	0.5
	8126163	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	4.09	CHEMBL4045	Homo sapiens	Inhibition	%	4.09
	8126387	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	3.26	CHEMBL4045	Homo sapiens	Inhibition	%	3.26
	8126502	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-0.8	CHEMBL4045	Homo sapiens	Inhibition	%	-0.8
	8126862	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	59.86	CHEMBL4045	Homo sapiens	Inhibition	%	59.86
	8126984	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	2.46	CHEMBL4045	Homo sapiens	Inhibition	%	2.46
	8127208	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	4.03	CHEMBL4045	Homo sapiens	Inhibition	%	4.03
	8127375	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	2.82	CHEMBL4045	Homo sapiens	Inhibition	%	2.82
	8127517	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	19.15	CHEMBL4045	Homo sapiens	Inhibition	%	19.15
	8127741	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	1.82	CHEMBL4045	Homo sapiens	Inhibition	%	1.82
	8127805	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	1.87	CHEMBL4045	Homo sapiens	Inhibition	%	1.87
	8128029	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	12.99	CHEMBL4045	Homo sapiens	Inhibition	%	12.99
	8128181	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	2.63	CHEMBL4045	Homo sapiens	Inhibition	%	2.63
	8128348	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	3.79	CHEMBL4045	Homo sapiens	Inhibition	%	3.79
	8128572	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	1.03	CHEMBL4045	Homo sapiens	Inhibition	%	1.03
	8128691	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	10.87	CHEMBL4045	Homo sapiens	Inhibition	%	10.87
	8129052	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	5.09	CHEMBL4045	Homo sapiens	Inhibition	%	5.09
	8129223	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-1.39	CHEMBL4045	Homo sapiens	Inhibition	%	-1.39
	8129636	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	2.09	CHEMBL4045	Homo sapiens	Inhibition	%	2.09
	8129775	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.39	CHEMBL4045	Homo sapiens	Inhibition	%	0.39
	8130160	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.67	CHEMBL4045	Homo sapiens	Inhibition	%	2.67
	8130332	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	2.46	CHEMBL4045	Homo sapiens	Inhibition	%	2.46
	8130716	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	9.99	CHEMBL4045	Homo sapiens	Inhibition	%	9.99
	8130832	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	2.41	CHEMBL4045	Homo sapiens	Inhibition	%	2.41
	8131056	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	3.51	CHEMBL4045	Homo sapiens	Inhibition	%	3.51
	8131195	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	3.09	CHEMBL4045	Homo sapiens	Inhibition	%	3.09
	8131539	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	2.91	CHEMBL4045	Homo sapiens	Inhibition	%	2.91
	8131706	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	5.78	CHEMBL4045	Homo sapiens	Inhibition	%	5.78
	8132071	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	5.16	CHEMBL4045	Homo sapiens	Inhibition	%	5.16
	8132357	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	1.44	CHEMBL4045	Homo sapiens	Inhibition	%	1.44
	8132504	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	1.76	CHEMBL4045	Homo sapiens	Inhibition	%	1.76
	8132896	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	2.25	CHEMBL4045	Homo sapiens	Inhibition	%	2.25
	8133017	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	-0.21	CHEMBL4045	Homo sapiens	Inhibition	%	-0.21
	8133241	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	1.83	CHEMBL4045	Homo sapiens	Inhibition	%	1.83
	8133379	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	2.47	CHEMBL4045	Homo sapiens	Inhibition	%	2.47
	8133551	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.8	CHEMBL4045	Homo sapiens	Inhibition	%	-0.8
	8133775	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.84	CHEMBL4045	Homo sapiens	Inhibition	%	-0.84
	8133955	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	5.52	CHEMBL4045	Homo sapiens	Inhibition	%	5.52
	8134103	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	0.03	CHEMBL4045	Homo sapiens	Inhibition	%	0.03
	8134327	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	0.8	CHEMBL4045	Homo sapiens	Inhibition	%	0.8
	8134487	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.17	CHEMBL4045	Homo sapiens	Inhibition	%	0.17
	8134671	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	0.57	CHEMBL4045	Homo sapiens	Inhibition	%	0.57
	8134895	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	12.04	CHEMBL4045	Homo sapiens	Inhibition	%	12.04
	8135055	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	0.33	CHEMBL4045	Homo sapiens	Inhibition	%	0.33
	8135394	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	3.06	CHEMBL4045	Homo sapiens	Inhibition	%	3.06
	8135535	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	7.3	CHEMBL4045	Homo sapiens	Inhibition	%	7.3
	8135880	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	3.45	CHEMBL4045	Homo sapiens	Inhibition	%	3.45
	8136048	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	1.52	CHEMBL4045	Homo sapiens	Inhibition	%	1.52
	8136272	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	2.74	CHEMBL4045	Homo sapiens	Inhibition	%	2.74
	8136416	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	2.72	CHEMBL4045	Homo sapiens	Inhibition	%	2.72
	8136706	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	0.94	CHEMBL4045	Homo sapiens	Inhibition	%	0.94
	8136841	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	6.35	CHEMBL4045	Homo sapiens	Inhibition	%	6.35
	8137065	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	34.82	CHEMBL4045	Homo sapiens	Inhibition	%	34.82
	8137228	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	1.8	CHEMBL4045	Homo sapiens	Inhibition	%	1.8
	8137572	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-0.07	CHEMBL4045	Homo sapiens	Inhibition	%	-0.07
	8137720	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	3.36	CHEMBL4045	Homo sapiens	Inhibition	%	3.36
	8138110	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	0.73	CHEMBL4045	Homo sapiens	Inhibition	%	0.73
	8138289	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	1.78	CHEMBL4045	Homo sapiens	Inhibition	%	1.78
	8138661	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-1.19	CHEMBL4045	Homo sapiens	Inhibition	%	-1.19
	8138819	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	1.06	CHEMBL4045	Homo sapiens	Inhibition	%	1.06
	8139228	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	1.53	CHEMBL4045	Homo sapiens	Inhibition	%	1.53
	8139387	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	3.53	CHEMBL4045	Homo sapiens	Inhibition	%	3.53
	8139725	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	2.92	CHEMBL4045	Homo sapiens	Inhibition	%	2.92
	8139866	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	3.59	CHEMBL4045	Homo sapiens	Inhibition	%	3.59
	8140090	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	5.6	CHEMBL4045	Homo sapiens	Inhibition	%	5.6
	8140213	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	1.57	CHEMBL4045	Homo sapiens	Inhibition	%	1.57
	8140596	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.77	CHEMBL4045	Homo sapiens	Inhibition	%	1.77
	8140739	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	3.99	CHEMBL4045	Homo sapiens	Inhibition	%	3.99
	8141041	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	2.03	CHEMBL4045	Homo sapiens	Inhibition	%	2.03
	8141395	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	-0.2	CHEMBL4045	Homo sapiens	Inhibition	%	-0.2
	8141555	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	3.53	CHEMBL4045	Homo sapiens	Inhibition	%	3.53
	8141898	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	0.48	CHEMBL4045	Homo sapiens	Inhibition	%	0.48
	8142059	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	1.06	CHEMBL4045	Homo sapiens	Inhibition	%	1.06
	8142283	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	1.64	CHEMBL4045	Homo sapiens	Inhibition	%	1.64
	8142451	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	5.76	CHEMBL4045	Homo sapiens	Inhibition	%	5.76
	8142627	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	2.03	CHEMBL4045	Homo sapiens	Inhibition	%	2.03
	8142851	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	1.11	CHEMBL4045	Homo sapiens	Inhibition	%	1.11
	8143000	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-1.42	CHEMBL4045	Homo sapiens	Inhibition	%	-1.42
	8143155	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.54	CHEMBL4045	Homo sapiens	Inhibition	%	1.54
	8143379	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	2.87	CHEMBL4045	Homo sapiens	Inhibition	%	2.87
	8143566	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	3.41	CHEMBL4045	Homo sapiens	Inhibition	%	3.41
	8143725	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	0.65	CHEMBL4045	Homo sapiens	Inhibition	%	0.65
	8143949	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	2.66	CHEMBL4045	Homo sapiens	Inhibition	%	2.66
	8144063	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	2.94	CHEMBL4045	Homo sapiens	Inhibition	%	2.94
	8144426	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	2.05	CHEMBL4045	Homo sapiens	Inhibition	%	2.05
	8144556	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	3.95	CHEMBL4045	Homo sapiens	Inhibition	%	3.95
	8144933	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.03	CHEMBL4045	Homo sapiens	Inhibition	%	2.03
	8145070	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	7.7	CHEMBL4045	Homo sapiens	Inhibition	%	7.7
	8145294	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	5.94	CHEMBL4045	Homo sapiens	Inhibition	%	5.94
	8145383	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.36	CHEMBL4045	Homo sapiens	Inhibition	%	0.36
	8145731	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	1.85	CHEMBL4045	Homo sapiens	Inhibition	%	1.85
	8145892	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	2.22	CHEMBL4045	Homo sapiens	Inhibition	%	2.22
	8146116	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	3.05	CHEMBL4045	Homo sapiens	Inhibition	%	3.05
	8146236	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.86	CHEMBL4045	Homo sapiens	Inhibition	%	0.86
	8146620	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	1.03	CHEMBL4045	Homo sapiens	Inhibition	%	1.03
	8146787	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	32.62	CHEMBL4045	Homo sapiens	Inhibition	%	32.62
	8147180	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	10.56	CHEMBL4045	Homo sapiens	Inhibition	%	10.56
	8147322	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	1.9	CHEMBL4045	Homo sapiens	Inhibition	%	1.9
	8147699	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	2.78	CHEMBL4045	Homo sapiens	Inhibition	%	2.78
	8147886	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	2.71	CHEMBL4045	Homo sapiens	Inhibition	%	2.71
	8148268	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	2.6	CHEMBL4045	Homo sapiens	Inhibition	%	2.6
	8148382	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	1.46	CHEMBL4045	Homo sapiens	Inhibition	%	1.46
	8148745	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	4.58	CHEMBL4045	Homo sapiens	Inhibition	%	4.58
	8148883	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	2.33	CHEMBL4045	Homo sapiens	Inhibition	%	2.33
	8149107	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	3.68	CHEMBL4045	Homo sapiens	Inhibition	%	3.68
	8149266	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	3.45	CHEMBL4045	Homo sapiens	Inhibition	%	3.45
	8149624	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	3.01	CHEMBL4045	Homo sapiens	Inhibition	%	3.01
	8149722	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	2.14	CHEMBL4045	Homo sapiens	Inhibition	%	2.14
	8149946	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	0.11	CHEMBL4045	Homo sapiens	Inhibition	%	0.11
	8150071	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	1.07	CHEMBL4045	Homo sapiens	Inhibition	%	1.07
	8150455	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.65	CHEMBL4045	Homo sapiens	Inhibition	%	0.65
	8150575	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.23	CHEMBL4045	Homo sapiens	Inhibition	%	0.23
	8150799	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.83	CHEMBL4045	Homo sapiens	Inhibition	%	0.83
	8150964	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-0.4	CHEMBL4045	Homo sapiens	Inhibition	%	-0.4
	8151127	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-1.87	CHEMBL4045	Homo sapiens	Inhibition	%	-1.87
	8151528	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.09	CHEMBL4045	Homo sapiens	Inhibition	%	1.09
	8151666	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	1.87	CHEMBL4045	Homo sapiens	Inhibition	%	1.87
	8151890	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	2.48	CHEMBL4045	Homo sapiens	Inhibition	%	2.48
	8152044	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	3.84	CHEMBL4045	Homo sapiens	Inhibition	%	3.84
	8152232	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	6.28	CHEMBL4045	Homo sapiens	Inhibition	%	6.28
	8152614	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	4.99	CHEMBL4045	Homo sapiens	Inhibition	%	4.99
	8152728	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	1.93	CHEMBL4045	Homo sapiens	Inhibition	%	1.93
	8152952	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	2.62	CHEMBL4045	Homo sapiens	Inhibition	%	2.62
	8153091	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.4	CHEMBL4045	Homo sapiens	Inhibition	%	2.4
	8153452	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	3.24	CHEMBL4045	Homo sapiens	Inhibition	%	3.24
	8153609	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	0.16	CHEMBL4045	Homo sapiens	Inhibition	%	0.16
	8153966	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	8.23	CHEMBL4045	Homo sapiens	Inhibition	%	8.23
	8154287	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	3.06	CHEMBL4045	Homo sapiens	Inhibition	%	3.06
	8154413	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	2.39	CHEMBL4045	Homo sapiens	Inhibition	%	2.39
	8154637	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	3.28	CHEMBL4045	Homo sapiens	Inhibition	%	3.28
	8154796	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	2.17	CHEMBL4045	Homo sapiens	Inhibition	%	2.17
	8155140	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-0.38	CHEMBL4045	Homo sapiens	Inhibition	%	-0.38
	8155316	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-1.23	CHEMBL4045	Homo sapiens	Inhibition	%	-1.23
	8155477	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	0.2	CHEMBL4045	Homo sapiens	Inhibition	%	0.2
	8155701	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	1.45	CHEMBL4045	Homo sapiens	Inhibition	%	1.45
	8155879	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	4.1	CHEMBL4045	Homo sapiens	Inhibition	%	4.1
	8156241	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	2.09	CHEMBL4045	Homo sapiens	Inhibition	%	2.09
	8156453	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	3.13	CHEMBL4045	Homo sapiens	Inhibition	%	3.13
	8156603	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	4.72	CHEMBL4045	Homo sapiens	Inhibition	%	4.72
	8156827	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	3.65	CHEMBL4045	Homo sapiens	Inhibition	%	3.65
	8156970	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	11.5	CHEMBL4045	Homo sapiens	Inhibition	%	11.5
	8157314	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	24.37	CHEMBL4045	Homo sapiens	Inhibition	%	24.37
	8157455	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	6.54	CHEMBL4045	Homo sapiens	Inhibition	%	6.54
	8157809	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	2.92	CHEMBL4045	Homo sapiens	Inhibition	%	2.92
	8157970	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-0.28	CHEMBL4045	Homo sapiens	Inhibition	%	-0.28
	8158194	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	1.09	CHEMBL4045	Homo sapiens	Inhibition	%	1.09
	8158444	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	4.01	CHEMBL4045	Homo sapiens	Inhibition	%	4.01
	8158602	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	7.1	CHEMBL4045	Homo sapiens	Inhibition	%	7.1
	8158995	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.32	CHEMBL4045	Homo sapiens	Inhibition	%	2.32
	8159130	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	4.66	CHEMBL4045	Homo sapiens	Inhibition	%	4.66
	8159474	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	3.33	CHEMBL4045	Homo sapiens	Inhibition	%	3.33
	8159605	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	11.1	CHEMBL4045	Homo sapiens	Inhibition	%	11.1
	8159829	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	6.07	CHEMBL4045	Homo sapiens	Inhibition	%	6.07
	8159970	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	2.34	CHEMBL4045	Homo sapiens	Inhibition	%	2.34
	8160331	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	4.25	CHEMBL4045	Homo sapiens	Inhibition	%	4.25
	8160481	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	3.45	CHEMBL4045	Homo sapiens	Inhibition	%	3.45
	8160775	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	5.1	CHEMBL4045	Homo sapiens	Inhibition	%	5.1
	8161149	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	4.22	CHEMBL4045	Homo sapiens	Inhibition	%	4.22
	8161292	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	4.61	CHEMBL4045	Homo sapiens	Inhibition	%	4.61
	8161641	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.85	CHEMBL4045	Homo sapiens	Inhibition	%	1.85
	8161779	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	39.21	CHEMBL4045	Homo sapiens	Inhibition	%	39.21
	8162003	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	3.82	CHEMBL4045	Homo sapiens	Inhibition	%	3.82
	8162133	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	5.01	CHEMBL4045	Homo sapiens	Inhibition	%	5.01
	8162517	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-0.25	CHEMBL4045	Homo sapiens	Inhibition	%	-0.25
	8162770	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	6.61	CHEMBL4045	Homo sapiens	Inhibition	%	6.61
	8162918	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	38.39	CHEMBL4045	Homo sapiens	Inhibition	%	38.39
	8163142	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	68.16	CHEMBL4045	Homo sapiens	Inhibition	%	68.16
	8163311	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	1.14	CHEMBL4045	Homo sapiens	Inhibition	%	1.14
	8163445	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	4.92	CHEMBL4045	Homo sapiens	Inhibition	%	4.92
	8163669	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	5.34	CHEMBL4045	Homo sapiens	Inhibition	%	5.34
	8163792	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	6.81	CHEMBL4045	Homo sapiens	Inhibition	%	6.81
	8164150	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	20.29	CHEMBL4045	Homo sapiens	Inhibition	%	20.29
	8164290	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.3	CHEMBL4045	Homo sapiens	Inhibition	%	0.3
	8164669	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	2.67	CHEMBL4045	Homo sapiens	Inhibition	%	2.67
	8164813	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	0.93	CHEMBL4045	Homo sapiens	Inhibition	%	0.93
	8165037	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	3.58	CHEMBL4045	Homo sapiens	Inhibition	%	3.58
	8165107	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	5.47	CHEMBL4045	Homo sapiens	Inhibition	%	5.47
	8165472	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	1.96	CHEMBL4045	Homo sapiens	Inhibition	%	1.96
	8165615	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	11.56	CHEMBL4045	Homo sapiens	Inhibition	%	11.56
	8165839	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	1.68	CHEMBL4045	Homo sapiens	Inhibition	%	1.68
	8165965	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	5.89	CHEMBL4045	Homo sapiens	Inhibition	%	5.89
	8166327	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	14.38	CHEMBL4045	Homo sapiens	Inhibition	%	14.38
	8166457	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	2.62	CHEMBL4045	Homo sapiens	Inhibition	%	2.62
	8166681	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	3.13	CHEMBL4045	Homo sapiens	Inhibition	%	3.13
	8166782	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	1.71	CHEMBL4045	Homo sapiens	Inhibition	%	1.71
	8167094	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	2.28	CHEMBL4045	Homo sapiens	Inhibition	%	2.28
	8167459	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	6.5	CHEMBL4045	Homo sapiens	Inhibition	%	6.5
	8167623	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	2.66	CHEMBL4045	Homo sapiens	Inhibition	%	2.66
	8167980	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	5.71	CHEMBL4045	Homo sapiens	Inhibition	%	5.71
	8168104	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	3.82	CHEMBL4045	Homo sapiens	Inhibition	%	3.82
	8168328	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	20.41	CHEMBL4045	Homo sapiens	Inhibition	%	20.41
	8168469	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	2.28	CHEMBL4045	Homo sapiens	Inhibition	%	2.28
	8168605	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.1	CHEMBL4045	Homo sapiens	Inhibition	%	1.1
	8168829	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-0.48	CHEMBL4045	Homo sapiens	Inhibition	%	-0.48
	8168993	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	10.4	CHEMBL4045	Homo sapiens	Inhibition	%	10.4
	8169359	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	6.37	CHEMBL4045	Homo sapiens	Inhibition	%	6.37
	8169439	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	6.88	CHEMBL4045	Homo sapiens	Inhibition	%	6.88
	8169663	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	57.26	CHEMBL4045	Homo sapiens	Inhibition	%	57.26
	8169797	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	4.1	CHEMBL4045	Homo sapiens	Inhibition	%	4.1
	8170166	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	0.27	CHEMBL4045	Homo sapiens	Inhibition	%	0.27
	8170291	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.8	CHEMBL4045	Homo sapiens	Inhibition	%	2.8
	8170515	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	4.3	CHEMBL4045	Homo sapiens	Inhibition	%	4.3
	8170655	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	13.84	CHEMBL4045	Homo sapiens	Inhibition	%	13.84
	8171014	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	1.84	CHEMBL4045	Homo sapiens	Inhibition	%	1.84
	8171211	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	1.6	CHEMBL4045	Homo sapiens	Inhibition	%	1.6
	8171428	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	2.06	CHEMBL4045	Homo sapiens	Inhibition	%	2.06
	8171793	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	7.07	CHEMBL4045	Homo sapiens	Inhibition	%	7.07
	8171946	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	2.52	CHEMBL4045	Homo sapiens	Inhibition	%	2.52
	8172302	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	6.25	CHEMBL4045	Homo sapiens	Inhibition	%	6.25
	8172654	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.79	CHEMBL4045	Homo sapiens	Inhibition	%	0.79
	8172796	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	7.4	CHEMBL4045	Homo sapiens	Inhibition	%	7.4
	8173156	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	0.34	CHEMBL4045	Homo sapiens	Inhibition	%	0.34
	8173321	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	2.59	CHEMBL4045	Homo sapiens	Inhibition	%	2.59
	8173686	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	3.07	CHEMBL4045	Homo sapiens	Inhibition	%	3.07
	8173997	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	86.58	CHEMBL4045	Homo sapiens	Inhibition	%	86.58
	8174129	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	2.38	CHEMBL4045	Homo sapiens	Inhibition	%	2.38
	8174353	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	5.18	CHEMBL4045	Homo sapiens	Inhibition	%	5.18
	8174501	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	2.2	CHEMBL4045	Homo sapiens	Inhibition	%	2.2
	8174847	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.46	CHEMBL4045	Homo sapiens	Inhibition	%	2.46
	8174990	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	51.91	CHEMBL4045	Homo sapiens	Inhibition	%	51.91
	8175350	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	3.55	CHEMBL4045	Homo sapiens	Inhibition	%	3.55
	8175606	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	19.34	CHEMBL4045	Homo sapiens	Inhibition	%	19.34
	8175769	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	1.01	CHEMBL4045	Homo sapiens	Inhibition	%	1.01
	8175993	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	1.93	CHEMBL4045	Homo sapiens	Inhibition	%	1.93
	8176146	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	5.3	CHEMBL4045	Homo sapiens	Inhibition	%	5.3
	8176295	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	5.15	CHEMBL4045	Homo sapiens	Inhibition	%	5.15
	8176519	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	10.15	CHEMBL4045	Homo sapiens	Inhibition	%	10.15
	8176651	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	19.98	CHEMBL4045	Homo sapiens	Inhibition	%	19.98
	8177005	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	3.29	CHEMBL4045	Homo sapiens	Inhibition	%	3.29
	8177147	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	3.54	CHEMBL4045	Homo sapiens	Inhibition	%	3.54
	8177371	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	3.56	CHEMBL4045	Homo sapiens	Inhibition	%	3.56
	8177509	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	37.04	CHEMBL4045	Homo sapiens	Inhibition	%	37.04
	8177673	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	9.15	CHEMBL4045	Homo sapiens	Inhibition	%	9.15
	8177897	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	3.33	CHEMBL4045	Homo sapiens	Inhibition	%	3.33
	8178037	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	3.3	CHEMBL4045	Homo sapiens	Inhibition	%	3.3
	8178349	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.01	CHEMBL4045	Homo sapiens	Inhibition	%	2.01
	8178700	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	3.38	CHEMBL4045	Homo sapiens	Inhibition	%	3.38
	8178849	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	3.29	CHEMBL4045	Homo sapiens	Inhibition	%	3.29
	8179196	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.35	CHEMBL4045	Homo sapiens	Inhibition	%	2.35
	8179340	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	41.71	CHEMBL4045	Homo sapiens	Inhibition	%	41.71
	8179564	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	75.49	CHEMBL4045	Homo sapiens	Inhibition	%	75.49
	8179701	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	0.05	CHEMBL4045	Homo sapiens	Inhibition	%	0.05
	8179958	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	5.95	CHEMBL4045	Homo sapiens	Inhibition	%	5.95
	8180336	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	1.8	CHEMBL4045	Homo sapiens	Inhibition	%	1.8
	8180492	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	7.27	CHEMBL4045	Homo sapiens	Inhibition	%	7.27
	8180864	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	44.51	CHEMBL4045	Homo sapiens	Inhibition	%	44.51
	8180997	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	2.21	CHEMBL4045	Homo sapiens	Inhibition	%	2.21
	8181221	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	5.69	CHEMBL4045	Homo sapiens	Inhibition	%	5.69
	8181352	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	1.16	CHEMBL4045	Homo sapiens	Inhibition	%	1.16
	8181716	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	3.49	CHEMBL4045	Homo sapiens	Inhibition	%	3.49
	8181855	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	78.04	CHEMBL4045	Homo sapiens	Inhibition	%	78.04
	8182242	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	5.29	CHEMBL4045	Homo sapiens	Inhibition	%	5.29
	8182382	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	1.79	CHEMBL4045	Homo sapiens	Inhibition	%	1.79
	8182606	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	0.39	CHEMBL4045	Homo sapiens	Inhibition	%	0.39
	8182698	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.18	CHEMBL4045	Homo sapiens	Inhibition	%	2.18
	8183044	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	5.57	CHEMBL4045	Homo sapiens	Inhibition	%	5.57
	8183193	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	1.32	CHEMBL4045	Homo sapiens	Inhibition	%	1.32
	8183417	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	1.33	CHEMBL4045	Homo sapiens	Inhibition	%	1.33
	8183546	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	1.3	CHEMBL4045	Homo sapiens	Inhibition	%	1.3
	8183912	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	6.79	CHEMBL4045	Homo sapiens	Inhibition	%	6.79
	8184048	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.68	CHEMBL4045	Homo sapiens	Inhibition	%	1.68
	8184314	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	5.95	CHEMBL4045	Homo sapiens	Inhibition	%	5.95
	8184685	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	0.98	CHEMBL4045	Homo sapiens	Inhibition	%	0.98
	8184842	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	3.0	CHEMBL4045	Homo sapiens	Inhibition	%	3.0
	8185066	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	1.48	CHEMBL4045	Homo sapiens	Inhibition	%	1.48
	8185215	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	1.28	CHEMBL4045	Homo sapiens	Inhibition	%	1.28
	8185570	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	4.2	CHEMBL4045	Homo sapiens	Inhibition	%	4.2
	8185701	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	9.79	CHEMBL4045	Homo sapiens	Inhibition	%	9.79
	8186064	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	4.22	CHEMBL4045	Homo sapiens	Inhibition	%	4.22
	8186205	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	5.22	CHEMBL4045	Homo sapiens	Inhibition	%	5.22
	8186429	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	9.36	CHEMBL4045	Homo sapiens	Inhibition	%	9.36
	8186593	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	4.29	CHEMBL4045	Homo sapiens	Inhibition	%	4.29
	8186956	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	2.62	CHEMBL4045	Homo sapiens	Inhibition	%	2.62
	8187054	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	1.98	CHEMBL4045	Homo sapiens	Inhibition	%	1.98
	8187278	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	1.85	CHEMBL4045	Homo sapiens	Inhibition	%	1.85
	8187402	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	4.09	CHEMBL4045	Homo sapiens	Inhibition	%	4.09
	8187774	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	1.05	CHEMBL4045	Homo sapiens	Inhibition	%	1.05
	8187903	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	4.07	CHEMBL4045	Homo sapiens	Inhibition	%	4.07
	8188270	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	16.09	CHEMBL4045	Homo sapiens	Inhibition	%	16.09
	8188405	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	1.41	CHEMBL4045	Homo sapiens	Inhibition	%	1.41
	8188629	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	2.0	CHEMBL4045	Homo sapiens	Inhibition	%	2.0
	8188679	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	5.32	CHEMBL4045	Homo sapiens	Inhibition	%	5.32
	8188903	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	5.69	CHEMBL4045	Homo sapiens	Inhibition	%	5.69
	8189051	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	1.32	CHEMBL4045	Homo sapiens	Inhibition	%	1.32
	8189431	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	3.31	CHEMBL4045	Homo sapiens	Inhibition	%	3.31
	8189580	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	3.03	CHEMBL4045	Homo sapiens	Inhibition	%	3.03
	8189936	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	6.4	CHEMBL4045	Homo sapiens	Inhibition	%	6.4
	8190068	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	4.85	CHEMBL4045	Homo sapiens	Inhibition	%	4.85
	8190292	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	9.85	CHEMBL4045	Homo sapiens	Inhibition	%	9.85
	8190432	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	3.6	CHEMBL4045	Homo sapiens	Inhibition	%	3.6
	8190793	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	2.98	CHEMBL4045	Homo sapiens	Inhibition	%	2.98
	8190957	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	5.67	CHEMBL4045	Homo sapiens	Inhibition	%	5.67
	8191319	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	5.07	CHEMBL4045	Homo sapiens	Inhibition	%	5.07
	8191639	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	1.92	CHEMBL4045	Homo sapiens	Inhibition	%	1.92
	8191761	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	7.03	CHEMBL4045	Homo sapiens	Inhibition	%	7.03
	8192134	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	1.48	CHEMBL4045	Homo sapiens	Inhibition	%	1.48
	8192263	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	0.41	CHEMBL4045	Homo sapiens	Inhibition	%	0.41
	8192487	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	5.85	CHEMBL4045	Homo sapiens	Inhibition	%	5.85
	8192631	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	3.16	CHEMBL4045	Homo sapiens	Inhibition	%	3.16
	8192991	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	0.25	CHEMBL4045	Homo sapiens	Inhibition	%	0.25
	8193263	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	2.78	CHEMBL4045	Homo sapiens	Inhibition	%	2.78
	8193408	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	4.22	CHEMBL4045	Homo sapiens	Inhibition	%	4.22
	8193632	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	1.36	CHEMBL4045	Homo sapiens	Inhibition	%	1.36
	8193789	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	11.98	CHEMBL4045	Homo sapiens	Inhibition	%	11.98
	8193938	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.36	CHEMBL4045	Homo sapiens	Inhibition	%	-0.36
	8194162	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	0.11	CHEMBL4045	Homo sapiens	Inhibition	%	0.11
	8194293	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	4.38	CHEMBL4045	Homo sapiens	Inhibition	%	4.38
	8194648	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	0.74	CHEMBL4045	Homo sapiens	Inhibition	%	0.74
	8194791	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	2.86	CHEMBL4045	Homo sapiens	Inhibition	%	2.86
	8195148	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	6.22	CHEMBL4045	Homo sapiens	Inhibition	%	6.22
	8195312	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	4.48	CHEMBL4045	Homo sapiens	Inhibition	%	4.48
	8195536	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	21.4	CHEMBL4045	Homo sapiens	Inhibition	%	21.4
	8195675	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	3.68	CHEMBL4045	Homo sapiens	Inhibition	%	3.68
	8195997	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	8.74	CHEMBL4045	Homo sapiens	Inhibition	%	8.74
	8196114	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	3.03	CHEMBL4045	Homo sapiens	Inhibition	%	3.03
	8196338	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	4.08	CHEMBL4045	Homo sapiens	Inhibition	%	4.08
	8196488	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	2.48	CHEMBL4045	Homo sapiens	Inhibition	%	2.48
	8196840	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	3.16	CHEMBL4045	Homo sapiens	Inhibition	%	3.16
	8196981	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	7.91	CHEMBL4045	Homo sapiens	Inhibition	%	7.91
	8197205	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	2.82	CHEMBL4045	Homo sapiens	Inhibition	%	2.82
	8197342	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	1.28	CHEMBL4045	Homo sapiens	Inhibition	%	1.28
	8197617	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	2.57	CHEMBL4045	Homo sapiens	Inhibition	%	2.57
	8197981	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	10.7	CHEMBL4045	Homo sapiens	Inhibition	%	10.7
	8198138	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	2.91	CHEMBL4045	Homo sapiens	Inhibition	%	2.91
	8198500	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	4.84	CHEMBL4045	Homo sapiens	Inhibition	%	4.84
	8198630	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	5.7	CHEMBL4045	Homo sapiens	Inhibition	%	5.7
	8198985	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	4.36	CHEMBL4045	Homo sapiens	Inhibition	%	4.36
	8199133	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	4.31	CHEMBL4045	Homo sapiens	Inhibition	%	4.31
	8199357	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	3.22	CHEMBL4045	Homo sapiens	Inhibition	%	3.22
	8199491	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	3.44	CHEMBL4045	Homo sapiens	Inhibition	%	3.44
	8199878	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	2.74	CHEMBL4045	Homo sapiens	Inhibition	%	2.74
	8200016	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	2.81	CHEMBL4045	Homo sapiens	Inhibition	%	2.81
	8200344	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	0.45	CHEMBL4045	Homo sapiens	Inhibition	%	0.45
	8200683	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	5.24	CHEMBL4045	Homo sapiens	Inhibition	%	5.24
	8200833	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	2.15	CHEMBL4045	Homo sapiens	Inhibition	%	2.15
	8201057	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	4.11	CHEMBL4045	Homo sapiens	Inhibition	%	4.11
	8201187	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	12.84	CHEMBL4045	Homo sapiens	Inhibition	%	12.84
	8201546	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	3.15	CHEMBL4045	Homo sapiens	Inhibition	%	3.15
	8201679	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.62	CHEMBL4045	Homo sapiens	Inhibition	%	-0.62
	8201958	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	2.01	CHEMBL4045	Homo sapiens	Inhibition	%	2.01
	8202322	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-0.3	CHEMBL4045	Homo sapiens	Inhibition	%	-0.3
	8202489	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	2.64	CHEMBL4045	Homo sapiens	Inhibition	%	2.64
	8202838	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	4.83	CHEMBL4045	Homo sapiens	Inhibition	%	4.83
	8202968	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	4.95	CHEMBL4045	Homo sapiens	Inhibition	%	4.95
	8203192	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	6.83	CHEMBL4045	Homo sapiens	Inhibition	%	6.83
	8203323	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	3.77	CHEMBL4045	Homo sapiens	Inhibition	%	3.77
	8203693	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	2.28	CHEMBL4045	Homo sapiens	Inhibition	%	2.28
	8203827	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	7.14	CHEMBL4045	Homo sapiens	Inhibition	%	7.14
	8204051	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	4.71	CHEMBL4045	Homo sapiens	Inhibition	%	4.71
	8204217	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	3.91	CHEMBL4045	Homo sapiens	Inhibition	%	3.91
	8204354	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	4.22	CHEMBL4045	Homo sapiens	Inhibition	%	4.22
	8204578	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	4.05	CHEMBL4045	Homo sapiens	Inhibition	%	4.05
	8204683	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	0.54	CHEMBL4045	Homo sapiens	Inhibition	%	0.54
	8205022	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	20.5	CHEMBL4045	Homo sapiens	Inhibition	%	20.5
	8205395	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	6.88	CHEMBL4045	Homo sapiens	Inhibition	%	6.88
	8205531	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	3.1	CHEMBL4045	Homo sapiens	Inhibition	%	3.1
	8205894	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	1.98	CHEMBL4045	Homo sapiens	Inhibition	%	1.98
	8206026	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.8	CHEMBL4045	Homo sapiens	Inhibition	%	-0.8
	8206250	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-0.96	CHEMBL4045	Homo sapiens	Inhibition	%	-0.96
	8206302	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	3.32	CHEMBL4045	Homo sapiens	Inhibition	%	3.32
	8206526	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	2.95	CHEMBL4045	Homo sapiens	Inhibition	%	2.95
	8206669	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	6.79	CHEMBL4045	Homo sapiens	Inhibition	%	6.79
	8206849	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	2.93	CHEMBL4045	Homo sapiens	Inhibition	%	2.93
	8207073	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	2.04	CHEMBL4045	Homo sapiens	Inhibition	%	2.04
	8207199	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	3.09	CHEMBL4045	Homo sapiens	Inhibition	%	3.09
	8207553	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	5.78	CHEMBL4045	Homo sapiens	Inhibition	%	5.78
	8207685	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	4.2	CHEMBL4045	Homo sapiens	Inhibition	%	4.2
	8207909	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	4.1	CHEMBL4045	Homo sapiens	Inhibition	%	4.1
	8208054	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	2.5	CHEMBL4045	Homo sapiens	Inhibition	%	2.5
	8208410	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	6.63	CHEMBL4045	Homo sapiens	Inhibition	%	6.63
	8208576	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	7.34	CHEMBL4045	Homo sapiens	Inhibition	%	7.34
	8208933	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	5.9	CHEMBL4045	Homo sapiens	Inhibition	%	5.9
	8209038	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	0.4	CHEMBL4045	Homo sapiens	Inhibition	%	0.4
	8209262	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	0.95	CHEMBL4045	Homo sapiens	Inhibition	%	0.95
	8209378	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	0.55	CHEMBL4045	Homo sapiens	Inhibition	%	0.55
	8209752	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	2.61	CHEMBL4045	Homo sapiens	Inhibition	%	2.61
	8209888	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	7.14	CHEMBL4045	Homo sapiens	Inhibition	%	7.14
	8210112	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	6.49	CHEMBL4045	Homo sapiens	Inhibition	%	6.49
	8210253	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	3.58	CHEMBL4045	Homo sapiens	Inhibition	%	3.58
	8210613	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	4.08	CHEMBL4045	Homo sapiens	Inhibition	%	4.08
	8210872	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	3.4	CHEMBL4045	Homo sapiens	Inhibition	%	3.4
	8211016	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	3.84	CHEMBL4045	Homo sapiens	Inhibition	%	3.84
	8211410	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	3.06	CHEMBL4045	Homo sapiens	Inhibition	%	3.06
	8211533	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	5.53	CHEMBL4045	Homo sapiens	Inhibition	%	5.53
	8211757	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	4.23	CHEMBL4045	Homo sapiens	Inhibition	%	4.23
	8211886	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	20.07	CHEMBL4045	Homo sapiens	Inhibition	%	20.07
	8212242	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	5.8	CHEMBL4045	Homo sapiens	Inhibition	%	5.8
	8212383	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	1.21	CHEMBL4045	Homo sapiens	Inhibition	%	1.21
	8212740	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	5.16	CHEMBL4045	Homo sapiens	Inhibition	%	5.16
	8212910	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	41.04	CHEMBL4045	Homo sapiens	Inhibition	%	41.04
	8213134	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.33	CHEMBL4045	Homo sapiens	Inhibition	%	0.33
	8213263	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	14.33	CHEMBL4045	Homo sapiens	Inhibition	%	14.33
	8213591	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.6	CHEMBL4045	Homo sapiens	Inhibition	%	-0.6
	8213704	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	2.96	CHEMBL4045	Homo sapiens	Inhibition	%	2.96
	8213928	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.12	CHEMBL4045	Homo sapiens	Inhibition	%	2.12
	8214075	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	2.22	CHEMBL4045	Homo sapiens	Inhibition	%	2.22
	8214436	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	23.72	CHEMBL4045	Homo sapiens	Inhibition	%	23.72
	8214570	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	2.46	CHEMBL4045	Homo sapiens	Inhibition	%	2.46
	8214946	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	0.65	CHEMBL4045	Homo sapiens	Inhibition	%	0.65
	8215197	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	3.37	CHEMBL4045	Homo sapiens	Inhibition	%	3.37
	8215350	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	8.18	CHEMBL4045	Homo sapiens	Inhibition	%	8.18
	8215574	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	2.92	CHEMBL4045	Homo sapiens	Inhibition	%	2.92
	8215738	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	1.13	CHEMBL4045	Homo sapiens	Inhibition	%	1.13
	8216081	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	5.78	CHEMBL4045	Homo sapiens	Inhibition	%	5.78
	8216200	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	2.58	CHEMBL4045	Homo sapiens	Inhibition	%	2.58
	8216560	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	5.27	CHEMBL4045	Homo sapiens	Inhibition	%	5.27
	8216698	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	4.56	CHEMBL4045	Homo sapiens	Inhibition	%	4.56
	8216922	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.15	CHEMBL4045	Homo sapiens	Inhibition	%	3.15
	8217056	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	6.56	CHEMBL4045	Homo sapiens	Inhibition	%	6.56
	8217454	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	3.46	CHEMBL4045	Homo sapiens	Inhibition	%	3.46
	8217585	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	33.37	CHEMBL4045	Homo sapiens	Inhibition	%	33.37
	8217910	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.54	CHEMBL4045	Homo sapiens	Inhibition	%	-0.54
	8218249	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	5.29	CHEMBL4045	Homo sapiens	Inhibition	%	5.29
	8218376	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	3.69	CHEMBL4045	Homo sapiens	Inhibition	%	3.69
	8218743	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	4.2	CHEMBL4045	Homo sapiens	Inhibition	%	4.2
	8218874	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	6.79	CHEMBL4045	Homo sapiens	Inhibition	%	6.79
	8219098	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	2.87	CHEMBL4045	Homo sapiens	Inhibition	%	2.87
	8219258	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-0.75	CHEMBL4045	Homo sapiens	Inhibition	%	-0.75
	8219508	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	3.19	CHEMBL4045	Homo sapiens	Inhibition	%	3.19
	8219893	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	3.4	CHEMBL4045	Homo sapiens	Inhibition	%	3.4
	8220062	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	3.92	CHEMBL4045	Homo sapiens	Inhibition	%	3.92
	8220415	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	4.54	CHEMBL4045	Homo sapiens	Inhibition	%	4.54
	8220529	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	4.41	CHEMBL4045	Homo sapiens	Inhibition	%	4.41
	8220753	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	18.44	CHEMBL4045	Homo sapiens	Inhibition	%	18.44
	8220891	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	13.41	CHEMBL4045	Homo sapiens	Inhibition	%	13.41
	8221251	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	11.46	CHEMBL4045	Homo sapiens	Inhibition	%	11.46
	8221384	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	3.98	CHEMBL4045	Homo sapiens	Inhibition	%	3.98
	8221773	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.38	CHEMBL4045	Homo sapiens	Inhibition	%	0.38
	8221904	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	74.56	CHEMBL4045	Homo sapiens	Inhibition	%	74.56
	8222128	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	3.13	CHEMBL4045	Homo sapiens	Inhibition	%	3.13
	8222226	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	2.21	CHEMBL4045	Homo sapiens	Inhibition	%	2.21
	8222584	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	4.14	CHEMBL4045	Homo sapiens	Inhibition	%	4.14
	8222702	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	12.29	CHEMBL4045	Homo sapiens	Inhibition	%	12.29
	8222926	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	4.08	CHEMBL4045	Homo sapiens	Inhibition	%	4.08
	8223070	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	8.8	CHEMBL4045	Homo sapiens	Inhibition	%	8.8
	8223423	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	2.98	CHEMBL4045	Homo sapiens	Inhibition	%	2.98
	8223584	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-0.17	CHEMBL4045	Homo sapiens	Inhibition	%	-0.17
	8223834	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	3.65	CHEMBL4045	Homo sapiens	Inhibition	%	3.65
	8224058	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	2.77	CHEMBL4045	Homo sapiens	Inhibition	%	2.77
	8224220	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	6.18	CHEMBL4045	Homo sapiens	Inhibition	%	6.18
	8224390	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	1.92	CHEMBL4045	Homo sapiens	Inhibition	%	1.92
	8224614	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.72	CHEMBL4045	Homo sapiens	Inhibition	%	2.72
	8224749	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	5.81	CHEMBL4045	Homo sapiens	Inhibition	%	5.81
	8225087	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	62.18	CHEMBL4045	Homo sapiens	Inhibition	%	62.18
	8225221	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	5.36	CHEMBL4045	Homo sapiens	Inhibition	%	5.36
	8225583	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.01	CHEMBL4045	Homo sapiens	Inhibition	%	1.01
	8225718	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	5.67	CHEMBL4045	Homo sapiens	Inhibition	%	5.67
	8225942	CHEMBL1961942	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	3.31	CHEMBL4045	Homo sapiens	Inhibition	%	3.31
	8226100	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.1	CHEMBL4045	Homo sapiens	Inhibition	%	0.1
	8226449	CHEMBL1961943	GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	5.37	CHEMBL4045	Homo sapiens	Inhibition	%	5.37
inactive	9532734	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C		CHEMBL1964290	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9532735	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9532736	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9532737	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)c1		CHEMBL1982880	=	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9532738	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9532739	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9532740	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	19.95	CHEMBL4045	Homo sapiens	pKi		7.7
inactive	9532741	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9532742	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9532743	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1		CHEMBL578061	<	Ki	nM	25118.86	CHEMBL4045	Homo sapiens	pKi		4.6
active	9532744	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	=	Ki	nM	63.1	CHEMBL4045	Homo sapiens	pKi		7.2
inactive	9532745	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9532746	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682345	=	Ki	nM	1258.93	CHEMBL4045	Homo sapiens	pKi		5.9
inactive	9532747	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9532748	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccc[nH]2)C(=O)N3)c1)Cc1ccccc1		CHEMBL1980407	=	Ki	nM	3.162	CHEMBL4045	Homo sapiens	pKi		8.5
inactive	9532749	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9532750	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9532751	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9532752	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1966628	=	Ki	nM	125.89	CHEMBL4045	Homo sapiens	pKi		6.9
inactive	9532753	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN(C)CCCN(C)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1964948	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9532754	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9532755	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	=	Ki	nM	794.33	CHEMBL4045	Homo sapiens	pKi		6.1
inactive	9532756	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1c(C)n(Cc2ccccc2)c2ccc(C(=O)Nc3nc[nH]n3)cc12		CHEMBL1979718	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9532757	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9532758	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=c1[nH][nH]c2cccc(-c3ccccc3)c12		CHEMBL1989834	<	Ki	nM	15848.93	CHEMBL4045	Homo sapiens	pKi		4.8
active	9532759	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCn1c2cc(Cl)c(O)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL523823	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9532760	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC1(C)CC2=Nc3cc(Cl)ccc3SC2=C(O)C1		CHEMBL1562756	=	Ki	nM	7943.28	CHEMBL4045	Homo sapiens	pKi		5.1
inactive	9532761	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCCc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1987430	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9532762	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL244378	=	Ki	nM	398.11	CHEMBL4045	Homo sapiens	pKi		6.4
active	9532763	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	=	Ki	nM	630.96	CHEMBL4045	Homo sapiens	pKi		6.2
inactive	9532764	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9532765	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9532766	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1ccccc1		CHEMBL1993413	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9532767	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	125.89	CHEMBL4045	Homo sapiens	pKi		6.9
active	9532768	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	=	Ki	nM	199.53	CHEMBL4045	Homo sapiens	pKi		6.7
active	9532769	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	=	Ki	nM	1258.93	CHEMBL4045	Homo sapiens	pKi		5.9
active	9532770	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	=	Ki	nM	1258.93	CHEMBL4045	Homo sapiens	pKi		5.9
inactive	9532771	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9532772	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9532773	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(O)C1CN(Cc2ccc(OCc3cccc(C(F)(F)F)c3)cc2Cl)C1		CHEMBL1986265	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9532774	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	=	Ki	nM	1258.93	CHEMBL4045	Homo sapiens	pKi		5.9
inactive	9532775	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9532776	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9532777	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN1c2ccc(N)cc2C(c2ccccc2)c2cc(N)ccc21		CHEMBL1991734	=	Ki	nM	501.19	CHEMBL4045	Homo sapiens	pKi		6.3
active	9532778	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	=	Ki	nM	398.11	CHEMBL4045	Homo sapiens	pKi		6.4
inactive	9532779	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9532780	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9532781	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9532782	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9532783	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C1NCc2c1cccc2-c1cccs1		CHEMBL1991782	<	Ki	nM	63095.73	CHEMBL4045	Homo sapiens	pKi		4.2
active	9532784	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1n[nH]c2ncc(Br)cc12		CHEMBL2002105	=	Ki	nM	39810.72	CHEMBL4045	Homo sapiens	pKi		4.4
inactive	9532785	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9532786	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCCCN(CCC#N)C(=O)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1983348	=	Ki	nM	398.11	CHEMBL4045	Homo sapiens	pKi		6.4
inactive	9532787	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9532788	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	=	Ki	nM	158.49	CHEMBL4045	Homo sapiens	pKi		6.8
inactive	9532789	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cc(O)ccc1-n1c2cc(Cl)ccc2c(=O)c2c(N)nc(N)nc21		CHEMBL1995592	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
active	9532790	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCOC(=O)Cc1nc2c3cc(Br)ccc3[nH]c(=O)n2n1		CHEMBL1974480	=	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9532791	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL2000934	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9532792	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9532793	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1cccc(Cl)c1)Nc1nc(CCNc2ncnc3ccsc23)cs1		CHEMBL1986177	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9532794	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccc(OC)c(CNC(=O)c2cc(N)c(C#N)c(OC(C)C)n2)c1		CHEMBL1982541	=	Ki	nM	7943.28	CHEMBL4045	Homo sapiens	pKi		5.1
inactive	9532795	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Clc1cc2nn[nH]c2cc1Cl		CHEMBL1996923	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9532796	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9532797	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9532798	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9532799	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCc1nc2c(c3cc(OC)c(OC)cc13)C(=O)NC2=O		CHEMBL2003524	=	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9532800	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	=	Ki	nM	125.89	CHEMBL4045	Homo sapiens	pKi		6.9
inactive	9532801	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccnc(Nc2cc(C)nc(-c3ccccc3)n2)c1		CHEMBL1985367	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9532802	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9532803	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1nc(N2CCNCC2)nc2ccccc12		CHEMBL1996510	=	Ki	nM	199.53	CHEMBL4045	Homo sapiens	pKi		6.7
active	9532804	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCCn1c(C2CCNCC2)nc(-c2ccc(Cl)c(Cl)c2)c1-c1ccnc(NC2CCCCC2)n1		CHEMBL437747	=	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9532805	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cn1cc(-c2cccc(NC(=O)c3ccc(C(C)(C)C)cc3)c2CO)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O		CHEMBL2001584	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9532806	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL507936	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
active	9532807	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=S(=O)(NCCNCC=Cc1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL1987756	=	Ki	nM	2511.89	CHEMBL4045	Homo sapiens	pKi		5.6
active	9532808	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1967998	=	Ki	nM	100.0	CHEMBL4045	Homo sapiens	pKi		7.0
inactive	9532809	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1		CHEMBL1994321	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
active	9532810	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(C#N)ccc21		CHEMBL1978562	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9532811	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	=	Ki	nM	31.62	CHEMBL4045	Homo sapiens	pKi		7.5
inactive	9532812	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	FC(F)(F)c1ccc(-c2nnc3ccc(NC4CC4)nn23)cc1		CHEMBL451964	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
active	9532813	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(O)c1csc2c1NCCNC2=O		CHEMBL1974875	=	Ki	nM	19952.62	CHEMBL4045	Homo sapiens	pKi		4.7
inactive	9532814	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL1964307	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9532815	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccnc2[nH]c3cc(C(C)C)ccc3c(=O)c12		CHEMBL1989471	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9532816	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9532817	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9532818	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1		CHEMBL1971694	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9532819	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9532820	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9532821	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(=O)c1cc2c(-c3ccc(Br)cc3)cncc2s1		CHEMBL1978195	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9532822	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1F		CHEMBL1994361	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9532823	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9532824	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9532825	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(COc1cncc(-c2cc3cnccc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1972840	=	Ki	nM	1995.26	CHEMBL4045	Homo sapiens	pKi		5.7
inactive	9532826	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2)cc1		CHEMBL1977148	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9532827	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccc(CN(C)C)cc1Nc1nccc(-c2c(-c3cccc(NC(=O)Cc4ccccc4)c3)nc3sccn23)n1		CHEMBL1966842	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9532828	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9532829	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9532830	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2002165	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9532831	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9532832	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9532833	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cn1cncc1C(OCc1c(-c2ccc(OC(F)(F)F)cc2)cc(C#N)c(=O)n1C)c1ccc(C#N)cc1		CHEMBL127898	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9532834	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	=	Ki	nM	1258.93	CHEMBL4045	Homo sapiens	pKi		5.9
inactive	9532835	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9532836	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	=	Ki	nM	125.89	CHEMBL4045	Homo sapiens	pKi		6.9
inactive	9532837	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	N#Cc1ccc2nc(N)n(-c3nc4c(s3)CCCC4)c2c1		CHEMBL1996345	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9532838	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	=	Ki	nM	100.0	CHEMBL4045	Homo sapiens	pKi		7.0
active	9532839	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COCOc1cccc(OCOC)c1-c1ccc(NS(C)(=O)=O)cc1C(=O)OC		CHEMBL2004025	=	Ki	nM	1258.93	CHEMBL4045	Homo sapiens	pKi		5.9
active	9532840	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccc(-c2cc3c(NCCN)ccc(C(N)=O)c3[nH]2)cc1		CHEMBL1996048	=	Ki	nM	158.49	CHEMBL4045	Homo sapiens	pKi		6.8
inactive	9532841	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL461876	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9532842	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1		CHEMBL1965033	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9532843	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9532844	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	<	Ki	nM	5011.87	CHEMBL4045	Homo sapiens	pKi		5.3
inactive	9532845	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cc(C)c2c(n1)sc1c(N)ncnc12		CHEMBL504950	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
active	9532846	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccc(C2=NNc3cccc4c(OC)ccc2c34)cc1OC		CHEMBL1997335	=	Ki	nM	794.33	CHEMBL4045	Homo sapiens	pKi		6.1
active	9532847	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN(C)CCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1966425	=	Ki	nM	630.96	CHEMBL4045	Homo sapiens	pKi		6.2
inactive	9532848	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9532849	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536748	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COC(=O)c1c(-c2ccc(NC(=O)Nc3ccccc3)cc2)c2c(N)ncnn2c1C		CHEMBL1977041	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
active	9536749	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(=O)c1cccc2c1Nc1nnc(Cl)cc1C(=O)N2		CHEMBL1968070	=	Ki	nM	2511.89	CHEMBL4045	Homo sapiens	pKi		5.6
active	9536750	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9536751	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536752	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9536753	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL1998159	=	Ki	nM	12.59	CHEMBL4045	Homo sapiens	pKi		7.9
inactive	9536754	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9536755	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	=	Ki	nM	31.62	CHEMBL4045	Homo sapiens	pKi		7.5
inactive	9536756	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9536757	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536758	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Oc1cnc2ccc(-c3ccncc3)cc2c1		CHEMBL1973868	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9536759	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCCCC#Cc1ccc(CN2CC(C(=O)O)C2)cc1		CHEMBL1972462	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9536760	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536761	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536762	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=c1[nH]c2cc(Cl)cc(Cl)c2c(-c2cc(Cl)ccc2O)c1O		CHEMBL1974803	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9536763	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL1970074	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9536764	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9536765	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	794.33	CHEMBL4045	Homo sapiens	pKi		6.1
inactive	9536766	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C1NCc2c(Br)cccc21		CHEMBL1984500	<	Ki	nM	63095.73	CHEMBL4045	Homo sapiens	pKi		4.2
active	9536767	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	=	Ki	nM	501.19	CHEMBL4045	Homo sapiens	pKi		6.3
inactive	9536768	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536769	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9536770	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCN(CC)CCOc1ccc(-c2nc3c(C(N)=O)cccc3[nH]2)cc1		CHEMBL1984044	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9536771	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536772	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12		CHEMBL1966816	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9536773	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536774	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	<	Ki	nM	2511.89	CHEMBL4045	Homo sapiens	pKi		5.6
inactive	9536775	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536776	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(=NNC(=O)c1nnn(-c2nonc2N)c1-c1ccccc1)c1ccco1		CHEMBL1890036	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9536777	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCCCNC(=O)c1cn(C(CC)CC)c(=O)c2cc(OC)c(OC)cc12		CHEMBL1982700	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9536778	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9536779	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C1CC(c2ccc(Cl)cc2Cl)Cc2nc3cc(Cl)ccc3c(O)c21		CHEMBL326282	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9536780	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(N)=O)cc2)n1		CHEMBL1977634	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9536781	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCOc1ccccc1C=NNC(=O)c1nnn(-c2nonc2N)c1N1CCCC1		CHEMBL1992732	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9536782	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536783	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536784	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9536785	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536786	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	5011.87	CHEMBL4045	Homo sapiens	pKi		5.3
inactive	9536787	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CCC(N2CCCC2)CC1		CHEMBL2007151	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9536788	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2)c1		CHEMBL1971606	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9536789	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536790	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	3981.07	CHEMBL4045	Homo sapiens	pKi		5.4
active	9536791	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)c1cc(=O)[nH]c2[nH][nH]c(=O)c12		CHEMBL1999120	=	Ki	nM	50118.72	CHEMBL4045	Homo sapiens	pKi		4.3
inactive	9536792	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9536793	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536794	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NCCOc1cccc(Nc2ccnc(N)n2)c1		CHEMBL1995448	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
active	9536795	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	=	Ki	nM	1258.93	CHEMBL4045	Homo sapiens	pKi		5.9
inactive	9536796	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(OC(F)F)ccc12		CHEMBL1981215	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9536797	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1974457	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9536798	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	<	Ki	nM	2511.89	CHEMBL4045	Homo sapiens	pKi		5.6
active	9536799	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1999414	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536800	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cc(F)cc12		CHEMBL1967336	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9536801	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1Cl)c1ccccc1F		CHEMBL2001228	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9536802	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1Cl		CHEMBL2006581	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9536803	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCC#N)c2)n1		CHEMBL1979855	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536804	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	<	Ki	nM	25118.86	CHEMBL4045	Homo sapiens	pKi		4.6
inactive	9536805	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	N#Cc1ccc(-c2ccncc2)cc1NCc1ccccc1		CHEMBL1967992	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9536806	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9536807	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536808	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL2006450	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9536809	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9536810	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	=	Ki	nM	398.11	CHEMBL4045	Homo sapiens	pKi		6.4
inactive	9536811	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536812	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)ccc(F)c12		CHEMBL2001987	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9536813	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	=	Ki	nM	316.23	CHEMBL4045	Homo sapiens	pKi		6.5
inactive	9536814	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCc1c(-c2ccc(C(C)=O)cc2)[nH]c2nccnc12		CHEMBL1994555	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9536815	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9536816	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3coc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1983640	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9536817	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	<	Ki	nM	3981.07	CHEMBL4045	Homo sapiens	pKi		5.4
active	9536818	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	=	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9536819	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	<	Ki	nM	2511.89	CHEMBL4045	Homo sapiens	pKi		5.6
active	9536820	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(=O)c1cc2c(-c3ccc(Br)c(F)c3F)cncc2s1		CHEMBL1999918	=	Ki	nM	630.96	CHEMBL4045	Homo sapiens	pKi		6.2
inactive	9536821	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1974254	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9536822	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	c1ccc(CNc2nc(Nc3cc(C4CC4)[nH]n3)c3sccc3n2)cc1		CHEMBL1997924	=	Ki	nM	3.981	CHEMBL4045	Homo sapiens	pKi		8.4
inactive	9536823	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536824	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9536825	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	=	Ki	nM	1000.0	CHEMBL4045	Homo sapiens	pKi		6.0
inactive	9536826	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN(C)c1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)c1ccccc1		CHEMBL1978267	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9536827	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9536828	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9536829	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	=	Ki	nM	630.96	CHEMBL4045	Homo sapiens	pKi		6.2
inactive	9536830	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCC(N)=O		CHEMBL485556	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
active	9536831	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	=	Ki	nM	316.23	CHEMBL4045	Homo sapiens	pKi		6.5
inactive	9536832	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536833	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536834	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12		CHEMBL2006778	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9536835	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
active	9536836	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	=	Ki	nM	1258.93	CHEMBL4045	Homo sapiens	pKi		5.9
inactive	9536837	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(=O)c1cccc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1997025	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
active	9536838	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	=	Ki	nM	1000.0	CHEMBL4045	Homo sapiens	pKi		6.0
active	9536839	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=c1[nH]c2cc(Br)cnc2[nH]1		CHEMBL1975921	=	Ki	nM	25118.86	CHEMBL4045	Homo sapiens	pKi		4.6
active	9536840	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)csc12		CHEMBL1982476	=	Ki	nM	7943.28	CHEMBL4045	Homo sapiens	pKi		5.1
inactive	9536841	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C1C(=NNc2cccc3c(=O)[nH][nH]c(=O)c23)C(c2ccccc2)=NN1c1ccccc1		CHEMBL1984274	<	Ki	nM	5011.87	CHEMBL4045	Homo sapiens	pKi		5.3
inactive	9536842	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9536843	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536844	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(CCC(=O)O)(c1ccc(O)c(N)c1)c1ccc(O)c(N)c1		CHEMBL1975923	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9536845	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cc(Nc2nc(Cl)cc(NCc3ccccc3)n2)n[nH]1		CHEMBL2005449	=	Ki	nM	1258.93	CHEMBL4045	Homo sapiens	pKi		5.9
inactive	9536846	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(O)C1CN(Cc2ccc(OCc3ccccc3)cc2Cl)C1		CHEMBL1987998	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9536847	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9536848	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(=O)c1cc2ccncc2s1		CHEMBL1971534	=	Ki	nM	31622.78	CHEMBL4045	Homo sapiens	pKi		4.5
inactive	9536849	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	5011.87	CHEMBL4045	Homo sapiens	pKi		5.3
active	9536850	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc([N+](=O)[O-])cc2)n1		CHEMBL242865	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536851	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1n[nH]c2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc12		CHEMBL1997623	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
active	9536852	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O		CHEMBL2002479	=	Ki	nM	39.81	CHEMBL4045	Homo sapiens	pKi		7.4
inactive	9536853	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCN(C)CCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1993166	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
active	9536854	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	=	Ki	nM	398.11	CHEMBL4045	Homo sapiens	pKi		6.4
inactive	9536855	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536856	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	c1ccc(-c2n[nH]cc2-c2ccncc2)cc1		CHEMBL1992644	<	Ki	nM	25118.86	CHEMBL4045	Homo sapiens	pKi		4.6
inactive	9536857	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(NS(=O)(=O)c1ccc(NCCSc2ccc(O)cc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1		CHEMBL1992645	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9536858	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536859	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	[2H]C([2H])([2H])Oc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1998110	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9536860	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536861	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F		CHEMBL1981079	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9536862	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	1995.26	CHEMBL4045	Homo sapiens	pKi		5.7
active	9536863	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	=	Ki	nM	630.96	CHEMBL4045	Homo sapiens	pKi		6.2
active	9536864	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	=	Ki	nM	316.23	CHEMBL4045	Homo sapiens	pKi		6.5
inactive	9536865	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1967116	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9536866	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4ccc(Cl)cc4)c3)c12		CHEMBL1990590	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9536867	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1nn(C)c2c1c(=O)c1cc(Cl)ccc1n2OCC(C)C		CHEMBL1977814	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
active	9536868	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	=	Ki	nM	1258.93	CHEMBL4045	Homo sapiens	pKi		5.9
inactive	9536869	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9536870	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	OCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1974617	=	Ki	nM	31622.78	CHEMBL4045	Homo sapiens	pKi		4.5
inactive	9536871	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9536872	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc(Nc2ncnc(N3CCCc4cc(C)ccc43)n2)cc(OC)c1OC		CHEMBL1992125	=	Ki	nM	1258.93	CHEMBL4045	Homo sapiens	pKi		5.9
inactive	9536873	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536874	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536875	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
active	9536876	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	125.89	CHEMBL4045	Homo sapiens	pKi		6.9
active	9536877	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	=	Ki	nM	630.96	CHEMBL4045	Homo sapiens	pKi		6.2
active	9536878	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C1NS(=O)(=O)c2ccc(Cl)cc21		CHEMBL1967612	=	Ki	nM	50118.72	CHEMBL4045	Homo sapiens	pKi		4.3
inactive	9536879	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536880	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536881	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Cc1ccccc1Cl)Nc1ccc2cn[nH]c2c1		CHEMBL1987533	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9536882	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9536883	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	Ki	nM	0.3162	CHEMBL4045	Homo sapiens	pKi		9.5
active	9536884	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	=	Ki	nM	1258.93	CHEMBL4045	Homo sapiens	pKi		5.9
inactive	9536885	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	<	Ki	nM	2511.89	CHEMBL4045	Homo sapiens	pKi		5.6
inactive	9536886	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	<	Ki	nM	2511.89	CHEMBL4045	Homo sapiens	pKi		5.6
inactive	9536887	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	<	Ki	nM	1258.93	CHEMBL4045	Homo sapiens	pKi		5.9
inactive	9536888	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536889	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	<	Ki	nM	5011.87	CHEMBL4045	Homo sapiens	pKi		5.3
active	9536890	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	=	Ki	nM	1258.93	CHEMBL4045	Homo sapiens	pKi		5.9
inactive	9536891	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2ccc(F)cc12		CHEMBL2007603	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9536892	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9536893	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9536894	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Cc1cccs1)Nc1nc2ccccc2s1		CHEMBL1421720	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9536895	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1nnc2cncc(Cl)n12		CHEMBL1968130	=	Ki	nM	19952.62	CHEMBL4045	Homo sapiens	pKi		4.7
inactive	9536896	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536897	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9536898	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536899	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1		CHEMBL2004771	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9536900	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1992922	=	Ki	nM	1000.0	CHEMBL4045	Homo sapiens	pKi		6.0
inactive	9536901	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CC(CN2CCCC2)C1		CHEMBL1988370	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9536902	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9536903	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	=	Ki	nM	1258.93	CHEMBL4045	Homo sapiens	pKi		5.9
inactive	9536904	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536905	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9536906	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(COc1cncc(-c2ccc(F)cc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1996543	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9536907	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536908	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9536909	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536910	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	<	Ki	nM	3981.07	CHEMBL4045	Homo sapiens	pKi		5.4
inactive	9536911	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536912	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536913	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1		CHEMBL2004872	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536914	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	<	Ki	nM	15848.93	CHEMBL4045	Homo sapiens	pKi		4.8
inactive	9536915	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cc(OCc2ccc(Cl)c(Cl)c2)ccc1CN1CC(C(=O)O)C1		CHEMBL1990223	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9536916	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536917	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)(c1cc(Br)c(O)c(I)c1)c1cc(Br)c(O)c(I)c1		CHEMBL1964382	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9536918	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN(C)CC(O)COc1ccc(Nc2nccc(Nc3cc(Cl)ccc3Cl)n2)cc1		CHEMBL101311	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9536919	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536920	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536921	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536922	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
active	9536923	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	=	Ki	nM	398.11	CHEMBL4045	Homo sapiens	pKi		6.4
active	9536924	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cc(=O)n2ccc(CN(C)C)c(O)c2n1		CHEMBL1988581	=	Ki	nM	50.12	CHEMBL4045	Homo sapiens	pKi		7.3
inactive	9536925	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(=O)O)cc2)n1		CHEMBL2005699	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9536926	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536927	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4snc(N)c34)cc2)c1		CHEMBL1976328	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9536928	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
active	9536929	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCN(C(C)=O)c1ccc(Nc2nc(NC3CC3)c3nc[nH]c3n2)cc1		CHEMBL2006564	=	Ki	nM	125.89	CHEMBL4045	Homo sapiens	pKi		6.9
active	9536930	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)cc1OC		CHEMBL1964399	=	Ki	nM	630.96	CHEMBL4045	Homo sapiens	pKi		6.2
active	9536931	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	=	Ki	nM	398.11	CHEMBL4045	Homo sapiens	pKi		6.4
active	9536932	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9536933	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	1995.26	CHEMBL4045	Homo sapiens	pKi		5.7
active	9536934	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2ccccc21		CHEMBL1978167	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536935	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1		CHEMBL1965988	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9536936	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	<	Ki	nM	2511.89	CHEMBL4045	Homo sapiens	pKi		5.6
inactive	9536937	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536938	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	c1ccc(Cc2cc(-c3ccc4[nH]ncc4c3)on2)cc1		CHEMBL1682357	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9536939	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	<	Ki	nM	1258.93	CHEMBL4045	Homo sapiens	pKi		5.9
inactive	9536940	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCOc1nc(C(=O)NCc2cccnc2)cc(N)c1C#N		CHEMBL209534	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9536941	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9536942	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Ki	nM	79.43	CHEMBL4045	Homo sapiens	pKi		7.1
inactive	9536943	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9536944	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	C(=Cc1cncc(OC2CCNC2)c1)c1ccncc1		CHEMBL1966087	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9536945	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536946	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536947	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
active	9536948	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536949	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1998470	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9536950	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C)c1		CHEMBL1984432	=	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9536951	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL219722	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9536952	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccccc1-c1ccnc(Nc2cccc(S(C)(=O)=O)c2)n1		CHEMBL1975903	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9536953	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9536954	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCOC(=O)C1=C(N)n2c(sc(=Cc3cccs3)c2=O)=C(C(N)=O)C1c1cccs1		CHEMBL2004365	=	Ki	nM	630.96	CHEMBL4045	Homo sapiens	pKi		6.2
inactive	9536955	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9536956	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Ki	nM	501.19	CHEMBL4045	Homo sapiens	pKi		6.3
inactive	9536957	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536958	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536959	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536960	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	N#Cc1ccc2nc(N)n(-c3nccs3)c2c1		CHEMBL1988805	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9536961	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	=	Ki	nM	794.33	CHEMBL4045	Homo sapiens	pKi		6.1
inactive	9536962	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9536963	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	=	Ki	nM	39.81	CHEMBL4045	Homo sapiens	pKi		7.4
inactive	9536964	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	<	Ki	nM	5011.87	CHEMBL4045	Homo sapiens	pKi		5.3
active	9536965	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	=	Ki	nM	1258.93	CHEMBL4045	Homo sapiens	pKi		5.9
inactive	9536966	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1ccc(-c2ccc3cn[nH]c3c2)cc1)Nc1cccc(F)c1		CHEMBL1969942	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9536967	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1978567	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9536968	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9536969	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	=	Ki	nM	1258.93	CHEMBL4045	Homo sapiens	pKi		5.9
active	9536970	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	=	Ki	nM	125.89	CHEMBL4045	Homo sapiens	pKi		6.9
inactive	9536971	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9536972	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	=	Ki	nM	1000.0	CHEMBL4045	Homo sapiens	pKi		6.0
active	9536973	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	=	Ki	nM	251.19	CHEMBL4045	Homo sapiens	pKi		6.6
inactive	9536974	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	3981.07	CHEMBL4045	Homo sapiens	pKi		5.4
inactive	9536975	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2006836	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9536976	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#Cc5cccnc5)cnc(N)c34)cc2)c1		CHEMBL1971947	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9536977	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	<	Ki	nM	3981.07	CHEMBL4045	Homo sapiens	pKi		5.4
inactive	9536978	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9536979	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9536980	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536981	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9536982	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL49120	=	Ki	nM	316.23	CHEMBL4045	Homo sapiens	pKi		6.5
inactive	9536983	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
active	9536984	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	19.95	CHEMBL4045	Homo sapiens	pKi		7.7
inactive	9536985	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9536986	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9540902	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9540903	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=S(=O)(O)c1ccc(NCc2ccc3c(c2)OCO3)c2c(O)cccc12		CHEMBL2004544	=	Ki	nM	398.11	CHEMBL4045	Homo sapiens	pKi		6.4
active	9540904	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCC(=O)Nc1ccc(C(=O)N2CCNCC2)c(O)c1		CHEMBL1988141	=	Ki	nM	398.11	CHEMBL4045	Homo sapiens	pKi		6.4
inactive	9540905	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9540906	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)cnc2c(-c3ccc4c(c3)OCO4)cnn12		CHEMBL1977134	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9540907	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9540908	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CSc1cnc2c(ccc3cnccc32)c1O		CHEMBL2006933	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9540909	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COCC#Cc1cccc2c1Cc1c(-c3cccs3)n[nH]c1-2		CHEMBL1985206	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9540910	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9540911	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9540912	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	=	Ki	nM	63.1	CHEMBL4045	Homo sapiens	pKi		7.2
inactive	9540913	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O		CHEMBL1987359	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9540914	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	C=CCc1cccc2c(=NO)cc(-c3ccccc3)oc12		CHEMBL1977749	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9540915	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(=NNC(=N)N)c1cc(NC(=O)c2cccc(C(=O)Nc3cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c3)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL2000685	=	Ki	nM	199.53	CHEMBL4045	Homo sapiens	pKi		6.7
active	9540916	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=c1[nH][nH]c2ccc(Br)cc12		CHEMBL2001613	=	Ki	nM	12589.25	CHEMBL4045	Homo sapiens	pKi		4.9
active	9540917	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	Ki	nM	630.96	CHEMBL4045	Homo sapiens	pKi		6.2
inactive	9540918	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccc2[nH]cc(C=C3C(=O)Nc4ccccc43)c2c1		CHEMBL1997275	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9540919	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(=O)c1cc2c(-c3ccc(Nc4nc5ccccc5o4)cc3)cnc(N)c2s1		CHEMBL1993904	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9540920	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2ccc(Cl)cc12		CHEMBL1967513	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9540921	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4ccc(C#N)cc4)c3)c12		CHEMBL2000724	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9540922	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(CO)ccc4F)cc3)c12		CHEMBL1985311	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9540923	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)cc3n21		CHEMBL1989265	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9540924	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9540925	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN(Cc1cc(Cl)c(O)c2ncccc12)C1CCCCC1		CHEMBL1982413	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9540926	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	=	Ki	nM	39.81	CHEMBL4045	Homo sapiens	pKi		7.4
inactive	9540927	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CCC(N2CCCC2)CC1		CHEMBL1965910	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9540928	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	<	Ki	nM	5011.87	CHEMBL4045	Homo sapiens	pKi		5.3
inactive	9540929	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(-c2c(-c3ccncc3)nc(NCC(N)Cc3ccccc3)n(C)c2=O)c1		CHEMBL1971430	<	Ki	nM	3981.07	CHEMBL4045	Homo sapiens	pKi		5.4
inactive	9540930	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9540931	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9540932	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1n[nH]c2ccc(-c3cncc(OCC(CN)Cc4ccccc4)c3)cc12		CHEMBL2000271	=	Ki	nM	630.96	CHEMBL4045	Homo sapiens	pKi		6.2
active	9540933	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cc(=O)[nH]c2[nH]n(-c3ccccc3)c(=O)c12		CHEMBL1985042	=	Ki	nM	79432.82	CHEMBL4045	Homo sapiens	pKi		4.1
inactive	9540934	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(F)c(F)cc12		CHEMBL1981792	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9540935	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(NCCc1cccs1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1987535	=	Ki	nM	1995.26	CHEMBL4045	Homo sapiens	pKi		5.7
inactive	9540936	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9540937	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1ccccc1		CHEMBL2004692	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9540938	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9540939	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Clc1cc(Nc2nc(NC3CC3)c3sccc3n2)ccc1N1CCOCC1		CHEMBL2002586	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9540940	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(=O)c1cc(-c2cccs2)n2nccc2n1		CHEMBL1987815	=	Ki	nM	100000.0	CHEMBL4045	Homo sapiens	pKi		4.0
inactive	9540941	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9540942	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1981133	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9540943	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)Oc1cc(Nc2nc(NC(C)c3ccc(F)cn3)ncc2Cl)n[nH]1		CHEMBL2007421	=	Ki	nM	158.49	CHEMBL4045	Homo sapiens	pKi		6.8
inactive	9540944	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9540945	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9540946	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c(=O)n(C)c1		CHEMBL1973138	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9540947	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	=	Ki	nM	251.19	CHEMBL4045	Homo sapiens	pKi		6.6
active	9540948	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=c1[nH]c2ccc(Cl)cc2c2ncnn12		CHEMBL1992673	=	Ki	nM	79432.82	CHEMBL4045	Homo sapiens	pKi		4.1
active	9540949	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	=	Ki	nM	251.19	CHEMBL4045	Homo sapiens	pKi		6.6
inactive	9540950	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9540951	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN(C)C1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1969151	=	Ki	nM	79.43	CHEMBL4045	Homo sapiens	pKi		7.1
inactive	9540952	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9540953	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(F)ccc21		CHEMBL1993335	=	Ki	nM	316.23	CHEMBL4045	Homo sapiens	pKi		6.5
inactive	9540954	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)NC1=NNC(=O)C1=Cc1cc2ccccc2[nH]1		CHEMBL1988692	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9540955	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1nc(Cl)cc(-c2c[nH]c3ncccc23)n1		CHEMBL2007574	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9540956	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9540957	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccc(-c2cnc3c(Br)cnn3c2)cc1		CHEMBL443962	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9540958	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9540959	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	<	Ki	nM	1000.0	CHEMBL4045	Homo sapiens	pKi		6.0
inactive	9540960	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cn1ncc2c1CCCC2=O		CHEMBL1981107	<	Ki	nM	25118.86	CHEMBL4045	Homo sapiens	pKi		4.6
inactive	9540961	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9540962	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)NCCO)c2)n1		CHEMBL1998680	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9540963	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
active	9540964	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	=	Ki	nM	794.33	CHEMBL4045	Homo sapiens	pKi		6.1
active	9540965	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9540966	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1		CHEMBL1979176	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9540967	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1970317	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9540968	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9540969	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9540970	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9540971	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCCNC(=O)c1ccc(Nc2nc(CC)c3cc[nH]c3n2)cc1		CHEMBL1997007	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9540972	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	<	Ki	nM	3981.07	CHEMBL4045	Homo sapiens	pKi		5.4
active	9540973	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCN(CC)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1983195	=	Ki	nM	630.96	CHEMBL4045	Homo sapiens	pKi		6.2
inactive	9540974	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1975490	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9540975	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	<	Ki	nM	2511.89	CHEMBL4045	Homo sapiens	pKi		5.6
inactive	9540976	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1nc2c(O)cccc2s1)Nc1ccccc1-c1ccccc1		CHEMBL2002690	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9540977	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccsc2)n1		CHEMBL2006567	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9540978	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9540979	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1985580	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9540980	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12		CHEMBL1980540	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9540981	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9540982	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9540983	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9540984	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccc(CN(C)C)cc1Nc1nccc(-c2c(-c3cccc(NC(=O)c4c(F)cccc4F)c3)nc3sccn23)n1		CHEMBL1997051	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9540985	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9540986	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C1Nc2ccccc2C1=Cc1c[nH]c2ccccc12		CHEMBL1986590	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9540987	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	<	Ki	nM	7943.28	CHEMBL4045	Homo sapiens	pKi		5.1
inactive	9540988	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	c1cc2[nH]ncc2cc1-c1cc(CN2CCCCC2)no1		CHEMBL1682360	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9540989	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9540990	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCC(N)C3)c21		CHEMBL1870106	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9540991	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9540992	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9540993	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9540994	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9540995	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	125.89	CHEMBL4045	Homo sapiens	pKi		6.9
active	9540996	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	c1ccc(-c2ccnc3[nH]ccc23)cc1		CHEMBL482538	=	Ki	nM	50118.72	CHEMBL4045	Homo sapiens	pKi		4.3
inactive	9540997	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9540998	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccc(C)c(NC(=O)c2cc(-c3ccco3)nc3ccccc23)c1		CHEMBL1984296	=	Ki	nM	1995.26	CHEMBL4045	Homo sapiens	pKi		5.7
inactive	9540999	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	<	Ki	nM	3981.07	CHEMBL4045	Homo sapiens	pKi		5.4
inactive	9541000	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9541001	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1n[nH]c2cccc(-c3ccc(Br)cc3)c12		CHEMBL1990346	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
active	9541002	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9541003	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CNCC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1964441	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9541004	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1c(F)cccc1F		CHEMBL1991410	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9541005	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	ON=C(c1nc2ccccc2[nH]1)c1nc2ccccc2[nH]1		CHEMBL546797	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9541006	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9541007	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9541008	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCOCCO)c2)n1		CHEMBL1978271	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9541009	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9541010	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc(OCCCn4cccc4)c4[nH]nc(N)c34)cc2)c1		CHEMBL2007266	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9541011	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	<	Ki	nM	2511.89	CHEMBL4045	Homo sapiens	pKi		5.6
inactive	9541012	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(CCC(=O)Nc1cc(C(F)(F)F)ccc1Cl)NN=Cc1c[nH]c2ccccc12		CHEMBL1994308	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9541013	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	=	Ki	nM	398.11	CHEMBL4045	Homo sapiens	pKi		6.4
active	9541014	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1nc(=O)[nH]c2sccc12		CHEMBL2007097	=	Ki	nM	50118.72	CHEMBL4045	Homo sapiens	pKi		4.3
active	9541015	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	398.11	CHEMBL4045	Homo sapiens	pKi		6.4
active	9541016	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	=	Ki	nM	158.49	CHEMBL4045	Homo sapiens	pKi		6.8
active	9541017	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9541018	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	=	Ki	nM	794.33	CHEMBL4045	Homo sapiens	pKi		6.1
active	9541019	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Ki	nM	10.0	CHEMBL4045	Homo sapiens	pKi		8.0
inactive	9541020	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9541021	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9541022	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	=	Ki	nM	63.1	CHEMBL4045	Homo sapiens	pKi		7.2
active	9541023	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	=	Ki	nM	158.49	CHEMBL4045	Homo sapiens	pKi		6.8
inactive	9541024	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9541025	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	=	Ki	nM	100.0	CHEMBL4045	Homo sapiens	pKi		7.0
active	9541026	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cnc(Nc2nc(NC(C)C)ncc2Br)s1		CHEMBL1973013	=	Ki	nM	1995.26	CHEMBL4045	Homo sapiens	pKi		5.7
inactive	9541027	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9541028	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	N#CC1=C(N)n2c(sc(=Cc3ccco3)c2=O)=C(C(N)=O)C1c1ccco1		CHEMBL1989805	=	Ki	nM	158.49	CHEMBL4045	Homo sapiens	pKi		6.8
inactive	9541029	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9541030	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9541031	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC		CHEMBL1983025	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
active	9541032	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccc(-n2ccc3cnc(Nc4cc(OC)c(OC)c(OC)c4)nc32)cc1		CHEMBL1975927	=	Ki	nM	398.11	CHEMBL4045	Homo sapiens	pKi		6.4
inactive	9541033	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	<	Ki	nM	1995.26	CHEMBL4045	Homo sapiens	pKi		5.7
inactive	9541034	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9541035	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9541036	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(=O)c1cc2c(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)cncc2s1		CHEMBL2002322	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
active	9541037	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(Nc1cncc(-n2cnc3ccc(C#N)cc32)n1)c1ccccc1F		CHEMBL1977138	=	Ki	nM	63.1	CHEMBL4045	Homo sapiens	pKi		7.2
inactive	9541038	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccc(F)c(-c2ccc3nnc(N)n3c2)c1		CHEMBL2002323	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
active	9541039	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	=	Ki	nM	7.943	CHEMBL4045	Homo sapiens	pKi		8.1
active	9541040	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	c1ccc(C2CCc3[nH]ncc3C2)cc1		CHEMBL2000879	=	Ki	nM	100000.0	CHEMBL4045	Homo sapiens	pKi		4.0
inactive	9541041	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9541042	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NCCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1972258	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9541043	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN(C)c1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)Cc1ccccc1		CHEMBL1969483	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9541044	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C1Nc2cc(-c3ccc(O)cc3)ccc2C1=Cc1ccc[nH]1		CHEMBL1980329	=	Ki	nM	158.49	CHEMBL4045	Homo sapiens	pKi		6.8
active	9541045	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	c1nc(-c2ccc3c(c2)OCO3)c2cc[nH]c2n1		CHEMBL2004515	=	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9541046	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	<	Ki	nM	5011.87	CHEMBL4045	Homo sapiens	pKi		5.3
active	9541047	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1cccc(C2Nc3ccc4ccccc4c3C3C=CCC32)c1)c1ccc(F)cc1		CHEMBL1992042	=	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9541048	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(Cl)cc4Cl)c(=O)c3=O)ccc21		CHEMBL2005548	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9541049	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9541050	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Ki	nM	158.49	CHEMBL4045	Homo sapiens	pKi		6.8
inactive	9541051	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL1992740	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9541052	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)s2)c1		CHEMBL1994724	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9541053	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc(-c2csc3c(C=CC(=O)NCCN(C)C)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1989267	=	Ki	nM	630.96	CHEMBL4045	Homo sapiens	pKi		6.2
inactive	9541054	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9541055	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9541056	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9541057	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9541058	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9541059	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Ki	nM	5011.87	CHEMBL4045	Homo sapiens	pKi		5.3
inactive	9541060	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9541061	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	C#Cc1cn(C2CCCC2)c2ncnc(N)c12		CHEMBL1993877	=	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9541062	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9541063	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	=	Ki	nM	630.96	CHEMBL4045	Homo sapiens	pKi		6.2
active	9541064	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COCc1nnn(-c2nonc2N)c1C(=O)NN=C(C)c1ccc(O)cc1O		CHEMBL1991180	=	Ki	nM	2511.89	CHEMBL4045	Homo sapiens	pKi		5.6
inactive	9541065	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	1995.26	CHEMBL4045	Homo sapiens	pKi		5.7
inactive	9541066	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9541067	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	<	Ki	nM	2511.89	CHEMBL4045	Homo sapiens	pKi		5.6
active	9541068	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCO)c(Cl)cc1NC(=O)N2		CHEMBL413779	=	Ki	nM	125.89	CHEMBL4045	Homo sapiens	pKi		6.9
inactive	9541069	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(Cl)ccc12		CHEMBL1981744	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9541070	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9541071	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1		CHEMBL2002446	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9541072	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9541073	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccccc1-c1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL2000029	=	Ki	nM	158.49	CHEMBL4045	Homo sapiens	pKi		6.8
inactive	9541074	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL1973961	<	Ki	nM	2511.89	CHEMBL4045	Homo sapiens	pKi		5.6
active	9541075	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	=	Ki	nM	630.96	CHEMBL4045	Homo sapiens	pKi		6.2
inactive	9541076	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	<	Ki	nM	7943.28	CHEMBL4045	Homo sapiens	pKi		5.1
inactive	9541077	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCCO)c2)n1		CHEMBL1994977	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9541078	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9541079	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Oc1ccc2nc(-c3ccc(Sc4ccc(-c5nc6ccc(O)cc6[nH]5)cc4)cc3)[nH]c2c1		CHEMBL2001149	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9541080	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9541081	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCOc1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)Cc1ccccc1		CHEMBL2000078	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9541082	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccc2c(c1)c(-c1cc3nc(Br)cnc3[nH]1)cn2C		CHEMBL2005478	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9541083	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	3.981	CHEMBL4045	Homo sapiens	pKi		8.4
active	9541084	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cccc(OC)c1CNc1nc(NC2CCCCC2)nc2ccc(Cl)cc12		CHEMBL1996646	=	Ki	nM	630.96	CHEMBL4045	Homo sapiens	pKi		6.2
inactive	9541085	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1979773	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9541086	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	=	Ki	nM	398.11	CHEMBL4045	Homo sapiens	pKi		6.4
inactive	9541087	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2003657	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9541088	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9541089	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Cc1ccccc1)Nc1cc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)ccc1Cl		CHEMBL2005482	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9541090	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCCN(C)C)cc2NC3=O)ccc1O		CHEMBL1996702	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9541091	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	2511.89	CHEMBL4045	Homo sapiens	pKi		5.6
inactive	9541092	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccccc1Nc1nccc(-c2c(-c3cccc(NC(=O)Cc4ccccc4)c3)nc3sccn23)n1		CHEMBL1997909	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9541093	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1ccc(-c2ccc(=O)[nH]n2)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL2007124	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9541094	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	<	Ki	nM	1995.26	CHEMBL4045	Homo sapiens	pKi		5.7
inactive	9541095	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)N(C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1)C(C)C		CHEMBL2006156	<	Ki	nM	5011.87	CHEMBL4045	Homo sapiens	pKi		5.3
active	9541096	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	N#Cc1ccc2c(c1)C(c1ccc3c(n1)CCCC3O)C(=O)N2		CHEMBL1985681	=	Ki	nM	1258.93	CHEMBL4045	Homo sapiens	pKi		5.9
inactive	9541097	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9541098	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	=	Ki	nM	3981.07	CHEMBL4045	Homo sapiens	pKi		5.4
inactive	9541099	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	<	Ki	nM	1000.0	CHEMBL4045	Homo sapiens	pKi		6.0
active	9541100	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	=	Ki	nM	2511.89	CHEMBL4045	Homo sapiens	pKi		5.6
active	9541101	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	=	Ki	nM	199.53	CHEMBL4045	Homo sapiens	pKi		6.7
active	9541102	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	=	Ki	nM	501.19	CHEMBL4045	Homo sapiens	pKi		6.3
active	9541103	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1ncnc2c1N=C(c1ccccc1)CCN2		CHEMBL262623	=	Ki	nM	15848.93	CHEMBL4045	Homo sapiens	pKi		4.8
inactive	9541104	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1984842	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9541105	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1		CHEMBL1969102	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
active	9541106	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL2004118	=	Ki	nM	1995.26	CHEMBL4045	Homo sapiens	pKi		5.7
active	9541107	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1682346	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9541108	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	=	Ki	nM	1258.93	CHEMBL4045	Homo sapiens	pKi		5.9
inactive	9541109	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CNC(=O)N1CCN(CCCOc2ccc3c(c2)-c2[nH]nc(-c4ccc(C#N)nc4)c2C3)CC1		CHEMBL2001998	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
active	9541110	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	=	Ki	nM	1995.26	CHEMBL4045	Homo sapiens	pKi		5.7
active	9541111	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9541112	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9541113	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9541114	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)(C)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1995211	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9541115	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	=	Ki	nM	794.33	CHEMBL4045	Homo sapiens	pKi		6.1
inactive	9541116	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9541117	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]ncc34)cc2)c1		CHEMBL375284	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9541118	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cccc(CNC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2006299	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9541119	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccc(-c2cc3nc(Br)cnc3[nH]2)cc1		CHEMBL1965169	=	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9541120	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Ki	nM	2511.89	CHEMBL4045	Homo sapiens	pKi		5.6
inactive	9541121	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(O)CO)c5)cnc(N)c34)cc2)cc1		CHEMBL1965170	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9541122	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9541123	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2005792	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9541124	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCOc1nc(C(=O)NCc2ccncc2)cc(N)c1C#N		CHEMBL1984206	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9541125	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O		CHEMBL462120	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9541126	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C1CCCCC1		CHEMBL1991577	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
active	9541127	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1n[nH]c2nc(Cl)sc12		CHEMBL1991867	=	Ki	nM	39810.72	CHEMBL4045	Homo sapiens	pKi		4.4
inactive	9541128	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9541129	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
active	9541130	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1c(-c2nc3ccccc3[nH]2)c(O)cc2oc(C)cc(=O)c12		CHEMBL1972355	=	Ki	nM	794.33	CHEMBL4045	Homo sapiens	pKi		6.1
inactive	9541131	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)c(Cl)c1		CHEMBL1997892	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9541132	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)(O)c1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL2001641	=	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
active	9541133	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccc(-c2cc(-c3cc(Br)ccc3O)[nH]c(=O)c2C#N)s1		CHEMBL1997193	=	Ki	nM	794.33	CHEMBL4045	Homo sapiens	pKi		6.1
inactive	9541134	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9541135	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)O)c2)n1		CHEMBL1964902	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9541136	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	=	Ki	nM	251.19	CHEMBL4045	Homo sapiens	pKi		6.6
inactive	9541137	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9541138	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL1972362	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9541139	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9541140	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	3981.07	CHEMBL4045	Homo sapiens	pKi		5.4
active	9545041	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	=	Ki	nM	199.53	CHEMBL4045	Homo sapiens	pKi		6.7
active	9545042	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)n2)s1		CHEMBL1983715	=	Ki	nM	100.0	CHEMBL4045	Homo sapiens	pKi		7.0
active	9545043	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1971017	=	Ki	nM	630.96	CHEMBL4045	Homo sapiens	pKi		6.2
active	9545044	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	=	Ki	nM	1000.0	CHEMBL4045	Homo sapiens	pKi		6.0
inactive	9545045	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12		CHEMBL1986597	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545046	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	<	Ki	nM	7943.28	CHEMBL4045	Homo sapiens	pKi		5.1
inactive	9545047	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545048	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL2000104	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
active	9545049	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	=	Ki	nM	1258.93	CHEMBL4045	Homo sapiens	pKi		5.9
inactive	9545050	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
active	9545051	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC1=NN(c2ccc(Cl)c(Cl)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1997349	=	Ki	nM	316.23	CHEMBL4045	Homo sapiens	pKi		6.5
inactive	9545052	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545053	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9545054	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9545055	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9545056	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9545057	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9545058	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545059	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9545060	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)Cc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL1980763	=	Ki	nM	1995.26	CHEMBL4045	Homo sapiens	pKi		5.7
active	9545061	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	=	Ki	nM	199.53	CHEMBL4045	Homo sapiens	pKi		6.7
inactive	9545062	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9545063	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	Ki	nM	398.11	CHEMBL4045	Homo sapiens	pKi		6.4
inactive	9545064	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc(-c2nn(C3CCC(N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1970879	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9545065	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1c(C=O)c(O)n2c(nc3ccccc32)c1C#N		CHEMBL1989856	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9545066	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9545067	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	<	Ki	nM	7943.28	CHEMBL4045	Homo sapiens	pKi		5.1
inactive	9545068	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9545069	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCCCNc1nc(N)c(C(=O)c2ccccc2)s1		CHEMBL2007479	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9545070	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN1CCC1COc1cncc(CCc2ccncc2)c1		CHEMBL1996155	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9545071	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2F)c1		CHEMBL1986851	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9545072	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	=	Ki	nM	10.0	CHEMBL4045	Homo sapiens	pKi		8.0
inactive	9545073	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	<	Ki	nM	7943.28	CHEMBL4045	Homo sapiens	pKi		5.1
inactive	9545074	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1682359	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
active	9545075	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4ccc(OC(F)F)cc4)cc3)c12		CHEMBL1972220	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9545076	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	=	Ki	nM	158.49	CHEMBL4045	Homo sapiens	pKi		6.8
inactive	9545077	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1ccccc1		CHEMBL1991846	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
active	9545078	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Fc1cccc(CNc2ncnc3[nH]cnc23)c1		CHEMBL2003785	=	Ki	nM	15848.93	CHEMBL4045	Homo sapiens	pKi		4.8
active	9545079	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	39.81	CHEMBL4045	Homo sapiens	pKi		7.4
active	9545080	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	=	Ki	nM	251.19	CHEMBL4045	Homo sapiens	pKi		6.6
inactive	9545081	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc(C=O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL207995	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9545082	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21		CHEMBL2001923	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9545083	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545084	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCOc1ccccc1-c1cccc(-c2n[nH]c3nc(O)cc(C)c23)c1		CHEMBL1983070	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9545085	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	=	Ki	nM	794.33	CHEMBL4045	Homo sapiens	pKi		6.1
inactive	9545086	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2003514	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9545087	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9545088	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9545089	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4c(Cl)cccc4Cl)s3)cc2)CC1		CHEMBL1989043	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9545090	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9545091	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	=	Ki	nM	1258.93	CHEMBL4045	Homo sapiens	pKi		5.9
inactive	9545092	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1OCC(O)CO		CHEMBL1981045	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9545093	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
active	9545094	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	c1ccc(Cn2nnc(-c3ccc4[nH]ncc4c3)c2C2CC2)cc1		CHEMBL1975418	=	Ki	nM	794.33	CHEMBL4045	Homo sapiens	pKi		6.1
inactive	9545095	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=c1[nH]c2ccc(Cl)cc2c(-c2ccccc2)c1C1=NNC(c2ccccc2)C1		CHEMBL1992796	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
active	9545096	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	=	Ki	nM	794.33	CHEMBL4045	Homo sapiens	pKi		6.1
inactive	9545097	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9545098	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCC(O)CO)c(Cl)cc1NC(=O)N2		CHEMBL223257	=	Ki	nM	1000.0	CHEMBL4045	Homo sapiens	pKi		6.0
inactive	9545099	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545100	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9545101	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCOC(=O)c1nc2c(=O)[nH]c3cc([N+](=O)[O-])c(NC(C)=O)cc3n2c1C		CHEMBL1997611	=	Ki	nM	2511.89	CHEMBL4045	Homo sapiens	pKi		5.6
active	9545102	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545103	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9545104	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1982465	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
active	9545105	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	=	Ki	nM	19.95	CHEMBL4045	Homo sapiens	pKi		7.7
inactive	9545106	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1		CHEMBL2003420	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545107	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545108	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1c(Cl)c(N2CCC(CN)C2)nc2[nH]cc(C(=O)O)c(=O)c12		CHEMBL1999774	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9545109	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
active	9545110	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(=O)Nc1ccc(-n2nc3ccc(N)nc3n2)cc1		CHEMBL2002723	=	Ki	nM	1258.93	CHEMBL4045	Homo sapiens	pKi		5.9
active	9545111	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	OC1CCN(c2ncnc3[nH]cc(-c4ccccc4)c23)CC1		CHEMBL1973395	=	Ki	nM	1258.93	CHEMBL4045	Homo sapiens	pKi		5.9
inactive	9545112	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545113	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545114	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C1Nc2ccccc2Nc2nnccc21		CHEMBL1971801	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
active	9545115	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C1Nc2ccccc2Nc2nnc(Cl)cc21		CHEMBL1968850	=	Ki	nM	3981.07	CHEMBL4045	Homo sapiens	pKi		5.4
inactive	9545116	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9545117	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	39.81	CHEMBL4045	Homo sapiens	pKi		7.4
inactive	9545118	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Brc1ccc2cnc(Nc3ccncn3)cc2c1		CHEMBL1984686	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9545119	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9545120	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9545121	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	=	Ki	nM	1258.93	CHEMBL4045	Homo sapiens	pKi		5.9
inactive	9545122	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9545123	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	=	Ki	nM	794.33	CHEMBL4045	Homo sapiens	pKi		6.1
inactive	9545124	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545125	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=S(=O)(Nc1ccc2c(c1)C(=NO)c1ccccc1-2)c1cccc(Br)c1		CHEMBL1973793	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9545126	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1		CHEMBL1969588	=	Ki	nM	3.981	CHEMBL4045	Homo sapiens	pKi		8.4
inactive	9545127	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC		CHEMBL1984711	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
active	9545128	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	1.0	CHEMBL4045	Homo sapiens	pKi		9.0
active	9545129	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCC1CC(NS(=O)(=O)C2CC2)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1992073	=	Ki	nM	1995.26	CHEMBL4045	Homo sapiens	pKi		5.7
inactive	9545130	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)cc1Cl		CHEMBL1990212	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
active	9545131	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9545132	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	=	Ki	nM	501.19	CHEMBL4045	Homo sapiens	pKi		6.3
active	9545133	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	=	Ki	nM	1000.0	CHEMBL4045	Homo sapiens	pKi		6.0
inactive	9545134	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(NC(CCO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1986143	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9545135	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1ncnc2sccc12		CHEMBL1972934	=	Ki	nM	50118.72	CHEMBL4045	Homo sapiens	pKi		4.3
inactive	9545136	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3sccc3n2)cc1		CHEMBL2007559	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9545137	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Cc1ccc(-c2cccnc2)cc1)Nc1ccc(SC(F)F)cc1		CHEMBL1992581	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9545138	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	c1ccc(Cc2cn(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682341	=	Ki	nM	2511.89	CHEMBL4045	Homo sapiens	pKi		5.6
inactive	9545139	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	<	Ki	nM	1995.26	CHEMBL4045	Homo sapiens	pKi		5.7
inactive	9545140	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545141	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545142	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	C#Cc1cc2c(cc1OC)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL1972250	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
active	9545143	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	=	Ki	nM	158.49	CHEMBL4045	Homo sapiens	pKi		6.8
inactive	9545144	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL2004072	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9545145	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545146	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9545147	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	=	Ki	nM	398.11	CHEMBL4045	Homo sapiens	pKi		6.4
inactive	9545148	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCNNc1cc(C)c(C#N)c2nc3ccccc3n12		CHEMBL2000433	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
active	9545149	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	N#CC(=Cc1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL1974157	=	Ki	nM	1258.93	CHEMBL4045	Homo sapiens	pKi		5.9
inactive	9545150	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(=O)OCCn1nc(-c2cccc(Br)c2)c2c(C(F)(F)F)cc(=O)[nH]c21		CHEMBL1984847	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9545151	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9545152	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545153	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Cc1ccc(OC(F)(F)F)cc1)N1CCC2(CC1)NCCc1c2[nH]c2ccccc12		CHEMBL1996576	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9545154	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccccc1Nc1nccc(-c2c(-c3cccc(NC(=O)c4ccccc4)c3)nc3sccn23)n1		CHEMBL1988076	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9545155	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9545156	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	=	Ki	nM	1995.26	CHEMBL4045	Homo sapiens	pKi		5.7
active	9545157	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	=	Ki	nM	100.0	CHEMBL4045	Homo sapiens	pKi		7.0
inactive	9545158	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545159	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL260092	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9545160	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	<	Ki	nM	5011.87	CHEMBL4045	Homo sapiens	pKi		5.3
inactive	9545161	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545162	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1n[nH]c2ncc(C#N)c(-c3ccccc3)c12		CHEMBL1965495	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9545163	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc2ncc3c(N)nc4c(C)c(N)ccc4c3c2cc1OC		CHEMBL235157	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9545164	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	=	Ki	nM	398.11	CHEMBL4045	Homo sapiens	pKi		6.4
inactive	9545165	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545166	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545167	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1		CHEMBL1173055	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9545168	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545169	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1		CHEMBL1992242	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
active	9545170	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	=	Ki	nM	1000.0	CHEMBL4045	Homo sapiens	pKi		6.0
inactive	9545171	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545172	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
active	9545173	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	=	Ki	nM	501.19	CHEMBL4045	Homo sapiens	pKi		6.3
inactive	9545174	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cccc(CNC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2004159	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9545175	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C1NC(=O)C(Nc2ccccc2)=C1Cl		CHEMBL2007138	<	Ki	nM	25118.86	CHEMBL4045	Homo sapiens	pKi		4.6
active	9545176	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	N#CC1=C(c2ccccc2)CC(c2ccc(Cl)cc2)C(C(=O)c2ccccc2)C1=O		CHEMBL1978371	=	Ki	nM	2511.89	CHEMBL4045	Homo sapiens	pKi		5.6
active	9545177	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	=	Ki	nM	398.11	CHEMBL4045	Homo sapiens	pKi		6.4
inactive	9545178	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545179	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9545180	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O		CHEMBL1999321	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545181	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545182	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc(Nc2ncnc3ccc(-c4ccc(CN5CC6C(CO)C6C5)cc4)cc23)ccc1Oc1ccccc1		CHEMBL1999749	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9545183	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545184	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545185	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc(C(=O)O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1983006	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
active	9545186	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	=	Ki	nM	100.0	CHEMBL4045	Homo sapiens	pKi		7.0
inactive	9545187	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)Nc1n[nH]c2ccc(N)cc12		CHEMBL1995391	<	Ki	nM	25118.86	CHEMBL4045	Homo sapiens	pKi		4.6
inactive	9545188	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1985580	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9545189	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9545190	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN(C)CCCCNC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL2001451	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9545191	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9545192	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	=	Ki	nM	1258.93	CHEMBL4045	Homo sapiens	pKi		5.9
active	9545193	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	=	Ki	nM	630.96	CHEMBL4045	Homo sapiens	pKi		6.2
inactive	9545194	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC1CCN(C(=O)CC#N)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1966175	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9545195	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545196	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC#Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL2007375	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9545197	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9545198	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21		CHEMBL379975	=	Ki	nM	251.19	CHEMBL4045	Homo sapiens	pKi		6.6
active	9545199	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	=	Ki	nM	25.12	CHEMBL4045	Homo sapiens	pKi		7.6
inactive	9545200	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1n[nH]c2c(OCCCn3cccc3)ccc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL1965387	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9545201	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cc(-c2ncnc3[nH]ccc23)ccc1F		CHEMBL1997041	=	Ki	nM	12589.25	CHEMBL4045	Homo sapiens	pKi		4.9
inactive	9545202	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545203	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc(-c2ccc3c(c2)Nc2c(O)cccc2NC3=O)ccc1O		CHEMBL550418	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9545204	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545205	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	2511.89	CHEMBL4045	Homo sapiens	pKi		5.6
inactive	9545206	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCOc1ccc(C=C2SC(=N)NC2=O)c(O)c1		CHEMBL1971289	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9545207	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(=O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1999556	=	Ki	nM	1995.26	CHEMBL4045	Homo sapiens	pKi		5.7
active	9545208	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	=	Ki	nM	251.19	CHEMBL4045	Homo sapiens	pKi		6.6
inactive	9545209	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(COc1cc(C=Cc2ccncc2)cnc1Cl)Cc1c[nH]c2ccccc12		CHEMBL1968245	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9545210	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1		CHEMBL1979577	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
active	9545211	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	=	Ki	nM	25.12	CHEMBL4045	Homo sapiens	pKi		7.6
inactive	9545212	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccc2c(c1)c(-c1cc3nccnc3[nH]1)cn2C		CHEMBL1233887	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9545213	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1		CHEMBL1991800	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9545214	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL52387	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9545215	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCCC(=O)O)cc2)n1		CHEMBL2003689	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9545216	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9545217	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9545218	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	N#Cc1ncc2nc1OCC(O)C(O)COc1ccc(Cl)cc1NC(=O)N2		CHEMBL1980802	=	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
active	9545219	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1996649	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9545220	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	=	Ki	nM	630.96	CHEMBL4045	Homo sapiens	pKi		6.2
active	9545221	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=c1c(NCc2ccc(Cl)cc2Cl)c(Nc2ccc3[nH]ncc3c2)c1=O		CHEMBL1979554	=	Ki	nM	158.49	CHEMBL4045	Homo sapiens	pKi		6.8
inactive	9545222	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1986756	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9545223	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCOc1nc(C(=O)NCc2ccc(S(N)(=O)=O)cc2)cc(N)c1C#N		CHEMBL2004355	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9545224	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	<	Ki	nM	1258.93	CHEMBL4045	Homo sapiens	pKi		5.9
inactive	9545225	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	3981.07	CHEMBL4045	Homo sapiens	pKi		5.4
inactive	9545226	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9545227	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	=	Ki	nM	63.1	CHEMBL4045	Homo sapiens	pKi		7.2
inactive	9545228	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9545229	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545230	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545231	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9545232	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9545233	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Ki	nM	501.19	CHEMBL4045	Homo sapiens	pKi		6.3
inactive	9545234	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9545235	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545236	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9545237	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(=O)c1ccc2nc(-c3ccc([N+](=O)[O-])o3)cn2c1		CHEMBL1973359	=	Ki	nM	158.49	CHEMBL4045	Homo sapiens	pKi		6.8
active	9545238	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	=	Ki	nM	398.11	CHEMBL4045	Homo sapiens	pKi		6.4
inactive	9545239	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1996390	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
active	9545240	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	125.89	CHEMBL4045	Homo sapiens	pKi		6.9
active	9545241	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1979690	=	Ki	nM	100.0	CHEMBL4045	Homo sapiens	pKi		7.0
inactive	9545242	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9545243	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545244	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9545245	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	=	Ki	nM	1000.0	CHEMBL4045	Homo sapiens	pKi		6.0
active	9545246	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	=	Ki	nM	63.1	CHEMBL4045	Homo sapiens	pKi		7.2
inactive	9545247	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1ncnc2c1c(-c1ccc(Oc3ccc(CO)cc3)cc1)cn2C1CCOC1		CHEMBL1976376	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9545248	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=c1[nH]sc2c1c(=O)c1cc(F)c(NCc3ccccc3)c(F)c1n2C1CC1		CHEMBL1991640	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
active	9545249	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(NN=Cc1cc(Br)c(O)c(Br)c1)Nc1ccccc1		CHEMBL1983575	=	Ki	nM	100.0	CHEMBL4045	Homo sapiens	pKi		7.0
inactive	9545250	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	N#Cc1cccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)n1		CHEMBL1968868	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9545251	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1375418	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9545252	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	=	Ki	nM	794.33	CHEMBL4045	Homo sapiens	pKi		6.1
active	9545253	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	=	Ki	nM	15.85	CHEMBL4045	Homo sapiens	pKi		7.8
active	9545254	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	=	Ki	nM	31.62	CHEMBL4045	Homo sapiens	pKi		7.5
active	9545255	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1ccc([N+](=O)[O-])cc1)N1CCc2[nH]c3c(Cl)cc(Cl)cc3c2C1		CHEMBL1976196	=	Ki	nM	1995.26	CHEMBL4045	Homo sapiens	pKi		5.7
active	9545256	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	=	Ki	nM	251.19	CHEMBL4045	Homo sapiens	pKi		6.6
inactive	9545257	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccccc1CNC(=N)Nc1nccc(-c2cccs2)n1		CHEMBL1997197	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9545258	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C1Cc2cc(-c3ccccc3)cnc2N1		CHEMBL1983630	=	Ki	nM	50118.72	CHEMBL4045	Homo sapiens	pKi		4.3
inactive	9545259	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545260	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545261	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Clc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1381197	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
active	9545262	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	=	Ki	nM	316.23	CHEMBL4045	Homo sapiens	pKi		6.5
active	9545263	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	=	Ki	nM	199.53	CHEMBL4045	Homo sapiens	pKi		6.7
inactive	9545264	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9545265	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ncccc2N1		CHEMBL336961	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9545266	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545267	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(Cl)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1987054	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9545268	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1ncc(-c2ccncc2)c2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1970083	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
active	9545269	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	=	Ki	nM	1000.0	CHEMBL4045	Homo sapiens	pKi		6.0
inactive	9545270	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)csc12		CHEMBL2005631	<	Ki	nM	5011.87	CHEMBL4045	Homo sapiens	pKi		5.3
inactive	9545271	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545272	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9545273	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1977223	=	Ki	nM	794.33	CHEMBL4045	Homo sapiens	pKi		6.1
active	9545274	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1cc(=O)[nH]n1-c1ccccn1		CHEMBL1995765	=	Ki	nM	15848.93	CHEMBL4045	Homo sapiens	pKi		4.8
inactive	9545275	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9545276	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO		CHEMBL1236126	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9545277	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	<	Ki	nM	1995.26	CHEMBL4045	Homo sapiens	pKi		5.7
active	9545278	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCCNC(=O)c1ccc(Nc2nc(CCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL1984760	=	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9545279	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9545280	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCCCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1991728	=	Ki	nM	2511.89	CHEMBL4045	Homo sapiens	pKi		5.6
inactive	9549177	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN(C)CC1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL360847	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9549178	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cc(F)ccc1F		CHEMBL1995811	=	Ki	nM	398.11	CHEMBL4045	Homo sapiens	pKi		6.4
active	9549179	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(=O)c1cc2c(-c3ccc(F)cc3F)cncc2s1		CHEMBL1975787	=	Ki	nM	1995.26	CHEMBL4045	Homo sapiens	pKi		5.7
inactive	9549180	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc(C=C(C#N)c2n[nH]c(N)c2C#N)ccc1O		CHEMBL2002407	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9549181	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9549182	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9549183	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	<	Ki	nM	5011.87	CHEMBL4045	Homo sapiens	pKi		5.3
active	9549184	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(=O)c1cccc2cn[nH]c12		CHEMBL451401	=	Ki	nM	100000.0	CHEMBL4045	Homo sapiens	pKi		4.0
inactive	9549185	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1CC#N		CHEMBL1985566	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9549186	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9549187	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9549188	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	=	Ki	nM	630.96	CHEMBL4045	Homo sapiens	pKi		6.2
inactive	9549189	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9549190	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9549191	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccc(-c2ccc(N)cc2)c2cnoc12		CHEMBL2002450	=	Ki	nM	79432.82	CHEMBL4045	Homo sapiens	pKi		4.1
inactive	9549192	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9549193	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9549194	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	=	Ki	nM	501.19	CHEMBL4045	Homo sapiens	pKi		6.3
inactive	9549195	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	3981.07	CHEMBL4045	Homo sapiens	pKi		5.4
inactive	9549196	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9549197	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	=	Ki	nM	1258.93	CHEMBL4045	Homo sapiens	pKi		5.9
inactive	9549198	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9549199	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9549200	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9549201	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9549202	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	3981.07	CHEMBL4045	Homo sapiens	pKi		5.4
inactive	9549203	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9549204	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1987648	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9549205	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCOC(=O)c1cn(-c2ccc(O)cc2C)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL1996780	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9549206	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9549207	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1966514	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9549208	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCCCCCCCCCCCOc1ccc(NC(=N)N)cc1NC(=N)N		CHEMBL1980715	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
active	9549209	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1		CHEMBL2003638	=	Ki	nM	100.0	CHEMBL4045	Homo sapiens	pKi		7.0
inactive	9549210	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9549211	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9549212	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1cccc(F)c1)Nc1cccc(-c2ccc3cn[nH]c3c2)c1		CHEMBL1983393	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9549213	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(COc1cncc(-c2cc3ccncc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1966524	=	Ki	nM	316.23	CHEMBL4045	Homo sapiens	pKi		6.5
inactive	9549214	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12		CHEMBL1993722	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9549215	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=c1[nH]c2sc3c(c2c2nc(-c4cccnc4)nn12)CCCC3		CHEMBL1970806	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9549216	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCCC3CCO)nc12		CHEMBL2006674	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9549217	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN(C)c1ccc(Nc2cc(-c3csc(Br)c3)[nH]n2)cc1		CHEMBL1984236	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9549218	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1cnccn1)Nc1cccc2c(O)cccc12		CHEMBL1992371	=	Ki	nM	1995.26	CHEMBL4045	Homo sapiens	pKi		5.7
active	9549219	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc(CN2CCCCC2)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL202635	=	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9549220	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9549221	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL1979970	<	Ki	nM	3981.07	CHEMBL4045	Homo sapiens	pKi		5.4
inactive	9549222	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(N3CC4COCC4C3)cc12		CHEMBL2002599	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9549223	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	=	Ki	nM	3981.07	CHEMBL4045	Homo sapiens	pKi		5.4
active	9549224	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1n[nH]c2ccc(-c3cccnc3)cc12		CHEMBL1967252	=	Ki	nM	19952.62	CHEMBL4045	Homo sapiens	pKi		4.7
inactive	9549225	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)C(C)Nc1ncc(Cl)c(Nc2nccs2)n1		CHEMBL1993374	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9549226	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)(C)NC(=O)c1ccc2nc3[nH]c4ccccc4c3nc2c1		CHEMBL1969264	=	Ki	nM	501.19	CHEMBL4045	Homo sapiens	pKi		6.3
inactive	9549227	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)N(CCCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1994318	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
active	9549228	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	N#Cc1c(O)[nH]c(=O)c2c(=N)oc3ccc(Cl)cc3c12		CHEMBL1973711	=	Ki	nM	2511.89	CHEMBL4045	Homo sapiens	pKi		5.6
inactive	9549229	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9549230	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9549231	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12		CHEMBL1624529	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9549232	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9549233	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9549234	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9549235	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9549236	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9549237	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	=	Ki	nM	501.19	CHEMBL4045	Homo sapiens	pKi		6.3
inactive	9549238	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	<	Ki	nM	5011.87	CHEMBL4045	Homo sapiens	pKi		5.3
active	9549239	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCOC(=O)c1c(C)n(-c2ccc(I)cc2)c2c1cc(O)c1ccccc12		CHEMBL1970352	=	Ki	nM	2511.89	CHEMBL4045	Homo sapiens	pKi		5.6
inactive	9549240	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1965631	<	Ki	nM	3981.07	CHEMBL4045	Homo sapiens	pKi		5.4
active	9549241	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	=	Ki	nM	251.19	CHEMBL4045	Homo sapiens	pKi		6.6
inactive	9549242	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9549243	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN(C)c1ccc(-c2cc(-c3ccc([N+](=O)[O-])cc3)nc(NS(=O)(=O)c3ccc(N)cc3)n2)cc1		CHEMBL1980167	=	Ki	nM	2511.89	CHEMBL4045	Homo sapiens	pKi		5.6
inactive	9549244	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9549245	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	10000.0	CHEMBL4045	Homo sapiens	pKi		5.0
inactive	9549246	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9549247	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9549248	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9549249	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	=	Ki	nM	794.33	CHEMBL4045	Homo sapiens	pKi		6.1
inactive	9549250	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9549251	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	<	Ki	nM	5011.87	CHEMBL4045	Homo sapiens	pKi		5.3
inactive	9549252	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9549253	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9549254	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
inactive	9549255	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NCc1cc(Nc2ncnc(-c3ccccc3)n2)ccc1O		CHEMBL1980246	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9549256	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9549257	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1		CHEMBL1983932	=	Ki	nM	1000.0	CHEMBL4045	Homo sapiens	pKi		6.0
active	9549258	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(-c3ccc(CO)cc3)s1)CC2		CHEMBL1983980	=	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9549259	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCNCC4)cc3)n2)s1		CHEMBL1999484	=	Ki	nM	50.12	CHEMBL4045	Homo sapiens	pKi		7.3
active	9549260	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	Ki	nM	1995.26	CHEMBL4045	Homo sapiens	pKi		5.7
active	9549261	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	NC(=O)c1csc2c1NCCC2=O		CHEMBL1973399	=	Ki	nM	50118.72	CHEMBL4045	Homo sapiens	pKi		4.3
active	9549262	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	c1ccc2c(c1)nnn2Cc1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL1966069	=	Ki	nM	3981.07	CHEMBL4045	Homo sapiens	pKi		5.4
inactive	9549263	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1ccc(NCc2ccc(-c3ccc(F)cc3)nc2)cc1		CHEMBL1986899	<	Ki	nM	3162.28	CHEMBL4045	Homo sapiens	pKi		5.5
inactive	9549264	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	<	Ki	nM	6309.57	CHEMBL4045	Homo sapiens	pKi		5.2
inactive	9549265	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1		CHEMBL1997822	<	Ki	nM	5011.87	CHEMBL4045	Homo sapiens	pKi		5.3
active	9549266	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	=	Ki	nM	1000.0	CHEMBL4045	Homo sapiens	pKi		6.0
inactive	9549267	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	2511.89	CHEMBL4045	Homo sapiens	pKi		5.6
active	9549268	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	=	Ki	nM	6.31	CHEMBL4045	Homo sapiens	pKi		8.2
inactive	9549269	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	<	Ki	nM	1584.89	CHEMBL4045	Homo sapiens	pKi		5.8
active	9549270	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	Cc1nn(C)c(C)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)O)[nH]c12		CHEMBL1984039	=	Ki	nM	1258.93	CHEMBL4045	Homo sapiens	pKi		5.9
active	9549271	CHEMBL1963701	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	=	Ki	nM	630.96	CHEMBL4045	Homo sapiens	pKi		6.2
	10849700	CHEMBL2019659	Inhibition of AMPKA1	B	CSc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCC3CC3)ncnc12		CHEMBL2017214	>	IC50	nM	40000.0	CHEMBL4045	Homo sapiens	IC50	uM	40.0
	10896857	CHEMBL2038921	Inhibition of AMPKalpha1 at 3 uM	B	C=CC(=O)NCc1coc(-c2c(N)ncnc2Nc2ccc(OCc3ccccn3)c(Cl)c2)n1		CHEMBL2035810	=	Inhibition	%	0.0	CHEMBL4045	Homo sapiens	INH	%	0.0
	10896876	CHEMBL2039250	Inhibition of AMPKalpha1	B	C=CC(=O)NCc1coc(-c2c(N)ncnc2Nc2ccc(OCc3ccccn3)c(Cl)c2)n1		CHEMBL2035810	>	IC50	nM	3000.0	CHEMBL4045	Homo sapiens	IC50	uM	3.0
	10925138	CHEMBL2046100	Inhibition of human AMPKalpha1 assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	CC(C)Nc1cc(-c2oc3ccccc3c(=O)c2-c2ccc(F)cc2)ccn1		CHEMBL2041958	=	Activity	%	97.0	CHEMBL4045	Homo sapiens	Activity	%	97.0
	10925139	CHEMBL2046100	Inhibition of human AMPKalpha1 assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	O=c1c(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)oc2ccccc12		CHEMBL2041962	=	Activity	%	102.0	CHEMBL4045	Homo sapiens	Activity	%	102.0
	12047332	CHEMBL2157609	Inhibition of PRKAA1 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	3.6	CHEMBL4045	Homo sapiens	INH	%	3.6
	12173739	CHEMBL2212076	Inhibition of AMPK-alpha1 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	97.0	CHEMBL4045	Homo sapiens	Activity	%	97.0
	12183831	CHEMBL2214429	Inhibition of PRKAA1	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL4045	Homo sapiens	pIC50		5.0
	12690696	CHEMBL2342878	Activation of AMPKalpha in human LS 174T cells assessed as phosphorylation at T172 at 1 to 3 uM by Western blotting analysis relative to urea-3,4-diCl	B	O=C(Nc1ccc(SC(F)(F)F)cc1)Nc1c(F)c(F)c(C(=O)O)c(F)c1F		CHEMBL2337776	=	FC		0.86	CHEMBL4045	Homo sapiens	FC		0.86
	12690697	CHEMBL2342878	Activation of AMPKalpha in human LS 174T cells assessed as phosphorylation at T172 at 1 to 3 uM by Western blotting analysis relative to urea-3,4-diCl	B	O=C(Nc1ccc(SC(F)(F)F)cc1)Nc1cc(F)c(F)c(F)c1F		CHEMBL2337775	=	FC		2.48	CHEMBL4045	Homo sapiens	FC		2.48
	12690698	CHEMBL2342878	Activation of AMPKalpha in human LS 174T cells assessed as phosphorylation at T172 at 1 to 3 uM by Western blotting analysis relative to urea-3,4-diCl	B	O=C(Nc1ccc(SC(F)(F)F)cc1)Nc1cc(Cl)c(Cl)c(Cl)c1		CHEMBL2337774	=	FC		2.32	CHEMBL4045	Homo sapiens	FC		2.32
	12690699	CHEMBL2342878	Activation of AMPKalpha in human LS 174T cells assessed as phosphorylation at T172 at 1 to 3 uM by Western blotting analysis relative to urea-3,4-diCl	B	O=C(Nc1ccc(SC(F)(F)F)cc1)Nc1cc(F)c(F)c(F)c1		CHEMBL2337773	=	FC		2.02	CHEMBL4045	Homo sapiens	FC		2.02
	12690700	CHEMBL2342878	Activation of AMPKalpha in human LS 174T cells assessed as phosphorylation at T172 at 1 to 3 uM by Western blotting analysis relative to urea-3,4-diCl	B	O=C(Nc1ccc(SC(F)(F)F)cc1)Nc1cc(F)c(F)cc1F		CHEMBL2337772	=	FC		1.21	CHEMBL4045	Homo sapiens	FC		1.21
	12690701	CHEMBL2342878	Activation of AMPKalpha in human LS 174T cells assessed as phosphorylation at T172 at 1 to 3 uM by Western blotting analysis relative to urea-3,4-diCl	B	O=C(Nc1ccc(SC(F)(F)F)cc1)Nc1ccc(SC(F)(F)F)c(Cl)c1		CHEMBL2337771	=	FC		0.93	CHEMBL4045	Homo sapiens	FC		0.93
	12690702	CHEMBL2342878	Activation of AMPKalpha in human LS 174T cells assessed as phosphorylation at T172 at 1 to 3 uM by Western blotting analysis relative to urea-3,4-diCl	B	N#Cc1cc(NC(=O)Nc2ccc(SC(F)(F)F)cc2)ccc1F		CHEMBL2337770	=	FC		0.96	CHEMBL4045	Homo sapiens	FC		0.96
	12690703	CHEMBL2342878	Activation of AMPKalpha in human LS 174T cells assessed as phosphorylation at T172 at 1 to 3 uM by Western blotting analysis relative to urea-3,4-diCl	B	O=C(Nc1ccc(SC(F)(F)F)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2337769	=	FC		1.52	CHEMBL4045	Homo sapiens	FC		1.52
	12690704	CHEMBL2342878	Activation of AMPKalpha in human LS 174T cells assessed as phosphorylation at T172 at 1 to 3 uM by Western blotting analysis relative to urea-3,4-diCl	B	O=C(Nc1ccc(SC(F)(F)F)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL2337768	=	FC		1.64	CHEMBL4045	Homo sapiens	FC		1.64
	12690705	CHEMBL2342878	Activation of AMPKalpha in human LS 174T cells assessed as phosphorylation at T172 at 1 to 3 uM by Western blotting analysis relative to urea-3,4-diCl	B	O=C(Nc1ccc(SC(F)(F)F)cc1)Nc1cccc(Cl)c1F		CHEMBL2337767	=	FC		0.72	CHEMBL4045	Homo sapiens	FC		0.72
	12690706	CHEMBL2342878	Activation of AMPKalpha in human LS 174T cells assessed as phosphorylation at T172 at 1 to 3 uM by Western blotting analysis relative to urea-3,4-diCl	B	O=C(Nc1ccc(SC(F)(F)F)cc1)Nc1ccc(F)c(Cl)c1		CHEMBL2337766	=	FC		1.05	CHEMBL4045	Homo sapiens	FC		1.05
	12690707	CHEMBL2342878	Activation of AMPKalpha in human LS 174T cells assessed as phosphorylation at T172 at 1 to 3 uM by Western blotting analysis relative to urea-3,4-diCl	B	O=C(Nc1ccc(SC(F)(F)F)cc1)Nc1cc(F)cc(F)c1		CHEMBL2337765	=	FC		1.14	CHEMBL4045	Homo sapiens	FC		1.14
	12690708	CHEMBL2342878	Activation of AMPKalpha in human LS 174T cells assessed as phosphorylation at T172 at 1 to 3 uM by Western blotting analysis relative to urea-3,4-diCl	B	O=C(Nc1ccc(SC(F)(F)F)cc1)Nc1ccc(F)c(F)c1		CHEMBL2337764	=	FC		1.11	CHEMBL4045	Homo sapiens	FC		1.11
	12690709	CHEMBL2342878	Activation of AMPKalpha in human LS 174T cells assessed as phosphorylation at T172 at 1 to 3 uM by Western blotting analysis relative to urea-3,4-diCl	B	O=C(Nc1ccc(SC(F)(F)F)cc1)Nc1cc(Cl)cc(Cl)c1		CHEMBL2338241	=	FC		1.59	CHEMBL4045	Homo sapiens	FC		1.59
	12690710	CHEMBL2342878	Activation of AMPKalpha in human LS 174T cells assessed as phosphorylation at T172 at 1 to 3 uM by Western blotting analysis relative to urea-3,4-diCl	B	N#Cc1ccc(NC(=O)Nc2ccc(SC(F)(F)F)cc2)cc1		CHEMBL2338240	=	FC		1.05	CHEMBL4045	Homo sapiens	FC		1.05
	12693321	CHEMBL2342878	Activation of AMPKalpha in human LS 174T cells assessed as phosphorylation at T172 at 1 to 3 uM by Western blotting analysis relative to urea-3,4-diCl	B	O=C(Nc1ccc(SC(F)(F)F)cc1)Nc1ccc(C(F)(F)F)cc1		CHEMBL2338239	=	FC		1.19	CHEMBL4045	Homo sapiens	FC		1.19
	12693322	CHEMBL2342878	Activation of AMPKalpha in human LS 174T cells assessed as phosphorylation at T172 at 1 to 3 uM by Western blotting analysis relative to urea-3,4-diCl	B	O=C(Nc1ccc(SC(F)(F)F)cc1)Nc1cccc(F)c1		CHEMBL2338238	=	FC		0.74	CHEMBL4045	Homo sapiens	FC		0.74
	12693323	CHEMBL2342878	Activation of AMPKalpha in human LS 174T cells assessed as phosphorylation at T172 at 1 to 3 uM by Western blotting analysis relative to urea-3,4-diCl	B	O=C(Nc1ccc(Cl)cc1)Nc1ccc(SC(F)(F)F)cc1		CHEMBL2338237	=	FC		0.71	CHEMBL4045	Homo sapiens	FC		0.71
	12693324	CHEMBL2342878	Activation of AMPKalpha in human LS 174T cells assessed as phosphorylation at T172 at 1 to 3 uM by Western blotting analysis relative to urea-3,4-diCl	B	O=C(Nc1ccc(C(F)(F)F)cc1)Nc1cc(F)c(F)c(F)c1		CHEMBL2338236	=	FC		4.0	CHEMBL4045	Homo sapiens	FC		4.0
	12693325	CHEMBL2342878	Activation of AMPKalpha in human LS 174T cells assessed as phosphorylation at T172 at 1 to 3 uM by Western blotting analysis relative to urea-3,4-diCl	B	O=C(Nc1cc(Cl)cc(Cl)c1)Nc1cccc(SC(F)(F)F)c1		CHEMBL2338235	=	FC		1.94	CHEMBL4045	Homo sapiens	FC		1.94
	12693326	CHEMBL2342878	Activation of AMPKalpha in human LS 174T cells assessed as phosphorylation at T172 at 1 to 3 uM by Western blotting analysis relative to urea-3,4-diCl	B	O=C(Nc1cc(F)cc(F)c1)Nc1cccc(SC(F)(F)F)c1		CHEMBL2338234	=	FC		1.83	CHEMBL4045	Homo sapiens	FC		1.83
	12693327	CHEMBL2342878	Activation of AMPKalpha in human LS 174T cells assessed as phosphorylation at T172 at 1 to 3 uM by Western blotting analysis relative to urea-3,4-diCl	B	O=C(Nc1ccc(C(F)(F)F)cc1)Nc1cccc(SC(F)(F)F)c1		CHEMBL2338233	=	FC		2.16	CHEMBL4045	Homo sapiens	FC		2.16
	12693328	CHEMBL2342878	Activation of AMPKalpha in human LS 174T cells assessed as phosphorylation at T172 at 1 to 3 uM by Western blotting analysis relative to urea-3,4-diCl	B	O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1cc(F)c(F)c(F)c1F		CHEMBL2338232	=	FC		0.8	CHEMBL4045	Homo sapiens	FC		0.8
	12693329	CHEMBL2342878	Activation of AMPKalpha in human LS 174T cells assessed as phosphorylation at T172 at 1 to 3 uM by Western blotting analysis relative to urea-3,4-diCl	B	O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1cc(Cl)c(Cl)c(Cl)c1		CHEMBL2338231	=	FC		0.96	CHEMBL4045	Homo sapiens	FC		0.96
	12693330	CHEMBL2342878	Activation of AMPKalpha in human LS 174T cells assessed as phosphorylation at T172 at 1 to 3 uM by Western blotting analysis relative to urea-3,4-diCl	B	O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1cc(F)c(F)c(F)c1		CHEMBL2338230	=	FC		0.99	CHEMBL4045	Homo sapiens	FC		0.99
	12693331	CHEMBL2342878	Activation of AMPKalpha in human LS 174T cells assessed as phosphorylation at T172 at 1 to 3 uM by Western blotting analysis relative to urea-3,4-diCl	B	O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1cc(Cl)cc(Cl)c1		CHEMBL2338229	=	FC		0.82	CHEMBL4045	Homo sapiens	FC		0.82
	12693332	CHEMBL2342878	Activation of AMPKalpha in human LS 174T cells assessed as phosphorylation at T172 at 1 to 3 uM by Western blotting analysis relative to urea-3,4-diCl	B	O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1cc(F)cc(F)c1		CHEMBL2338228	=	FC		1.44	CHEMBL4045	Homo sapiens	FC		1.44
	12693333	CHEMBL2342878	Activation of AMPKalpha in human LS 174T cells assessed as phosphorylation at T172 at 1 to 3 uM by Western blotting analysis relative to urea-3,4-diCl	B	O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1ccc(SC(F)(F)F)c(Cl)c1		CHEMBL2338227	=	FC		2.6	CHEMBL4045	Homo sapiens	FC		2.6
	12693334	CHEMBL2342878	Activation of AMPKalpha in human LS 174T cells assessed as phosphorylation at T172 at 1 to 3 uM by Western blotting analysis relative to urea-3,4-diCl	B	O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1ccc(C(F)(F)F)cc1		CHEMBL2338226	=	FC		2.37	CHEMBL4045	Homo sapiens	FC		2.37
Active	12693339	CHEMBL2342875	Activation of AMPKalpha in human LS 174T cells assessed as phosphorylation at T172 at 1 to 3 uM by Western blotting analysis	B	O=C(Nc1ccc(SC(F)(F)F)cc1)Nc1ccc(Cl)c(Cl)c1		CHEMBL587615		Activity			CHEMBL4045	Homo sapiens	Activity		
Not Active	12693340	CHEMBL2342875	Activation of AMPKalpha in human LS 174T cells assessed as phosphorylation at T172 at 1 to 3 uM by Western blotting analysis	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		Activity			CHEMBL4045	Homo sapiens	Activity		
Not Active	12693341	CHEMBL2342879	Activation of AMPKalpha in human LS 174T cells assessed as phosphorylation at T172 at 3 uM by Western blotting analysis	B	O=C(Nc1ccc(SC(F)(F)F)cc1)Nc1ccc(Cl)c(Cl)c1		CHEMBL587615		Activity			CHEMBL4045	Homo sapiens	Activity		
	13324767	CHEMBL2390481	Activation of recombinant AMPK alpha1 (1 to 394) (unknown origin) after 2 hrs by scintillation proximity assay	B	O=C(O)c1cccc(CN2C(=O)/C(=C/c3ccc(-c4cccc([N+](=O)[O-])c4)o3)c3ccccc32)c1		CHEMBL2385951	=	EC50	nM	2100.0	CHEMBL4045	Homo sapiens	EC50	uM	2.1
	13324768	CHEMBL2390481	Activation of recombinant AMPK alpha1 (1 to 394) (unknown origin) after 2 hrs by scintillation proximity assay	B	Cc1cc(-c2ccc(/C=C3\S/C(=N\c4ccc(Cl)c(C(=O)O)c4)NC3=O)o2)c([N+](=O)[O-])cc1C		CHEMBL1242297	=	EC50	nM	9600.0	CHEMBL4045	Homo sapiens	EC50	uM	9.6
	13324769	CHEMBL2390482	Activation of recombinant AMPK alpha1 (1 to 394) (unknown origin) at 20 ug/mL after 2 hrs by scintillation proximity assay relative to PT1	B	O=C(O)c1cccc(CN2C(=O)/C(=C/c3ccc(-c4cccc([N+](=O)[O-])c4)o3)c3ccccc32)c1		CHEMBL2385951	=	Activity	%	341.0	CHEMBL4045	Homo sapiens	Activity	%	341.0
	13324770	CHEMBL2390482	Activation of recombinant AMPK alpha1 (1 to 394) (unknown origin) at 20 ug/mL after 2 hrs by scintillation proximity assay relative to PT1	B	Cc1cc(-c2ccc(/C=C3\SC(=S)N(c4cccc(C(=O)O)c4)C3=O)o2)c([N+](=O)[O-])cc1C		CHEMBL2385950	<	Activity	%	50.0	CHEMBL4045	Homo sapiens	Activity	%	50.0
	13324771	CHEMBL2390482	Activation of recombinant AMPK alpha1 (1 to 394) (unknown origin) at 20 ug/mL after 2 hrs by scintillation proximity assay relative to PT1	B	Cc1cc(-c2ccc(/C=C3\S/C(=N\c4cccc(C(=O)O)c4)NC3=O)o2)c([N+](=O)[O-])cc1C		CHEMBL2385949	=	Activity	%	106.0	CHEMBL4045	Homo sapiens	Activity	%	106.0
	13324772	CHEMBL2390482	Activation of recombinant AMPK alpha1 (1 to 394) (unknown origin) at 20 ug/mL after 2 hrs by scintillation proximity assay relative to PT1	B	Cc1cc(-c2ccc(/C=C3\S/C(=N\c4ccccc4C(=O)O)NC3=O)o2)c([N+](=O)[O-])cc1C		CHEMBL2385948	=	Activity	%	55.0	CHEMBL4045	Homo sapiens	Activity	%	55.0
	13324773	CHEMBL2390482	Activation of recombinant AMPK alpha1 (1 to 394) (unknown origin) at 20 ug/mL after 2 hrs by scintillation proximity assay relative to PT1	B	Cc1cc(-c2ccc(/C=C3\S/C(=N\c4ccc(F)cc4)NC3=O)o2)c([N+](=O)[O-])cc1C		CHEMBL2385947	<	Activity	%	50.0	CHEMBL4045	Homo sapiens	Activity	%	50.0
	13324774	CHEMBL2390482	Activation of recombinant AMPK alpha1 (1 to 394) (unknown origin) at 20 ug/mL after 2 hrs by scintillation proximity assay relative to PT1	B	COC(=O)c1cc(/N=C2/NC(=O)/C(=C/c3ccc(-c4cc(C)c(C)cc4[N+](=O)[O-])o3)S2)ccc1Cl		CHEMBL2385946	<	Activity	%	50.0	CHEMBL4045	Homo sapiens	Activity	%	50.0
	13324775	CHEMBL2390482	Activation of recombinant AMPK alpha1 (1 to 394) (unknown origin) at 20 ug/mL after 2 hrs by scintillation proximity assay relative to PT1	B	O=C1N/C(=N/c2ccc(Cl)c(C(=O)O)c2)S/C1=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL2385945	=	Activity	%	176.0	CHEMBL4045	Homo sapiens	Activity	%	176.0
	13324776	CHEMBL2390482	Activation of recombinant AMPK alpha1 (1 to 394) (unknown origin) at 20 ug/mL after 2 hrs by scintillation proximity assay relative to PT1	B	O=C1N/C(=N/c2ccc(Cl)c(C(=O)O)c2)S/C1=C\c1ccc(-c2ccccc2[N+](=O)[O-])o1		CHEMBL2385944	<	Activity	%	50.0	CHEMBL4045	Homo sapiens	Activity	%	50.0
	13324777	CHEMBL2390482	Activation of recombinant AMPK alpha1 (1 to 394) (unknown origin) at 20 ug/mL after 2 hrs by scintillation proximity assay relative to PT1	B	O=C1N/C(=N/c2ccc(Cl)c(C(=O)O)c2)S/C1=C\c1ccc(-c2ccccc2Cl)o1		CHEMBL2385943	<	Activity	%	50.0	CHEMBL4045	Homo sapiens	Activity	%	50.0
	13324779	CHEMBL2390484	Activation of human AMPK alpha1 (1 to 394) expressed in African green monkey COS7 cells	B	Cc1cc(-c2ccc(/C=C3\S/C(=N\c4ccc(Cl)c(C(=O)O)c4)NC3=O)o2)c([N+](=O)[O-])cc1C		CHEMBL1242297	=	EC50	nM	9000.0	CHEMBL4045	Homo sapiens	EC50	uM	9.0
	13351583	CHEMBL2399996	Inhibition of human AMPKalpha1 at 10 uM relative to control	B	Cl.O=c1[nH]nc2c(NCCCc3ccncc3)cc(Cl)cn12		CHEMBL2397859	=	Inhibition	%	-1.0	CHEMBL4045	Homo sapiens	INH	%	-1.0
	13442405	CHEMBL2428027	Competitive binding affinity to AMPKalpha1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL4045	Homo sapiens	INH	%	50.0
	13445540	CHEMBL2428027	Competitive binding affinity to AMPKalpha1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	92.0	CHEMBL4045	Homo sapiens	INH	%	92.0
	13448595	CHEMBL2428027	Competitive binding affinity to AMPKalpha1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL4045	Homo sapiens	INH	%	50.0
	13448731	CHEMBL2428027	Competitive binding affinity to AMPKalpha1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	<	Inhibition	%	50.0	CHEMBL4045	Homo sapiens	INH	%	50.0
	13451526	CHEMBL2428027	Competitive binding affinity to AMPKalpha1 (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	=	Inhibition	%	86.0	CHEMBL4045	Homo sapiens	INH	%	86.0
	13454711	CHEMBL2428027	Competitive binding affinity to AMPKalpha1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL4045	Homo sapiens	INH	%	50.0
	14663205	CHEMBL3268844	Inhibition of AMPKalpha1 (unknown origin) at 1 uM relative to control	B	CCOC(=O)c1sc(-c2ccncc2)nc1O		CHEMBL3261228	=	Inhibition	%	68.0	CHEMBL4045	Homo sapiens	INH	%	68.0
	14663206	CHEMBL3268844	Inhibition of AMPKalpha1 (unknown origin) at 1 uM relative to control	B	NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl		CHEMBL3261514	=	Inhibition	%	100.0	CHEMBL4045	Homo sapiens	INH	%	100.0
	14663207	CHEMBL3268844	Inhibition of AMPKalpha1 (unknown origin) at 1 uM relative to control	B	COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1		CHEMBL3261517	=	Inhibition	%	76.0	CHEMBL4045	Homo sapiens	INH	%	76.0
	14979197	CHEMBL3379068	Inhibition of AMPKalpha1 (unknown origin) at 1 uM by Millipore kinase analysis	B	COc1cc(-c2cn[nH]c2)ccc1C(=O)Nc1ccc2c(c1)CCNCC2		CHEMBL3355059	=	Inhibition	%	5.0	CHEMBL4045	Homo sapiens	INH	%	5.0
	15007967	CHEMBL3367748	Inhibition of human AMPKalpha1 at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)Cc4ccccc4)cc23)c1		CHEMBL3330255	=	Inhibition	%	22.0	CHEMBL4045	Homo sapiens	INH	%	22.0
	15007968	CHEMBL3367748	Inhibition of human AMPKalpha1 at 1 uM by radiometric Assay	B	COC(C(=O)Nc1ccc2[nH]nc(-c3cccc(S(N)(=O)=O)c3)c2c1)c1ccccc1		CHEMBL3330401	=	Inhibition	%	9.0	CHEMBL4045	Homo sapiens	INH	%	9.0
	15007969	CHEMBL3367748	Inhibition of human AMPKalpha1 at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)C(c4ccsc4)N4CCCC4)cc23)c1		CHEMBL3330410	=	Inhibition	%	30.0	CHEMBL4045	Homo sapiens	INH	%	30.0
	15018682	CHEMBL3361574	Inhibition of PRKAA1 (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	6.0	CHEMBL4045	Homo sapiens	INH	%	6.0
	15019150	CHEMBL3364074	Inhibition of AMPKalpha1 (unknown origin) at 1 uM in presence of 100 uM ATP	B	C=CC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C		CHEMBL3298512	=	Inhibition	%	46.0	CHEMBL4045	Homo sapiens	INH	%	46.0
	15037044	CHEMBL3368324	Inhibition of AMPKalpha 1 (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2cnc3[nH]cc(-c4ccc(OC)c(OC)c4)c3c2)cc1N		CHEMBL3319470	=	Inhibition	%	98.0	CHEMBL4045	Homo sapiens	INH	%	98.0
	15037106	CHEMBL3368324	Inhibition of AMPKalpha 1 (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2cnc3[nH]cc(-c4ccc(OC)c(OC)c4)c3c2)cc1OC		CHEMBL3102948	=	Inhibition	%	100.0	CHEMBL4045	Homo sapiens	INH	%	100.0
	15037107	CHEMBL3368324	Inhibition of AMPKalpha 1 (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1cc(-c2c[nH]c3ncc(-c4cccc(N)c4)cc23)cc(OC)c1OC		CHEMBL3319457	=	Inhibition	%	90.0	CHEMBL4045	Homo sapiens	INH	%	90.0
	15037108	CHEMBL3368324	Inhibition of AMPKalpha 1 (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2c[nH]c3ncc(-c4ccc(C(=O)N5CCOCC5)c(N)c4)cc23)cc1OC		CHEMBL3319467	=	Inhibition	%	84.0	CHEMBL4045	Homo sapiens	INH	%	84.0
	15037109	CHEMBL3368324	Inhibition of AMPKalpha 1 (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2c[nH]c3ncc(-c4cc(OC)c(OC)c(OC)c4)cc23)cc1OC		CHEMBL3319468	=	Inhibition	%	95.0	CHEMBL4045	Homo sapiens	INH	%	95.0
	15122488	CHEMBL3367678	Inhibition of human AMPKalpha1 assessed as residual activity at 10 uM by KinaseProfiler assay	B	CCOC(=O)C1=C(C)N=c2s/c(=C\c3ccc(O)c(O)c3)c(=O)n2C1c1ccc(Cl)cc1		CHEMBL3331445	=	Activity	%	82.0	CHEMBL4045	Homo sapiens	Activity	%	82.0
	15126949	CHEMBL3367678	Inhibition of human AMPKalpha1 assessed as residual activity at 10 uM by KinaseProfiler assay	B	CCOC(=O)C1=C(C)N=c2s/c(=C\c3cc(O)c(O)c(O)c3)c(=O)n2C1c1ccc(Cl)cc1		CHEMBL3331446	=	Activity	%	64.0	CHEMBL4045	Homo sapiens	Activity	%	64.0
	15126981	CHEMBL3367678	Inhibition of human AMPKalpha1 assessed as residual activity at 10 uM by KinaseProfiler assay	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Activity	%	75.0	CHEMBL4045	Homo sapiens	Activity	%	75.0
	15149612	CHEMBL3395070	Activation of human recombinant AMPK alpha1 subunit	B	Cc1cc(-c2ccc(/C=C3\S/C(=N\c4ccc(Cl)c(C(=O)O)c4)NC3=O)o2)c([N+](=O)[O-])cc1C		CHEMBL1242297	=	EC50	nM	8000.0	CHEMBL4045	Homo sapiens	EC50	uM	8.0
	15728393	CHEMBL3624109	Inhibition of AMPK-alpha1 (unknown origin) at 10 uM	B	COc1ccc(-c2cnccc2-c2cnc(NC(=O)C(C)C)s2)c(C(F)(F)F)c1		CHEMBL3623443	>	Inhibition	%	90.0	CHEMBL4045	Homo sapiens	INH	%	90.0
	15736627	CHEMBL3625824	Inhibition of human recombinant AMPKalpha1	B	CN(C)CCCNC(=O)c1csc2nc(-c3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)cn12		CHEMBL3623375	>	IC50	nM	10000.0	CHEMBL4045	Homo sapiens	IC50	uM	10.0
	15754264	CHEMBL3631690	Inhibition of PRKAA1 (unknown origin) at 1 uM by FRET method	B	N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)n(C3CCCC3)n2)c1		CHEMBL3629013	=	Inhibition	%	1.8	CHEMBL4045	Homo sapiens	INH	%	1.8
	16425256	CHEMBL3751128	Inhibition of PRKAA1 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	-2.2	CHEMBL4045	Homo sapiens	INH	%	-2.2
	16451590	CHEMBL3761171	Inhibition of PRKAA1 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	-3.1	CHEMBL4045	Homo sapiens	INH	%	-3.1
	16451748	CHEMBL3761171	Inhibition of PRKAA1 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4c(Cl)cccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758602	=	Inhibition	%	27.8	CHEMBL4045	Homo sapiens	INH	%	27.8
	16495200	CHEMBL3777528	Inhibition of N-terminal His6-tagged recombinant human PRKAA1 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-6.0	CHEMBL4045	Homo sapiens	Activity	%	-6.0
	16496119	CHEMBL3777528	Inhibition of N-terminal His6-tagged recombinant human PRKAA1 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-9.0	CHEMBL4045	Homo sapiens	Activity	%	-9.0
	16508909	CHEMBL3777528	Inhibition of N-terminal His6-tagged recombinant human PRKAA1 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	3.0	CHEMBL4045	Homo sapiens	Activity	%	3.0
	16515254	CHEMBL3784665	Inhibition of AMPKa1 (unknown origin)	B	N[C@H]1CC[C@@H](Nc2cc[nH]c(=O)c2-c2nc3ccccc3[nH]2)CC1		CHEMBL3780091	=	IC50	nM	5.5	CHEMBL4045	Homo sapiens	IC50	nM	5.5
	16578378	CHEMBL3802250	Inhibition of partial length wild type human AMPKalpha1 expressed in bacterial system assessed as enzyme activity at 1 uM relative to control	B	CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F		CHEMBL3798256	=	Activity	%	92.0	CHEMBL4045	Homo sapiens	Activity	%	92.0
	16619692	CHEMBL3820260	Inhibition of recombinant human PRKAA1 at 1 uM relative to control	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Inhibition	%	75.0	CHEMBL4045	Homo sapiens	INH	%	75.0
	16627480	CHEMBL3821248	Inhibition of recombinant human C-terminal His-tagged AMPK alpha1 expressed in baculovirus infected Spodoptera frugiperda cells coexpressing human C-terminal His-tagged AMPKbeta1/gamma1 at 1 uM by radiometric assay relative to control	B	Cc1cc(-c2cnn3c(NCC4CCOCC4)nc(Oc4ccccc4)nc23)ccc1C(=O)NC1CC1		CHEMBL3819210	=	Inhibition	%	-4.0	CHEMBL4045	Homo sapiens	INH	%	-4.0
	16627481	CHEMBL3821248	Inhibition of recombinant human C-terminal His-tagged AMPK alpha1 expressed in baculovirus infected Spodoptera frugiperda cells coexpressing human C-terminal His-tagged AMPKbeta1/gamma1 at 1 uM by radiometric assay relative to control	B	O=C(N[C@@H](c1ccccn1)C1CC1)c1ccc2[nH]nc(-c3ccc(N4C5CCC4CC(O)C5)cc3)c2c1		CHEMBL3818239	=	Inhibition	%	17.0	CHEMBL4045	Homo sapiens	INH	%	17.0
	16749991	CHEMBL3859880	Activation of human recombinant AMPK alpha1 (1 to 394 residues) expressed in Escherichia coli BL21-CodonPlus (DE3)-RIPL using SAMS peptide after 10 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(-c2ccc(/C=C3\S/C(=N\c4ccc(Cl)c(C(=O)O)c4)NC3=O)o2)c([N+](=O)[O-])cc1C		CHEMBL1242297	=	EC50	nM	8000.0	CHEMBL4045	Homo sapiens	EC50	uM	8.0
344435	17721453	CHEMBL3887604	AMPK Activation Assay: In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of AMPK and 1.25 ul of the peptide (final concentration of 1 uM) and 1.25 ul of ATP (final concentration of 30 uM), both dissolved in assay buffer. This step was followed by an incubation time of 60 min. Then 5 ul of ADP Glo Reagent was added. This was followed by 40 min of incubation. Then 10 ul of Kinase Detection Reagent was admixed. The plates were sealed and after an incubation period of 30 min, the luminescence signal was measured in an Envision reader. All incubation steps were accomplished at room temperature. Each assay microtiter plate contained wells with vehicle controls instead of compound (0.1% DMSO in water) as reference for the low signal (100% CTL, low signal), and wells with serial dilutions of AMP (final 30 uM) as reference for high signals. The luminescence signal generated was proportional to the ADP concentration produced and was correlated with AMPK activity.	B	CCCC(=O)NC1CCN(c2ccc(-c3nc4[nH]c(O[C@@H]5COC6C5OC[C@H]6O)nc4cc3Cl)cc2)CC1		CHEMBL4110683	=	EC50	nM	1.2	CHEMBL4045	Homo sapiens	EC50	nM	1.2
344436	17721454	CHEMBL3887604	AMPK Activation Assay: In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of AMPK and 1.25 ul of the peptide (final concentration of 1 uM) and 1.25 ul of ATP (final concentration of 30 uM), both dissolved in assay buffer. This step was followed by an incubation time of 60 min. Then 5 ul of ADP Glo Reagent was added. This was followed by 40 min of incubation. Then 10 ul of Kinase Detection Reagent was admixed. The plates were sealed and after an incubation period of 30 min, the luminescence signal was measured in an Envision reader. All incubation steps were accomplished at room temperature. Each assay microtiter plate contained wells with vehicle controls instead of compound (0.1% DMSO in water) as reference for the low signal (100% CTL, low signal), and wells with serial dilutions of AMP (final 30 uM) as reference for high signals. The luminescence signal generated was proportional to the ADP concentration produced and was correlated with AMPK activity.	B	CN(C)C(=O)OC1CCN(c2ccc(-c3nc4[nH]c(O[C@@H]5COC6C5OC[C@H]6O)nc4cc3Cl)cc2)CC1		CHEMBL4112083	=	EC50	nM	32.0	CHEMBL4045	Homo sapiens	EC50	nM	32.0
344437	17721455	CHEMBL3887604	AMPK Activation Assay: In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of AMPK and 1.25 ul of the peptide (final concentration of 1 uM) and 1.25 ul of ATP (final concentration of 30 uM), both dissolved in assay buffer. This step was followed by an incubation time of 60 min. Then 5 ul of ADP Glo Reagent was added. This was followed by 40 min of incubation. Then 10 ul of Kinase Detection Reagent was admixed. The plates were sealed and after an incubation period of 30 min, the luminescence signal was measured in an Envision reader. All incubation steps were accomplished at room temperature. Each assay microtiter plate contained wells with vehicle controls instead of compound (0.1% DMSO in water) as reference for the low signal (100% CTL, low signal), and wells with serial dilutions of AMP (final 30 uM) as reference for high signals. The luminescence signal generated was proportional to the ADP concentration produced and was correlated with AMPK activity.	B	O=C(N[C@H]1CC[C@@H](c2ccc(-c3nc4[nH]c(O[C@@H]5COC6C5OC[C@H]6O)nc4cc3Cl)cc2)CC1)OC1CCCC1		CHEMBL4109630	=	EC50	nM	108.0	CHEMBL4045	Homo sapiens	EC50	nM	108.0
344438	17721456	CHEMBL3887604	AMPK Activation Assay: In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of AMPK and 1.25 ul of the peptide (final concentration of 1 uM) and 1.25 ul of ATP (final concentration of 30 uM), both dissolved in assay buffer. This step was followed by an incubation time of 60 min. Then 5 ul of ADP Glo Reagent was added. This was followed by 40 min of incubation. Then 10 ul of Kinase Detection Reagent was admixed. The plates were sealed and after an incubation period of 30 min, the luminescence signal was measured in an Envision reader. All incubation steps were accomplished at room temperature. Each assay microtiter plate contained wells with vehicle controls instead of compound (0.1% DMSO in water) as reference for the low signal (100% CTL, low signal), and wells with serial dilutions of AMP (final 30 uM) as reference for high signals. The luminescence signal generated was proportional to the ADP concentration produced and was correlated with AMPK activity.	B	CC(C)OC(=O)NC1CCN(c2ccc(-c3nc4[nH]c(O[C@@H]5COC6C5OC[C@H]6O)nc4cc3Cl)cc2)CC1		CHEMBL4112696	=	EC50	nM	12.0	CHEMBL4045	Homo sapiens	EC50	nM	12.0
344439	17721457	CHEMBL3887604	AMPK Activation Assay: In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of AMPK and 1.25 ul of the peptide (final concentration of 1 uM) and 1.25 ul of ATP (final concentration of 30 uM), both dissolved in assay buffer. This step was followed by an incubation time of 60 min. Then 5 ul of ADP Glo Reagent was added. This was followed by 40 min of incubation. Then 10 ul of Kinase Detection Reagent was admixed. The plates were sealed and after an incubation period of 30 min, the luminescence signal was measured in an Envision reader. All incubation steps were accomplished at room temperature. Each assay microtiter plate contained wells with vehicle controls instead of compound (0.1% DMSO in water) as reference for the low signal (100% CTL, low signal), and wells with serial dilutions of AMP (final 30 uM) as reference for high signals. The luminescence signal generated was proportional to the ADP concentration produced and was correlated with AMPK activity.	B	O=C(N[C@H]1CC[C@@H](c2ccc(-c3nc4[nH]c(O[C@@H]5COC6C5OC[C@H]6O)nc4cc3Cl)cc2)CC1)OC1CCOCC1		CHEMBL4108035	=	EC50	nM	119.0	CHEMBL4045	Homo sapiens	EC50	nM	119.0
344440	17721458	CHEMBL3887604	AMPK Activation Assay: In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of AMPK and 1.25 ul of the peptide (final concentration of 1 uM) and 1.25 ul of ATP (final concentration of 30 uM), both dissolved in assay buffer. This step was followed by an incubation time of 60 min. Then 5 ul of ADP Glo Reagent was added. This was followed by 40 min of incubation. Then 10 ul of Kinase Detection Reagent was admixed. The plates were sealed and after an incubation period of 30 min, the luminescence signal was measured in an Envision reader. All incubation steps were accomplished at room temperature. Each assay microtiter plate contained wells with vehicle controls instead of compound (0.1% DMSO in water) as reference for the low signal (100% CTL, low signal), and wells with serial dilutions of AMP (final 30 uM) as reference for high signals. The luminescence signal generated was proportional to the ADP concentration produced and was correlated with AMPK activity.	B	O=C(O[C@H]1CC[C@H](c2ccc(-c3nc4[nH]c(O[C@@H]5COC6C5OC[C@H]6O)nc4cc3Cl)cc2)CC1)N1CCOCC1		CHEMBL4113617	=	EC50	nM	6.0	CHEMBL4045	Homo sapiens	EC50	nM	6.0
344441	17721459	CHEMBL3887604	AMPK Activation Assay: In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of AMPK and 1.25 ul of the peptide (final concentration of 1 uM) and 1.25 ul of ATP (final concentration of 30 uM), both dissolved in assay buffer. This step was followed by an incubation time of 60 min. Then 5 ul of ADP Glo Reagent was added. This was followed by 40 min of incubation. Then 10 ul of Kinase Detection Reagent was admixed. The plates were sealed and after an incubation period of 30 min, the luminescence signal was measured in an Envision reader. All incubation steps were accomplished at room temperature. Each assay microtiter plate contained wells with vehicle controls instead of compound (0.1% DMSO in water) as reference for the low signal (100% CTL, low signal), and wells with serial dilutions of AMP (final 30 uM) as reference for high signals. The luminescence signal generated was proportional to the ADP concentration produced and was correlated with AMPK activity.	B	CCNC(=O)O[C@H]1CC[C@H](c2ccc(-c3nc4[nH]c(O[C@@H]5COC6C5OC[C@H]6O)nc4cc3Cl)cc2)CC1		CHEMBL4111746	=	EC50	nM	468.0	CHEMBL4045	Homo sapiens	EC50	nM	468.0
344442	17721460	CHEMBL3887604	AMPK Activation Assay: In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of AMPK and 1.25 ul of the peptide (final concentration of 1 uM) and 1.25 ul of ATP (final concentration of 30 uM), both dissolved in assay buffer. This step was followed by an incubation time of 60 min. Then 5 ul of ADP Glo Reagent was added. This was followed by 40 min of incubation. Then 10 ul of Kinase Detection Reagent was admixed. The plates were sealed and after an incubation period of 30 min, the luminescence signal was measured in an Envision reader. All incubation steps were accomplished at room temperature. Each assay microtiter plate contained wells with vehicle controls instead of compound (0.1% DMSO in water) as reference for the low signal (100% CTL, low signal), and wells with serial dilutions of AMP (final 30 uM) as reference for high signals. The luminescence signal generated was proportional to the ADP concentration produced and was correlated with AMPK activity.	B	CC(C)NC(=O)O[C@H]1CC[C@H](c2ccc(-c3nc4[nH]c(O[C@@H]5COC6C5OC[C@H]6O)nc4cc3Cl)cc2)CC1		CHEMBL4114389	=	EC50	nM	339.0	CHEMBL4045	Homo sapiens	EC50	nM	339.0
344443	17721461	CHEMBL3887604	AMPK Activation Assay: In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of AMPK and 1.25 ul of the peptide (final concentration of 1 uM) and 1.25 ul of ATP (final concentration of 30 uM), both dissolved in assay buffer. This step was followed by an incubation time of 60 min. Then 5 ul of ADP Glo Reagent was added. This was followed by 40 min of incubation. Then 10 ul of Kinase Detection Reagent was admixed. The plates were sealed and after an incubation period of 30 min, the luminescence signal was measured in an Envision reader. All incubation steps were accomplished at room temperature. Each assay microtiter plate contained wells with vehicle controls instead of compound (0.1% DMSO in water) as reference for the low signal (100% CTL, low signal), and wells with serial dilutions of AMP (final 30 uM) as reference for high signals. The luminescence signal generated was proportional to the ADP concentration produced and was correlated with AMPK activity.	B	O=C(O[C@H]1CC[C@H](c2ccc(-c3nc4[nH]c(O[C@@H]5COC6C5OC[C@H]6O)nc4cc3Cl)cc2)CC1)N1CCCC1		CHEMBL4113596	=	EC50	nM	17.0	CHEMBL4045	Homo sapiens	EC50	nM	17.0
344444	17721462	CHEMBL3887604	AMPK Activation Assay: In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of AMPK and 1.25 ul of the peptide (final concentration of 1 uM) and 1.25 ul of ATP (final concentration of 30 uM), both dissolved in assay buffer. This step was followed by an incubation time of 60 min. Then 5 ul of ADP Glo Reagent was added. This was followed by 40 min of incubation. Then 10 ul of Kinase Detection Reagent was admixed. The plates were sealed and after an incubation period of 30 min, the luminescence signal was measured in an Envision reader. All incubation steps were accomplished at room temperature. Each assay microtiter plate contained wells with vehicle controls instead of compound (0.1% DMSO in water) as reference for the low signal (100% CTL, low signal), and wells with serial dilutions of AMP (final 30 uM) as reference for high signals. The luminescence signal generated was proportional to the ADP concentration produced and was correlated with AMPK activity.	B	CCNC(=O)O[C@H]1CC[C@@H](c2ccc(-c3nc4[nH]c(O[C@@H]5COC6C5OC[C@H]6O)nc4cc3Cl)cc2)CC1		CHEMBL4114318	=	EC50	nM	26.0	CHEMBL4045	Homo sapiens	EC50	nM	26.0
344445	17721463	CHEMBL3887604	AMPK Activation Assay: In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of AMPK and 1.25 ul of the peptide (final concentration of 1 uM) and 1.25 ul of ATP (final concentration of 30 uM), both dissolved in assay buffer. This step was followed by an incubation time of 60 min. Then 5 ul of ADP Glo Reagent was added. This was followed by 40 min of incubation. Then 10 ul of Kinase Detection Reagent was admixed. The plates were sealed and after an incubation period of 30 min, the luminescence signal was measured in an Envision reader. All incubation steps were accomplished at room temperature. Each assay microtiter plate contained wells with vehicle controls instead of compound (0.1% DMSO in water) as reference for the low signal (100% CTL, low signal), and wells with serial dilutions of AMP (final 30 uM) as reference for high signals. The luminescence signal generated was proportional to the ADP concentration produced and was correlated with AMPK activity.	B	CC(C)NC(=O)O[C@H]1CC[C@@H](c2ccc(-c3nc4[nH]c(O[C@@H]5COC6C5OC[C@H]6O)nc4cc3Cl)cc2)CC1		CHEMBL4108269	=	EC50	nM	35.0	CHEMBL4045	Homo sapiens	EC50	nM	35.0
344446	17721464	CHEMBL3887604	AMPK Activation Assay: In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of AMPK and 1.25 ul of the peptide (final concentration of 1 uM) and 1.25 ul of ATP (final concentration of 30 uM), both dissolved in assay buffer. This step was followed by an incubation time of 60 min. Then 5 ul of ADP Glo Reagent was added. This was followed by 40 min of incubation. Then 10 ul of Kinase Detection Reagent was admixed. The plates were sealed and after an incubation period of 30 min, the luminescence signal was measured in an Envision reader. All incubation steps were accomplished at room temperature. Each assay microtiter plate contained wells with vehicle controls instead of compound (0.1% DMSO in water) as reference for the low signal (100% CTL, low signal), and wells with serial dilutions of AMP (final 30 uM) as reference for high signals. The luminescence signal generated was proportional to the ADP concentration produced and was correlated with AMPK activity.	B	O=C(O[C@H]1CC[C@@H](c2ccc(-c3nc4[nH]c(O[C@@H]5COC6C5OC[C@H]6O)nc4cc3Cl)cc2)CC1)N1CCOCC1		CHEMBL4109595	=	EC50	nM	1311.0	CHEMBL4045	Homo sapiens	EC50	nM	1311.0
344447	17721465	CHEMBL3887604	AMPK Activation Assay: In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of AMPK and 1.25 ul of the peptide (final concentration of 1 uM) and 1.25 ul of ATP (final concentration of 30 uM), both dissolved in assay buffer. This step was followed by an incubation time of 60 min. Then 5 ul of ADP Glo Reagent was added. This was followed by 40 min of incubation. Then 10 ul of Kinase Detection Reagent was admixed. The plates were sealed and after an incubation period of 30 min, the luminescence signal was measured in an Envision reader. All incubation steps were accomplished at room temperature. Each assay microtiter plate contained wells with vehicle controls instead of compound (0.1% DMSO in water) as reference for the low signal (100% CTL, low signal), and wells with serial dilutions of AMP (final 30 uM) as reference for high signals. The luminescence signal generated was proportional to the ADP concentration produced and was correlated with AMPK activity.	B	O=C(O[C@H]1CC[C@@H](c2ccc(-c3nc4[nH]c(O[C@@H]5COC6C5OC[C@H]6O)nc4cc3Cl)cc2)CC1)N1CCCC1		CHEMBL4114222	=	EC50	nM	2043.0	CHEMBL4045	Homo sapiens	EC50	nM	2043.0
344448	17721466	CHEMBL3887604	AMPK Activation Assay: In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of AMPK and 1.25 ul of the peptide (final concentration of 1 uM) and 1.25 ul of ATP (final concentration of 30 uM), both dissolved in assay buffer. This step was followed by an incubation time of 60 min. Then 5 ul of ADP Glo Reagent was added. This was followed by 40 min of incubation. Then 10 ul of Kinase Detection Reagent was admixed. The plates were sealed and after an incubation period of 30 min, the luminescence signal was measured in an Envision reader. All incubation steps were accomplished at room temperature. Each assay microtiter plate contained wells with vehicle controls instead of compound (0.1% DMSO in water) as reference for the low signal (100% CTL, low signal), and wells with serial dilutions of AMP (final 30 uM) as reference for high signals. The luminescence signal generated was proportional to the ADP concentration produced and was correlated with AMPK activity.	B	CC(C)NC(=O)OC1CCN(c2ccc(-c3nc4[nH]c(O[C@@H]5COC6C5OC[C@H]6O)nc4cc3Cl)cc2)CC1		CHEMBL4114379	=	EC50	nM	578.0	CHEMBL4045	Homo sapiens	EC50	nM	578.0
344449	17721467	CHEMBL3887604	AMPK Activation Assay: In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of AMPK and 1.25 ul of the peptide (final concentration of 1 uM) and 1.25 ul of ATP (final concentration of 30 uM), both dissolved in assay buffer. This step was followed by an incubation time of 60 min. Then 5 ul of ADP Glo Reagent was added. This was followed by 40 min of incubation. Then 10 ul of Kinase Detection Reagent was admixed. The plates were sealed and after an incubation period of 30 min, the luminescence signal was measured in an Envision reader. All incubation steps were accomplished at room temperature. Each assay microtiter plate contained wells with vehicle controls instead of compound (0.1% DMSO in water) as reference for the low signal (100% CTL, low signal), and wells with serial dilutions of AMP (final 30 uM) as reference for high signals. The luminescence signal generated was proportional to the ADP concentration produced and was correlated with AMPK activity.	B	O=C(OC1CCN(c2ccc(-c3nc4[nH]c(O[C@@H]5COC6C5OC[C@H]6O)nc4cc3Cl)cc2)CC1)N1CCOCC1		CHEMBL4109084	=	EC50	nM	133.0	CHEMBL4045	Homo sapiens	EC50	nM	133.0
344450	17721468	CHEMBL3887604	AMPK Activation Assay: In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of AMPK and 1.25 ul of the peptide (final concentration of 1 uM) and 1.25 ul of ATP (final concentration of 30 uM), both dissolved in assay buffer. This step was followed by an incubation time of 60 min. Then 5 ul of ADP Glo Reagent was added. This was followed by 40 min of incubation. Then 10 ul of Kinase Detection Reagent was admixed. The plates were sealed and after an incubation period of 30 min, the luminescence signal was measured in an Envision reader. All incubation steps were accomplished at room temperature. Each assay microtiter plate contained wells with vehicle controls instead of compound (0.1% DMSO in water) as reference for the low signal (100% CTL, low signal), and wells with serial dilutions of AMP (final 30 uM) as reference for high signals. The luminescence signal generated was proportional to the ADP concentration produced and was correlated with AMPK activity.	B	CC(C)OC(=O)NC1CCN(c2ccc(-c3nc4[nH]c(O[C@@H]5COC6C5OC[C@H]6O)nc4cc3Cl)cc2)CC1		CHEMBL4112696	=	EC50	nM	290.0	CHEMBL4045	Homo sapiens	EC50	nM	290.0
412004	17776719	CHEMBL3888648	Mobility Shift Assay: Agents: 1-fold kinase buffer without MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 2 mM DTT. 1-fold kinase buffer with MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 10 mM MnCl2, 2 mM DTT. Termination solution: 100 mM HEPES, pH 7.5, 0.0015% Brij-35, 0.2% Coating Reagent#3, 50 mM EDTA. 2.5-fold kinase solution: The kinase was added to the 1-fold kinase buffer to form a 2.5-fold kinase solution. 2.5-fold substrate solution: FAM fluorescence-labelled polypeptide and ATP were added to the 1-fold kinase buffer to form a 2.5-fold substrate solution. Compounds: The final test concentration of the compound was 10 M at maximum. Firstly, a 50-fold concentration (i.e. 500 M) was prepared with 100% DMSO. The compound was diluted with 100% DMSO by 5 folds at 5 concentrations (successively 500 M, 100 M, 20 M, 4 M, and 0.8 M). After diluting with 1-fold kinase buffer by 10 folds, 5 l of the samples were transferred to a 384-well reaction plate. Two negative control wells and two positive control wells were set at each line respectively. Replication was made in a 96-well plate in five concentrations of 5-fold compound. 10% DMSO was added to the positive control well, and 5 l of EDTA (250 mM) was added to the negative control well. Procedure: To the 384-well reaction plate was added 5-fold compound dissolved in 10% DMSO at 5 l/well. To the 384-well reaction plate was added 2.5-fold kinase solution at 10 l/well. The plate was incubated at room temperature for 10 mins. To the 384-well reaction plate was added 2.5-fold substrate solution at 10 l/well. The plate was incubated at 28 C. for a certain period. 25 l termination solution was added to terminate the reaction.	B	Nc1ccc(-c2ccc3ncc4c(=O)[nH]c(=O)n(-c5cccc(C(F)(F)F)c5)c4c3n2)cn1		CHEMBL3903725	>	IC50	nM	10000.0	CHEMBL4045	Homo sapiens	IC50	nM	10000.0
Inactive	17928096	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928097	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928098	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928099	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928100	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928101	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928102	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928103	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928104	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928105	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928106	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928107	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Active	17928108	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	Kd	nM	6.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	6.0
Inactive	17928109	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928110	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928111	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928112	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928113	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928114	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928115	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928116	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928117	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928118	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928119	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928120	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928121	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928122	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928123	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Active	17928124	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Kd	nM	319.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	319.0
Inactive	17928125	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928126	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928127	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Active	17928128	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	159.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	159.0
Inactive	17928129	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928130	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928131	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928132	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928133	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928134	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928135	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928136	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928137	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928138	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928139	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928140	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Active	17928141	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	4015.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	4015.0
Inactive	17928142	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928143	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928144	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928145	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928146	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928147	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928148	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928149	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928150	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928151	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Active	17928152	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	840.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	840.0
Inactive	17928153	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928154	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928155	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928156	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928157	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928158	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928159	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928160	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928161	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928162	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928163	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928164	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Active	17928165	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Kd	nM	350.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	350.0
Inactive	17928166	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928167	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928168	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Active	17928169	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	=	Kd	nM	1247.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	1247.0
Inactive	17928170	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928171	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928172	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928173	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928174	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928175	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928176	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928177	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928178	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928179	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928180	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928181	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928182	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928183	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928184	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928185	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928186	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928187	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928188	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928189	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Active	17928190	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	50.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	50.0
Active	17928191	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	=	Kd	nM	1324.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	1324.0
Active	17928192	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	1141.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	1141.0
Inactive	17928193	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928194	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928195	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928196	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928197	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928198	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928199	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Active	17928200	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	=	Kd	nM	3050.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	3050.0
Inactive	17928201	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928202	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928203	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928204	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928205	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928206	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928207	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928208	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928209	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928210	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928211	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928212	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928213	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928214	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928215	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928216	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17928217	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	2344.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	2344.0
Inactive	17928218	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928219	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928220	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928221	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Active	17928222	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	=	Kd	nM	762.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	762.0
Inactive	17928223	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928224	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928225	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928226	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928227	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928228	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Active	17928229	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	=	Kd	nM	10773.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	10773.0
Inactive	17928230	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928231	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928232	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928233	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928234	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Active	17928235	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	=	Kd	nM	15389.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	15389.0
Inactive	17928236	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928237	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928238	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928239	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928240	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928241	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928242	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Active	17928243	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	5500.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	5500.0
Inactive	17928244	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Active	17928245	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	12843.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	12843.0
Inactive	17928246	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928247	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928248	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928249	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928250	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928251	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928252	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928253	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Active	17928254	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	=	Kd	nM	3269.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	3269.0
Inactive	17928255	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Active	17928256	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	69.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	69.0
Inactive	17928257	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928258	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928259	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928260	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928261	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928262	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928263	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928264	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928265	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928266	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928267	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928268	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928269	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928270	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928271	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928272	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928273	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928274	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928275	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928276	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928277	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928278	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928279	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928280	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928281	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Active	17928282	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	=	Kd	nM	380.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	380.0
Inactive	17928283	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928284	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Active	17928285	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	2310.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	2310.0
Inactive	17928286	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Active	17928287	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	=	Kd	nM	1821.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	1821.0
Inactive	17928288	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928289	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928290	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Active	17928291	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1079.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	1079.0
Inactive	17928292	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928293	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928294	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928295	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928296	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928297	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928298	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928299	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928300	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Active	17928301	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	461.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	461.0
Inactive	17928302	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928303	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928304	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928305	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928306	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928307	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928308	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928309	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928310	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928311	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928312	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Active	17928313	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	=	Kd	nM	865.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	865.0
Inactive	17928314	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928315	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928316	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928317	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928318	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928319	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928320	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928321	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928322	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928323	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928324	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928325	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928326	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928327	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928328	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928329	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928330	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928331	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928332	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928333	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928334	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928335	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928336	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928337	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928338	CHEMBL3991835	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL4045	Homo sapiens	Kd apparent	nM	30000.0
	18048975	CHEMBL4011143	Inhibition of PRKAA1 (unknown origin)	B	CC(C)(C)c1ccc(C(=O)Nc2cn3cc(-n4ccnc4)ccc3n2)cc1		CHEMBL1642655	=	IC50	nM	13803.84	CHEMBL4045	Homo sapiens	pIC50		4.86
	18048976	CHEMBL4011143	Inhibition of PRKAA1 (unknown origin)	B	COCCn1cc(NC(=O)c2csc(-c3nncn3C(C)C)n2)cn1		CHEMBL4073198	=	IC50	nM	794.33	CHEMBL4045	Homo sapiens	pIC50		6.1
	18114482	CHEMBL4025012	Inhibition of wild-type human partial length AMPK alpha1 (M1 to E306 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	89.0	CHEMBL4045	Homo sapiens	Activity	%	89.0
	18117600	CHEMBL4025913	Inhibition of full length recombinant human C-terminal His-tagged AMPKalpha1 expressed in Spodoptera frugiperda insect cells at 3 uM relative to control	B	COc1ccc(-c2nnc(-n3c(-c4ccccc4)nc4cc(Cl)ccc4c3=O)s2)cc1		CHEMBL4103440	=	Inhibition	%	0.0	CHEMBL4045	Homo sapiens	INH	%	0.0
	18153137	CHEMBL4034256	Inhibition of AMPKa1 Lysine 2 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	12.6	CHEMBL4045	Homo sapiens	INH	%	12.6
	18153138	CHEMBL4034254	Inhibition of AMPKa1 Lysine 1 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	6.0	CHEMBL4045	Homo sapiens	INH	%	6.0
	18153352	CHEMBL4034253	Inhibition of AMPKa1 (unknown origin) labeling at ATP binding loop at 10 uM relative to control	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	>	Inhibition	%	35.0	CHEMBL4045	Homo sapiens	INH	%	35.0
	18203402	CHEMBL4043823	Inhibition of wild-type human partial length AMPK alpha1 (M1 to E306 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	96.0	CHEMBL4045	Homo sapiens	Activity	%	96.0
	18211608	CHEMBL4045636	Inhibition of AMPKa1 labeling at conserved Lys2 (DLKPENVLLDAHMNAK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	17.5	CHEMBL4045	Homo sapiens	INH	%	17.5
	18211632	CHEMBL4045634	Inhibition of AMPKa1 labeling at conserved Lys1 (VAVKILNR) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	17.3	CHEMBL4045	Homo sapiens	INH	%	17.3
	18211781	CHEMBL4045877	Inhibition of AMPKa1 labeling at conserved Lys1 (VAVKILNR) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	7.7	CHEMBL4045	Homo sapiens	INH	%	7.7
	18211783	CHEMBL4045879	Inhibition of AMPKa1 labeling at conserved Lys2 (DLKPENVLLDAHMNAK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	14.0	CHEMBL4045	Homo sapiens	INH	%	14.0
	18212075	CHEMBL4045623	Inhibition of AMPKa1 ATP loop (IGHYILGDTLGVGTFGKVK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	13.1	CHEMBL4045	Homo sapiens	INH	%	13.1
	18212076	CHEMBL4046112	Inhibition of AMPKa1 ATP loop (IGHYILGDTLGVGTFGKVK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	21.4	CHEMBL4045	Homo sapiens	INH	%	21.4
	18212144	CHEMBL4046162	Inhibition of AMPKa1 (unknown origin) at 1 uM relative to control	B	Cc1c(-c2ccncc2)c[nH]c1C(N)=O		CHEMBL4100387	<	Inhibition	%	20.0	CHEMBL4045	Homo sapiens	INH	%	20.0
	18225280	CHEMBL4048661	Inhibition of AMPKA1 (unknown origin) at 1 uM relative to control	B	N[C@H]1C[C@H](Oc2ccc3ncc(-c4ccc5cnccc5c4)n3n2)C1		CHEMBL4094080	=	Inhibition	%	17.0	CHEMBL4045	Homo sapiens	INH	%	17.0
	18250429	CHEMBL4054246	Inhibition of full length recombinant human AMPKalpha1 using AMARAASAAALARRR as substrate at 100 uM after 40 mins in presence of ATP relative to control	B	CCCCCCCCCCCCCCC(=O)NC1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4081419	=	Inhibition	%	34.0	CHEMBL4045	Homo sapiens	INH	%	34.0
	18253273	CHEMBL4054920	Inhibition of wild-type human partial length AMPK alpha1 (M1 to E306 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	37.0	CHEMBL4045	Homo sapiens	Activity	%	37.0
	18253274	CHEMBL4054920	Inhibition of wild-type human partial length AMPK alpha1 (M1 to E306 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	62.0	CHEMBL4045	Homo sapiens	Activity	%	62.0
	18274740	CHEMBL4118292	Inhibition of AMPKa1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPENVLLDAHMNAK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	76.0	CHEMBL4045	Homo sapiens	INH	%	76.0
	18274741	CHEMBL4118292	Inhibition of AMPKa1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPENVLLDAHMNAK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	0.2	CHEMBL4045	Homo sapiens	INH	%	0.2
	18274742	CHEMBL4118292	Inhibition of AMPKa1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPENVLLDAHMNAK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	33.6	CHEMBL4045	Homo sapiens	INH	%	33.6
Active	18276065	CHEMBL4119025	Binding affinity to PRKAA1 in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL4045	Homo sapiens	Activity		
	18282211	CHEMBL4120166	Inhibition of PRKAA1 (unknown origin) at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	5.0	CHEMBL4045	Homo sapiens	INH	%	5.0
	18282530	CHEMBL4120166	Inhibition of PRKAA1 (unknown origin) at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	3.3	CHEMBL4045	Homo sapiens	INH	%	3.3
	18440078	CHEMBL4156902	Binding affinity to wild-type human partial length AMPK alpha1 (M1 to E306 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL4045	Homo sapiens	Activity	%	100.0
	18484518	CHEMBL4185681	Binding affinity to wild-type human partial length AMPK alpha1 (M1 to E306 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	64.0	CHEMBL4045	Homo sapiens	Activity	%	64.0
	18485103	CHEMBL4185681	Binding affinity to wild-type human partial length AMPK alpha1 (M1 to E306 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	70.0	CHEMBL4045	Homo sapiens	Activity	%	70.0
	18507902	CHEMBL4190860	Inhibition of recombinant full-length human AMPKalpha1 at 1 uM using AMARAASAAALARRR as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	-9.0	CHEMBL4045	Homo sapiens	INH	%	-9.0
	18655639	CHEMBL4230581	Binding affinity to wild-type human partial length AMPK alpha1 (M1 to E306 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	92.0	CHEMBL4045	Homo sapiens	Activity	%	92.0
	18725369	CHEMBL4259066	Inhibition of AMPK alpha1 (unknown origin) (1 to 550 residues)	B	CC(=O)n1nc(C)c(-c2ccc(Cl)c(Cl)c2)c1N		CHEMBL4276946	>	IC50	nM	100000.0	CHEMBL4045	Homo sapiens	IC50	uM	100.0
	18751733	CHEMBL4264170	Binding affinity to wild-type human partial length AMPK alpha1 (M1 to E306 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	94.0	CHEMBL4045	Homo sapiens	Activity	%	94.0
	18851345	CHEMBL4305837	Inhibition of AMPKa1 (unknown origin)	B	Cc1nc2c(F)cc(-c3nc(Nc4ccc5c(n4)CCN(CCN(C)C)C5)ncc3F)cc2n1C(C)C		CHEMBL4448494	=	IC50	nM	865.0	CHEMBL4045	Homo sapiens	IC50	nM	865.0
	18857841	CHEMBL4307687	Binding affinity to wild-type human partial length AMPK alpha1 (M1 to E306 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	93.0	CHEMBL4045	Homo sapiens	Activity	%	93.0
Not Active	18883565	CHEMBL4312664	Activity at human AMPKalpha1 at 10 uM	B	CS(=O)(=O)c1ccc(Oc2cc(F)cc(C#N)c2)c2c1[C@H](O)[C@H](F)[C@@H]2F		CHEMBL4585668		Activity			CHEMBL4045	Homo sapiens	Activity		
	18892559	CHEMBL4314713	Inhibition of recombinant full-length human AMPKalpha1 assessed as residual activity at 10 uM using AMARAASAAALARRR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	119.5	CHEMBL4045	Homo sapiens	Activity	%	119.5
	18958684	CHEMBL4333279	Binding affinity to wild-type human partial length AMPK alpha1 (M1 to E306 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	70.0	CHEMBL4045	Homo sapiens	Activity	%	70.0
	18964064	CHEMBL4334966	Inhibition of recombinant full length human AMPKalpha1 assessed as residual activity at 1 uM using AMARAASAAALAR as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	44.0	CHEMBL4045	Homo sapiens	Activity	%	44.0
	18964065	CHEMBL4334966	Inhibition of recombinant full length human AMPKalpha1 assessed as residual activity at 1 uM using AMARAASAAALAR as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	24.0	CHEMBL4045	Homo sapiens	Activity	%	24.0
	18971783	CHEMBL4336793	Inhibition of recombinant full length human AMPKalpha1 assessed as residual activity at 10 uM using AMARAASAAALAR as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	45.0	CHEMBL4045	Homo sapiens	Activity	%	45.0
	19032176	CHEMBL4349769	Inhibition of recombinant human full length N-terminal GST/His6-tagged AMPKalpha1 (M1 to Q550) expressed in Sf9 insect cells at 20 nM using phosphatidylserine as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cn1cc(-c2n[nH]c3ccc(NCc4cc(F)ccc4S(C)(=O)=O)cc23)cn1		CHEMBL4555442	=	Inhibition	%	-9.0	CHEMBL4045	Homo sapiens	INH	%	-9.0
Not Active	19039899	CHEMBL4351740	Inhibition of recombinant full-length human AMPKalpha1 at 10 uM using AMARAASAAALARRR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL4045	Homo sapiens	INH		
	19059458	CHEMBL4357759	Binding affinity to wild-type human partial length AMPK alpha1 (M1 to E306 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL4045	Homo sapiens	Activity	%	100.0
	19072952	CHEMBL4362127	Effect on AMPK alpha1 at T183 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to control	B	CCOc1ccc(-c2nc(C(=O)NO)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4443725	=	FC		0.92	CHEMBL4045	Homo sapiens	FC		0.92
	19072991	CHEMBL4362166	Effect on AMPK alpha1 at T183 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to beta-catenin	B	CCOc1ccc(-c2nc(C(=O)NO)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4443725	=	FC		1.03	CHEMBL4045	Homo sapiens	FC		1.03
	19073030	CHEMBL4362127	Effect on AMPK alpha1 at T183 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to control	B	CCOc1ccc(-c2nc(C(=O)NO)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4443725	=	log2FC		-0.12	CHEMBL4045	Homo sapiens	log2FC		-0.12
	19073069	CHEMBL4362166	Effect on AMPK alpha1 at T183 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to beta-catenin	B	CCOc1ccc(-c2nc(C(=O)NO)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4443725	=	log2FC		0.05	CHEMBL4045	Homo sapiens	log2FC		0.05
	19073131	CHEMBL4362127	Effect on AMPK alpha1 at T183 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to control	B	CCOc1ccc(-c2nc(/C(N)=N/O)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4515196	=	FC		0.89	CHEMBL4045	Homo sapiens	FC		0.89
	19073170	CHEMBL4362166	Effect on AMPK alpha1 at T183 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to beta-catenin	B	CCOc1ccc(-c2nc(/C(N)=N/O)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4515196	=	FC		1.04	CHEMBL4045	Homo sapiens	FC		1.04
	19073209	CHEMBL4362127	Effect on AMPK alpha1 at T183 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to control	B	CCOc1ccc(-c2nc(/C(N)=N/O)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4515196	=	log2FC		-0.18	CHEMBL4045	Homo sapiens	log2FC		-0.18
	19073248	CHEMBL4362166	Effect on AMPK alpha1 at T183 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to beta-catenin	B	CCOc1ccc(-c2nc(/C(N)=N/O)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4515196	=	log2FC		0.05	CHEMBL4045	Homo sapiens	log2FC		0.05
	19090031	CHEMBL4365605	Inhibition of wild-type human partial length AMPK alpha1 (M1 to E306 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL4045	Homo sapiens	Activity	%	100.0
	19114499	CHEMBL4371421	Binding affinity to PRKAA1 in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4443828	=	Kd	nM	616.0	CHEMBL4045	Homo sapiens	Kd(free)	uM	0.616
	19114693	CHEMBL4371421	Binding affinity to PRKAA1 in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	=	Kd	nM	786.0	CHEMBL4045	Homo sapiens	Kd(free)	uM	0.786
	19144613	CHEMBL4377629	Inhibition of full length recombinant human AMPK alpha1 at 1 uM using AMARAASAAALARRR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	11.0	CHEMBL4045	Homo sapiens	INH	%	11.0
	19146819	CHEMBL4378973	Inhibition of recombinant full length human AMPKalpha1 at 10 uM using AMARAASAAALARRR as substrate after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	2.0	CHEMBL4045	Homo sapiens	INH	%	2.0
	19147744	CHEMBL4379140	Inhibition of human full length AMPKalpha1 recombinant using AMARAASAAALAR as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL4045	Homo sapiens	IC50	uM	10.0
	19159286	CHEMBL4382390	Binding affinity to wild-type human partial length AMPK alpha1 (M1 to E306 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	16.0	CHEMBL4045	Homo sapiens	Activity	%	16.0
	19181412	CHEMBL4387395	Inhibition of recombinant full length human PRKAA1 expressed in baculovirus expression system at 0.1 uM using CREBtide as substrate 60 mins by Lanthascreen assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	13.5	CHEMBL4045	Homo sapiens	INH	%	13.5
	19181413	CHEMBL4387395	Inhibition of recombinant full length human PRKAA1 expressed in baculovirus expression system at 0.1 uM using CREBtide as substrate 60 mins by Lanthascreen assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	10.0	CHEMBL4045	Homo sapiens	INH	%	10.0
	19191239	CHEMBL4389586	Inhibition of wild-type human partial length AMPK alpha1 (M1 to E306 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	61.0	CHEMBL4045	Homo sapiens	INH	%	61.0
	19191721	CHEMBL4389109	Inhibition of wild-type human partial length AMPK alpha1 (M1 to E306 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	6.6	CHEMBL4045	Homo sapiens	INH	%	6.6
	19200010	CHEMBL4391212	Binding affinity to wild-type human partial length AMPK alpha1 (M1 to E306 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	31.0	CHEMBL4045	Homo sapiens	Activity	%	31.0
	19242705	CHEMBL4400040	Inhibition of human full length recombinant AMPKalpha1 assessed as residual activity at 10 uM using AMARAASAAALAR as substrate incubated for 40 mins in presence of [gamma-33P]ATP at Km concentration by radiometric assay relative to control	B	COc1ccc2c(CCNc3nc(NCc4ccc(=O)[nH]c4)c4nc[nH]c4n3)c[nH]c2c1		CHEMBL4555782	=	Activity	%	97.0	CHEMBL4045	Homo sapiens	Activity	%	97.0
	19275926	CHEMBL4407929	Inhibition of recombinant full length human AMPKalpha1 at 1 uM using AMARAASAAALAR as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	40.0	CHEMBL4045	Homo sapiens	INH	%	40.0
Not Active	19296715	CHEMBL4412651	Inhibition of AMPKA1 (unknown origin) at 10 uM after 60 mins by ADP-Glo luminescence assay	B	COc1ccc(Cn2cc(C(=O)N/N=C3/C(=O)Nc4c(C)cccc43)nn2)cc1		CHEMBL4529234		Inhibition	%		CHEMBL4045	Homo sapiens	INH		
	19303763	CHEMBL4414215	Inhibition of AMPKalpha1 (unknown origin) assessed as residual activity at 50 uM relative to control	B	O=C(O)c1ccc(Nc2nc(-c3cccc([N+](=O)[O-])c3)cs2)cc1		CHEMBL4462082	=	Activity	%	71.0	CHEMBL4045	Homo sapiens	Activity	%	71.0
	22392148	CHEMBL4667243	Inhibition of PRKAA1 (unknown origin) by selectscreen kinase assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	3.0	CHEMBL4045	Homo sapiens	INH	%	3.0
	22809785	CHEMBL4713320	Inhibition of recombinant full length human AMPKalpha1 assessed as residual activity at 1 uM using AMARAASAAALAR as substrate incubated for 40 mins in presence of Km ATP by radiometric scintillation counting analysis relative to control	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1		CHEMBL4761365	=	Activity	%	52.0	CHEMBL4045	Homo sapiens	Activity	%	52.0
	22883484	CHEMBL4727569	Inhibition of PRKKA1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(N2Cc3ccccc3C2=O)n1		CHEMBL3952214	=	IC50	nM	199.53	CHEMBL4045	Homo sapiens	pIC50		6.7
	22883485	CHEMBL4727569	Inhibition of PRKKA1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)C2CCCCO2)n1		CHEMBL4759397	<	IC50	nM	19952.62	CHEMBL4045	Homo sapiens	pIC50		4.7
	22949000	CHEMBL4765727	Inhibition of human AMPKalpha1 (1 to 550 residues assessed as residual activity at 0.1 uM relative to control	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(OC)cc13)C(=O)N2		CHEMBL104519	=	Activity	%	104.0	CHEMBL4045	Homo sapiens	Activity	%	104.0
	22949001	CHEMBL4765727	Inhibition of human AMPKalpha1 (1 to 550 residues assessed as residual activity at 0.1 uM relative to control	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(O)cc13)C(=O)N2		CHEMBL4798255	=	Activity	%	103.0	CHEMBL4045	Homo sapiens	Activity	%	103.0
	22949002	CHEMBL4765727	Inhibition of human AMPKalpha1 (1 to 550 residues assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc31)cn2C		CHEMBL322153	=	Activity	%	98.0	CHEMBL4045	Homo sapiens	Activity	%	98.0
	22949003	CHEMBL4765727	Inhibition of human AMPKalpha1 (1 to 550 residues assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(S(N)(=O)=O)cc43)c2c1		CHEMBL106226	=	Activity	%	101.0	CHEMBL4045	Homo sapiens	Activity	%	101.0
	22949004	CHEMBL4765727	Inhibition of human AMPKalpha1 (1 to 550 residues assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C		CHEMBL104333	=	Activity	%	94.0	CHEMBL4045	Homo sapiens	Activity	%	94.0
	22949005	CHEMBL4765727	Inhibition of human AMPKalpha1 (1 to 550 residues assessed as residual activity at 0.1 uM relative to control	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Activity	%	83.0	CHEMBL4045	Homo sapiens	Activity	%	83.0
	22949006	CHEMBL4765728	Inhibition of human AMPKalpha1 (1 to 550 residues assessed as residual activity at 1 uM relative to control	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(OC)cc13)C(=O)N2		CHEMBL104519	=	Activity	%	88.0	CHEMBL4045	Homo sapiens	Activity	%	88.0
	22949007	CHEMBL4765728	Inhibition of human AMPKalpha1 (1 to 550 residues assessed as residual activity at 1 uM relative to control	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(O)cc13)C(=O)N2		CHEMBL4798255	=	Activity	%	87.0	CHEMBL4045	Homo sapiens	Activity	%	87.0
	22949008	CHEMBL4765728	Inhibition of human AMPKalpha1 (1 to 550 residues assessed as residual activity at 1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc31)cn2C		CHEMBL322153	=	Activity	%	91.0	CHEMBL4045	Homo sapiens	Activity	%	91.0
	22949009	CHEMBL4765728	Inhibition of human AMPKalpha1 (1 to 550 residues assessed as residual activity at 1 uM relative to control	B	COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(S(N)(=O)=O)cc43)c2c1		CHEMBL106226	=	Activity	%	72.0	CHEMBL4045	Homo sapiens	Activity	%	72.0
	22949010	CHEMBL4765728	Inhibition of human AMPKalpha1 (1 to 550 residues assessed as residual activity at 1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C		CHEMBL104333	=	Activity	%	89.0	CHEMBL4045	Homo sapiens	Activity	%	89.0
	22949011	CHEMBL4765728	Inhibition of human AMPKalpha1 (1 to 550 residues assessed as residual activity at 1 uM relative to control	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Activity	%	56.0	CHEMBL4045	Homo sapiens	Activity	%	56.0
	22952752	CHEMBL4766689	Inhibition of recombinant full length human AMPKalpha1 assessed as residual activity at 10 uM using AMARAASAAALARRR as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	96.0	CHEMBL4045	Homo sapiens	Activity	%	96.0
	22964270	CHEMBL4769103	Inhibition of recombinant human His6-tagged AMPK alpha1 using ULight CRBtide as substrate incubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET assay	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	158.0	CHEMBL4045	Homo sapiens	IC50	nM	158.0
	22964271	CHEMBL4769103	Inhibition of recombinant human His6-tagged AMPK alpha1 using ULight CRBtide as substrate incubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET assay	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NCCN		CHEMBL3542333	=	IC50	nM	393.0	CHEMBL4045	Homo sapiens	IC50	nM	393.0
	22964272	CHEMBL4769103	Inhibition of recombinant human His6-tagged AMPK alpha1 using ULight CRBtide as substrate incubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET assay	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NCCN(C)C		CHEMBL13976	=	IC50	nM	136.0	CHEMBL4045	Homo sapiens	IC50	nM	136.0
	22964273	CHEMBL4769103	Inhibition of recombinant human His6-tagged AMPK alpha1 using ULight CRBtide as substrate incubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET assay	B	CCNCCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL3542344	=	IC50	nM	180.0	CHEMBL4045	Homo sapiens	IC50	nM	180.0
	22964274	CHEMBL4769103	Inhibition of recombinant human His6-tagged AMPK alpha1 using ULight CRBtide as substrate incubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET assay	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NCCCN(C)C		CHEMBL4799580	=	IC50	nM	221.0	CHEMBL4045	Homo sapiens	IC50	nM	221.0
	22964275	CHEMBL4769103	Inhibition of recombinant human His6-tagged AMPK alpha1 using ULight CRBtide as substrate incubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET assay	B	CCN(CC)CCCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL4788980	=	IC50	nM	152.0	CHEMBL4045	Homo sapiens	IC50	nM	152.0
	22964276	CHEMBL4769103	Inhibition of recombinant human His6-tagged AMPK alpha1 using ULight CRBtide as substrate incubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET assay	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL275117	=	IC50	nM	246.0	CHEMBL4045	Homo sapiens	IC50	nM	246.0
	22964277	CHEMBL4769103	Inhibition of recombinant human His6-tagged AMPK alpha1 using ULight CRBtide as substrate incubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET assay	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3cc(F)ccc32)c1C		CHEMBL4779166	=	IC50	nM	240.0	CHEMBL4045	Homo sapiens	IC50	nM	240.0
	22964278	CHEMBL4769103	Inhibition of recombinant human His6-tagged AMPK alpha1 using ULight CRBtide as substrate incubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET assay	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3cc(Cl)ccc32)c1C		CHEMBL4786972	=	IC50	nM	217.0	CHEMBL4045	Homo sapiens	IC50	nM	217.0
	22964279	CHEMBL4769103	Inhibition of recombinant human His6-tagged AMPK alpha1 using ULight CRBtide as substrate incubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET assay	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3cc(Br)ccc32)c1C		CHEMBL4782796	=	IC50	nM	208.0	CHEMBL4045	Homo sapiens	IC50	nM	208.0
	22964280	CHEMBL4769103	Inhibition of recombinant human His6-tagged AMPK alpha1 using ULight CRBtide as substrate incubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET assay	B	CCc1ccc2c(c1)NC(=O)/C2=C\c1[nH]c(C)c(C(=O)NCCN(CC)CC)c1C		CHEMBL4785831	=	IC50	nM	348.0	CHEMBL4045	Homo sapiens	IC50	nM	348.0
	22964281	CHEMBL4769103	Inhibition of recombinant human His6-tagged AMPK alpha1 using ULight CRBtide as substrate incubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET assay	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(C#N)cc32)c1C		CHEMBL4794096	=	IC50	nM	93.0	CHEMBL4045	Homo sapiens	IC50	nM	93.0
	22964282	CHEMBL4769103	Inhibition of recombinant human His6-tagged AMPK alpha1 using ULight CRBtide as substrate incubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET assay	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(CNC(N)=O)cc32)c1C		CHEMBL4792246	=	IC50	nM	205.0	CHEMBL4045	Homo sapiens	IC50	nM	205.0
	22964283	CHEMBL4769103	Inhibition of recombinant human His6-tagged AMPK alpha1 using ULight CRBtide as substrate incubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET assay	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(CCOC)cc32)c1C		CHEMBL4781062	=	IC50	nM	296.0	CHEMBL4045	Homo sapiens	IC50	nM	296.0
	22964284	CHEMBL4769103	Inhibition of recombinant human His6-tagged AMPK alpha1 using ULight CRBtide as substrate incubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET assay	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(CCOC(C)=O)cc32)c1C		CHEMBL4799631	=	IC50	nM	418.0	CHEMBL4045	Homo sapiens	IC50	nM	418.0
	22964285	CHEMBL4769103	Inhibition of recombinant human His6-tagged AMPK alpha1 using ULight CRBtide as substrate incubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET assay	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(CCO)cc32)c1C		CHEMBL4800500	=	IC50	nM	173.0	CHEMBL4045	Homo sapiens	IC50	nM	173.0
	22964286	CHEMBL4769103	Inhibition of recombinant human His6-tagged AMPK alpha1 using ULight CRBtide as substrate incubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET assay	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(CCC#N)cc32)c1C		CHEMBL4788376	=	IC50	nM	164.0	CHEMBL4045	Homo sapiens	IC50	nM	164.0
	22964287	CHEMBL4769103	Inhibition of recombinant human His6-tagged AMPK alpha1 using ULight CRBtide as substrate incubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET assay	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(CCC(N)=O)cc32)c1C		CHEMBL4781578	=	IC50	nM	107.0	CHEMBL4045	Homo sapiens	IC50	nM	107.0
	22964288	CHEMBL4769103	Inhibition of recombinant human His6-tagged AMPK alpha1 using ULight CRBtide as substrate incubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET assay	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(CCN(C)C)cc32)c1C		CHEMBL4779730	=	IC50	nM	2100.0	CHEMBL4045	Homo sapiens	IC50	nM	2100.0
	22964289	CHEMBL4769103	Inhibition of recombinant human His6-tagged AMPK alpha1 using ULight CRBtide as substrate incubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET assay	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(CCNC(C)=O)cc32)c1C		CHEMBL4795330	=	IC50	nM	184.0	CHEMBL4045	Homo sapiens	IC50	nM	184.0
	22964290	CHEMBL4769103	Inhibition of recombinant human His6-tagged AMPK alpha1 using ULight CRBtide as substrate incubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET assay	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(CCN=[N+]=[N-])cc32)c1C		CHEMBL4796639	=	IC50	nM	139.0	CHEMBL4045	Homo sapiens	IC50	nM	139.0
	22964291	CHEMBL4769104	Inhibition of recombinant human His6-tagged AMPK alpha1 at 20 uM using ULight CRBtide as substrate incubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET assay relative to control	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)O		CHEMBL1778707	=	Inhibition	%	78.0	CHEMBL4045	Homo sapiens	INH	%	78.0
	22964292	CHEMBL4769104	Inhibition of recombinant human His6-tagged AMPK alpha1 at 20 uM using ULight CRBtide as substrate incubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET assay relative to control	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)N(C)c3ccc(F)cc32)c1C		CHEMBL4799798	=	Inhibition	%	40.0	CHEMBL4045	Homo sapiens	INH	%	40.0
	22964293	CHEMBL4769104	Inhibition of recombinant human His6-tagged AMPK alpha1 at 20 uM using ULight CRBtide as substrate incubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET assay relative to control	B	CCCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL4795455	=	Inhibition	%	30.0	CHEMBL4045	Homo sapiens	INH	%	30.0
	22964294	CHEMBL4769104	Inhibition of recombinant human His6-tagged AMPK alpha1 at 20 uM using ULight CRBtide as substrate incubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET assay relative to control	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3cc(Br)ccc32)c1C		CHEMBL4782796	=	Inhibition	%	89.0	CHEMBL4045	Homo sapiens	INH	%	89.0
	22964295	CHEMBL4769104	Inhibition of recombinant human His6-tagged AMPK alpha1 at 20 uM using ULight CRBtide as substrate incubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET assay relative to control	B	CCc1ccc2c(c1)NC(=O)/C2=C\c1[nH]c(C)c(C(=O)NCCN(CC)CC)c1C		CHEMBL4785831	=	Inhibition	%	70.0	CHEMBL4045	Homo sapiens	INH	%	70.0
	22964380	CHEMBL4769119	Inhibition of wild-type human partial length AMPK alpha1 (M1 to E306 residues) expressed in bacterial expression system at 100 nM by Kinomescan method relative to control	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Inhibition	%	50.0	CHEMBL4045	Homo sapiens	INH	%	50.0
	22964381	CHEMBL4769119	Inhibition of wild-type human partial length AMPK alpha1 (M1 to E306 residues) expressed in bacterial expression system at 100 nM by Kinomescan method relative to control	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(CCO)cc32)c1C		CHEMBL4800500	=	Inhibition	%	49.0	CHEMBL4045	Homo sapiens	INH	%	49.0
	22964382	CHEMBL4769119	Inhibition of wild-type human partial length AMPK alpha1 (M1 to E306 residues) expressed in bacterial expression system at 100 nM by Kinomescan method relative to control	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(CCC(N)=O)cc32)c1C		CHEMBL4781578	=	Inhibition	%	29.0	CHEMBL4045	Homo sapiens	INH	%	29.0
	23120166	CHEMBL4804341	Inhibition of AMPKa1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	1800.0	CHEMBL4045	Homo sapiens	IC50	uM	1.8
	23120167	CHEMBL4804341	Inhibition of AMPKa1 in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1	Outside typical range	CHEMBL4860979	=	IC50	nM	-1600.0	CHEMBL4045	Homo sapiens	IC50	uM	-1.6
	23120168	CHEMBL4804341	Inhibition of AMPKa1 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1	Outside typical range	CHEMBL4867931	=	IC50	nM	-8200.0	CHEMBL4045	Homo sapiens	IC50	uM	-8.2
	23120169	CHEMBL4804341	Inhibition of AMPKa1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	20500.0	CHEMBL4045	Homo sapiens	IC50	uM	20.5
	23120170	CHEMBL4804341	Inhibition of AMPKa1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	39000.0	CHEMBL4045	Homo sapiens	IC50	uM	39.0
	23120171	CHEMBL4804341	Inhibition of AMPKa1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	52000.0	CHEMBL4045	Homo sapiens	IC50	uM	52.0
	23121211	CHEMBL4804523	Inhibition of AMPKa1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL4045	Homo sapiens	INH	%	0.0
	23121212	CHEMBL4804523	Inhibition of AMPKa1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL4045	Homo sapiens	INH	%	0.0
	23121213	CHEMBL4804523	Inhibition of AMPKa1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL4045	Homo sapiens	INH	%	0.0
	23121214	CHEMBL4804523	Inhibition of AMPKa1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL4045	Homo sapiens	INH	%	0.0
	23121215	CHEMBL4804523	Inhibition of AMPKa1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	35.0	CHEMBL4045	Homo sapiens	INH	%	35.0
	23121216	CHEMBL4804523	Inhibition of AMPKa1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	50.0	CHEMBL4045	Homo sapiens	INH	%	50.0
	23122444	CHEMBL4804795	Inhibition of human AMPK-alpha1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	94.0	CHEMBL4045	Homo sapiens	Activity	%	94.0
	23123139	CHEMBL4805383	Inhibition of human AMPK-alpha1 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	92.0	CHEMBL4045	Homo sapiens	Activity	%	92.0
	23123748	CHEMBL4805992	Inhibition of DNA-tagged human AMPK-alpha1 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL4045	Homo sapiens	Activity	%	100.0
	23124368	CHEMBL4806400	Inhibition of human AMPK-alpha1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL4045	Homo sapiens	Activity	%	100.0
	23124369	CHEMBL4806400	Inhibition of human AMPK-alpha1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL4045	Homo sapiens	Activity	%	100.0
	23127813	CHEMBL4807746	Inhibition of AMPKalpha1 ((1 to 550) (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL4045	Homo sapiens	Activity	%	75.0
	23127814	CHEMBL4807746	Inhibition of AMPKalpha1 ((1 to 550) (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL4045	Homo sapiens	Activity	%	75.0
	23127815	CHEMBL4807746	Inhibition of AMPKalpha1 ((1 to 550) (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL4045	Homo sapiens	Activity	%	75.0
Not Active	23317279	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	99.0	CHEMBL4045	Homo sapiens	% Control	%	99.0
Not Active	23317747	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	73.0	CHEMBL4045	Homo sapiens	% Control	%	73.0
Not Active	23318421	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	99.0	CHEMBL4045	Homo sapiens	% Control	%	99.0
Not Active	23318897	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23319537	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23320009	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	96.7	CHEMBL4045	Homo sapiens	% Control	%	96.7
Not Active	23320687	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23321155	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	83.0	CHEMBL4045	Homo sapiens	% Control	%	83.0
Not Active	23321785	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23322253	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	96.0	CHEMBL4045	Homo sapiens	% Control	%	96.0
Not Active	23322942	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	80.0	CHEMBL4045	Homo sapiens	% Control	%	80.0
Not Active	23323410	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23324264	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23324899	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23325367	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23326014	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	71.0	CHEMBL4045	Homo sapiens	% Control	%	71.0
Not Active	23326482	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	80.0	CHEMBL4045	Homo sapiens	% Control	%	80.0
Slightly Active	23327182	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	39.0	CHEMBL4045	Homo sapiens	% Control	%	39.0
Not Active	23327650	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	97.0	CHEMBL4045	Homo sapiens	% Control	%	97.0
Not Active	23328237	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	86.0	CHEMBL4045	Homo sapiens	% Control	%	86.0
Not Active	23328705	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23329246	CHEMBL4880953	AMPK1(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	101.0	CHEMBL4045	Homo sapiens	% residual kinase activity	%	101.0
Not Active	23329651	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	87.0	CHEMBL4045	Homo sapiens	% Control	%	87.0
Not Active	23330119	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	98.0	CHEMBL4045	Homo sapiens	% Control	%	98.0
Not Active	23330875	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23331343	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23331930	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	77.0	CHEMBL4045	Homo sapiens	% Control	%	77.0
Not Active	23332398	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23333114	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	85.4	CHEMBL4045	Homo sapiens	% Control	%	85.4
Not Active	23333753	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23334221	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	93.0	CHEMBL4045	Homo sapiens	% Control	%	93.0
Not Active	23335200	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23335668	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23336295	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23336763	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	92.0	CHEMBL4045	Homo sapiens	% Control	%	92.0
Not Active	23337844	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	95.0	CHEMBL4045	Homo sapiens	% Control	%	95.0
Not Active	23338312	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	98.0	CHEMBL4045	Homo sapiens	% Control	%	98.0
Not Active	23338924	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23339392	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23340029	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	99.0	CHEMBL4045	Homo sapiens	% Control	%	99.0
Not Active	23340497	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23341154	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	97.0	CHEMBL4045	Homo sapiens	% Control	%	97.0
Not Active	23341622	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23342238	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	99.0	CHEMBL4045	Homo sapiens	% Control	%	99.0
Not Active	23342706	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	91.0	CHEMBL4045	Homo sapiens	% Control	%	91.0
Not Active	23343336	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23343804	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	81.0	CHEMBL4045	Homo sapiens	% Control	%	81.0
Not Active	23344442	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23345015	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23345483	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23346060	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23346529	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	77.6	CHEMBL4045	Homo sapiens	% Control	%	77.6
Not Active	23347139	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	91.0	CHEMBL4045	Homo sapiens	% Control	%	91.0
Not Active	23347620	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23348199	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23348667	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23349254	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23349872	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23350340	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23350945	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23351413	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	85.0	CHEMBL4045	Homo sapiens	% Control	%	85.0
Not Active	23352437	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	86.0	CHEMBL4045	Homo sapiens	% Control	%	86.0
Not Active	23352905	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	93.0	CHEMBL4045	Homo sapiens	% Control	%	93.0
Not Active	23353787	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23354255	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	98.0	CHEMBL4045	Homo sapiens	% Control	%	98.0
Not Active	23354987	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23355455	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23356091	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23356559	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23357168	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23357815	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	88.0	CHEMBL4045	Homo sapiens	% Control	%	88.0
Not Active	23358283	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23358869	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	70.3	CHEMBL4045	Homo sapiens	% Control	%	70.3
Not Active	23359467	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	92.0	CHEMBL4045	Homo sapiens	% Control	%	92.0
Not Active	23359935	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23360520	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	98.0	CHEMBL4045	Homo sapiens	% Control	%	98.0
Not Active	23360988	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23361561	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	89.0	CHEMBL4045	Homo sapiens	% Control	%	89.0
Not Active	23362097	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23362565	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23364207	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	73.0	CHEMBL4045	Homo sapiens	% Control	%	73.0
Not Active	23364675	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	84.0	CHEMBL4045	Homo sapiens	% Control	%	84.0
Not Active	23365414	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23365957	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	82.0	CHEMBL4045	Homo sapiens	% Control	%	82.0
Not Active	23366547	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23367015	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23367471	CHEMBL4883824	AMPK-alpha1 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	84.0	CHEMBL4045	Homo sapiens	% Residual activity with Skepinone-L	%	84.0
Not Active	23367893	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	88.0	CHEMBL4045	Homo sapiens	% Control	%	88.0
Not Active	23368361	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	96.0	CHEMBL4045	Homo sapiens	% Control	%	96.0
Not Active	23368960	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23369428	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23369971	CHEMBL4884218	AMPKalpha1(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	1.0	CHEMBL4045	Homo sapiens	% residual kinase activity	%	1.0
	23369972	CHEMBL4884218	AMPKalpha1(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		IC50	nM	10.0	CHEMBL4045	Homo sapiens	IC50	nM	10.0
Active	23370342	CHEMBL4884203	Biochemical PRKAA1 assay with 10 M ATP (Bayer in house)	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		IC50	nM	1.4	CHEMBL4045	Homo sapiens	IC50	nM	1.4
Active	23370343	CHEMBL4884204	Biochemical PRKAA1 assay with  2 mM ATP (Bayer in house)	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		IC50	nM	15.0	CHEMBL4045	Homo sapiens	IC50	nM	15.0
Active	23370344	CHEMBL4884205	Eurofins kinase panel (PRKAA1)	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		IC50	nM	7.0	CHEMBL4045	Homo sapiens	IC50	nM	7.0
	23370346	CHEMBL4884207	Cellular mechanistic pACC assay using IMR-32 neuroblastoma cells	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		IC50	nM	150.0	CHEMBL4045	Homo sapiens	IC50	nM	150.0
	23370347	CHEMBL4884208	Cellular mechanistic pACC assay using Colo-320 cells	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		IC50	nM	390.0	CHEMBL4045	Homo sapiens	IC50	nM	390.0
Not Active	23370355	CHEMBL4884203	Biochemical PRKAA1 assay with 10 M ATP (Bayer in house)	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1	Non standard unit for type	CHEMBL4630642	>	IC50	M	20.0	CHEMBL4045	Homo sapiens	IC50	M	20.0
Not Active	23370356	CHEMBL4884204	Biochemical PRKAA1 assay with  2 mM ATP (Bayer in house)	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1	Non standard unit for type	CHEMBL4630642	>	IC50	M	20.0	CHEMBL4045	Homo sapiens	IC50	M	20.0
Not Active	23370357	CHEMBL4884207	Cellular mechanistic pACC assay using IMR-32 neuroblastoma cells	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1	Non standard unit for type	CHEMBL4630642	>	IC50	M	30.0	CHEMBL4045	Homo sapiens	IC50	M	30.0
Not Active	23370358	CHEMBL4884208	Cellular mechanistic pACC assay using Colo-320 cells	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1	Non standard unit for type	CHEMBL4630642	>	IC50	M	30.0	CHEMBL4045	Homo sapiens	IC50	M	30.0
Active	23370396	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	7.5	CHEMBL4045	Homo sapiens	% Control	%	7.5
Not Active	23370864	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	77.0	CHEMBL4045	Homo sapiens	% Control	%	77.0
Not Active	23371673	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23372141	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
	23372854	CHEMBL4884819	AMPKalpha1(PRA1PGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL4045	Homo sapiens	pIC50		6.0
	23373263	CHEMBL4885110	AMPKalpha1(PRA1PGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL4045	Homo sapiens	pIC50		6.0
	23373619	CHEMBL4885396	AMPKalpha1(PRA1PGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL4045	Homo sapiens	pIC50		6.0
Not Active	23375083	CHEMBL4886071	PRKAA1 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	5.5	CHEMBL4045	Homo sapiens	% Inhibition	%	5.5
Not Active	23375355	CHEMBL4886337	protein kinase, AMP-activated, alpha 1 catalytic subunit Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1	Outside typical range	CHEMBL2180408		Inhibition	%	-11.0	CHEMBL4045	Homo sapiens	% inhibition	%	-11.0
Not Active	23375568	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23376036	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23376614	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23377083	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23377941	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23378409	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	91.0	CHEMBL4045	Homo sapiens	% Control	%	91.0
Not Active	23379576	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23380044	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23380738	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23381386	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23381854	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL4045	Homo sapiens	% Control	%	100.0
Not Active	23382478	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	84.0	CHEMBL4045	Homo sapiens	% Control	%	84.0
Not Active	23382946	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	80.0	CHEMBL4045	Homo sapiens	% Control	%	80.0
Not Active	23384177	CHEMBL4887772	AMPKalpha1(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	-1.91	CHEMBL4045	Homo sapiens	% inhibition	%	-1.91
Not Active	23384861	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	99.0	CHEMBL4045	Homo sapiens	% Control	%	99.0
Not Active	23385328	CHEMBL4879585	KinomeScan assay: inhibition of AMPK-alpha1	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	92.0	CHEMBL4045	Homo sapiens	% Control	%	92.0
